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ABSTRACT
Benito González, Ana. Ph.D., Biomedical Sciences Program, Wright State University,
2011. V1-derived Renshaw Cells and Ia Inhibitory Interneurons Differentiate Early
During Embryonic Development.

Locomotor development is dependent on the maturation of spinal cord circuits
controlling motor output, but little is known about the development of the spinal
interneurons that control motoneuron activity. This study focused on the development
of Renshaw cells (RCs) and Ia inhibitory interneurons (IaINs), which mediate recurrent
and reciprocal inhibition, respectively, two basic inhibitory circuits for motorneuron
control. Both interneurons originate from the same progenitor pool (p1) giving rise to
ventral spinal embryonic interneurons denominated V1. V1-derived interneurons (V1INs) establish local inhibitory connections with ipsilateral motoneurons and express the
transcription factor engrailed-1. This characteristic permitted the generation of
transgenic mice that were used in this study to genetically label V1 interneuron lineages
from embryo to adult. Adult V1-derived Renshaw cells and IaINs share some similar
properties, both being inhibitory and establishing ipsilateral connections; but differ in
morphology, location in relation to motor pools, expression of calcium binding proteins
(calbindin vs. parvabumin), synaptic connectivity and function. These differences are
already present in neonates, therefore the purpose of this study was to determine
possible embryonic differentiation mechanisms.

Using 5‟-bromodeoxyuridine birth-dating we demonstrated that V1-INs can be
divided into early and late born groups. The early group quickly upregulates calbindin
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expression and includes the Renshaw cells, which maintain calbindin expression
through life. The second group includes many cells that postnatally upregulate
parvalbumin, including IaINs. This later born group is characterized by upregulation of
the transcription factor FoxP2 as they start to differentiate and is retained up to the first
postnatal week in many V1-derived IaINs. In contrast, Renshaw cells express the
transcription factor MafB that seems relatively specific to them within the V1-INs.
Furthermore, Renshaw cells appear attracted to the ventral root exit region and follow a
unique migratory route to become specifically placed at this location. In contrast, other
V1 interneurons settle more medially and far from the ventral root exit region. MafB
expression is upregulated in Renshaw cells only after they have reached their final
position among motor axons. Therefore, the specific migration of Renshaw cells might
be responsible for their final differentiation and unique relationship with motor axons in
adult.
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I. INTRODUCTION

Higher primates, including humans, lack locomotor skills at birth. This is
contrary to other mammals, such as elephants and giraffes that quickly develop their
body position, posture and ability to walk around the time of birth. It is therefore
tempting to speculate that development of motor circuits in humans occurs postnatally
through activity-dependent refinement mechanisms. Nevertheless, basic circuits of the
spinal motor system seem preformed in embryo in all species. For example, recurrent
and reciprocal inhibition, two fundamental circuits of motor control and that are the
focus of this study, are present in newborn babies (Mc Donough et al., 2001). Although
they also undergo significant postnatal maturation their presence at birth implies earlier
specification of the basic elements that create these circuits. As will be explained
below, motor circuit development is in fact not too different in species that start to walk
at birth or days, weeks or months after birth. In both cases basic motor circuit elements
likely develop in embryo through activity-independent mechanisms. This of course
does not exclude posterior functional refinement of the preformed circuits.
Species with different onsets of walking after birth are categorized as altricial or
precocial. Altricial refers to species that "require nourishment", meaning they are not
able to walk at birth, while precocial are species that can walk at, or just after, birth.
The significance of these differences has been discussed for many years. Recent data
however suggest that motor system development is in fact a functional continuum
among all species (Garwicz et al., 2009), and that there are no qualitative differences.
The key is to measure onset of locomotion since conception and not from birth and
1

correct this for brain size. In this case brain size and time for full brain development
emerge as the main factors that determine the onset of walking (Garwicz et al., 2009).
Natural selection will tend to favor rapid development, especially during early stages
associated with high mortality. Thus, a long postnatal period until motor maturity must
be considered the price paid by some other evolutionary more advantageous feature,
such as early birth or a larger more complex brain. Differences in postnatal maturation
might not imply, however, major differences in the ealier process of basic motor circuit
assembly.
Interestingly, some factors were identified that might delay the onset of walking
(Garwicz et al., 2009). The most important one was adopting the plantigrade position
characteristic of humans and rodents, and frequently associated with manipulative
capacity in the upper extremities or forelimbs. In this sense, animals like ungulates and
carnivores with simplified extremities adapted for fast locomotion might accelerate
motor system development by losing circuit components that allow finer control of
movement. In any case, the conclusions from Garwicz and colleagues imply that the
major developmental milestones for the assembly of basic locomotor motor circuits are
conserved in most mammalian species (altricial or precocial) and occur in embryo or
postnatally (depending of time of birth and brain size). But in both cases it could be
expected that they are similar processes, and thus, likely independent of activitydependent refinement. In this thesis we will investigate early embryonic mechanisms
for the assembly of key elements of inhibitory spinal motor circuits. These circuits are
present at birth and later undergo postnatal maturation (Mc Donough et al., 2001).
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Locomotion, as many behaviors fundamental to animal life, such as breathing,
and chewing, are rhythmic activities controlled by neuronal networks located in
different parts of the central nervous system. The central nervous system hierarchically
controls movement, involving different structures, such as cortex, brainstem, spinal
cord, cerebellum and basal ganglia. Each component provides different motor control
features. The basic rhythmicity and patterning for stepping and other locomotion
behaviors is produced by neuronal circuits contained entirely within the spinal cord.
Little is known about how spinal cord circuits develop and how different types of
neurons are generated, specified and incorporate themselves into these circuits.
Understanding how and when cell specialization occurs and what factors are involved
in the differentiation process are key for understanding the maturation of motor control
and the abnormalities and dysfunctions originated during early development.
Within spinal cord circuits two types of neurons need to mature: motoneurons
and interneurons (INs). Motoneurons generate the motor output to the muscle, while
INs establish local circuits that control the activity of motoneurons. Past research has
focused on motoneuron development (Jessell, 2000), recently, interest has turned to
spinal cord INs. A major breakthrough was the finding that all adult spinal INs develop
from a few embryonic subclasses; six dorsal (dl1, dl2, dl3, dl4, dl5, and dl6) and four
ventral (V0, V1, V2, and V3), each derived from a progenitor domain located in a
different dorso-ventral region of the proliferative neuroepithelium in the early neural
tube (Goulding, 2009).
This study is concerned with the diversification of two subtypes of inhibitory
INs, Renshaw cells (RCs) and Ia inhibitory interneurons (IaINs) from the V1
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embryonic group. Renshaw cells and IaINs have different functional roles and
connections in the adult. Renshaw cells are activated by inputs from motor axons and
mediate recurrent inhibition by inhibiting homonymous and synergistic motoneurons
(Eccles et al., 1954). IaINs receive inputs from Ia proprioceptive afferents and mediate
reciprocal inhibition by inhibiting motoneurons in motor pools innervating muscles that
are antagonists of the muscle of origin of the Ia afferent (Eccles et al., 1956).
These different INs express very different phenotypes not only in the adult but
also in neonates. These include different connections, location and expression of
calcium binding proteins (Alvarez et al., 2005; Siembab et al., 2010). Their advanced
phenotypic differentiation in the newborn implies an earlier embryological program for
their differentiation. Thus, the purpose of this study was to determine when these two
groups of V1-derived INs start to differentiate from each other in embryo and generate
some plausible hypothesis about their mechanisms of differentiation. We investigated
the times at which these two types of V1-INs are generated (“birthdate”) and start their
differentiation, what transcription factors are specific to them and could direct their
differentiation, and finally we analyzed their early migration pathways to provide some
explanations for their different relationship with motor axons.

4

II. BACKGROUND
The main goal of this thesis is to better understand the development of
interneurons (INs) in the motor circuits of the spinal cord ventral horn. Interneurons
control motoneuron firing during locomotion and convey sensory feedback information
to modulate the motor output; they also relay the descending commands that exert
voluntary control of motor behaviors.

Overview of motor system and its development
The motor system is involved in the control and generation of voluntary and
reflex movements. In order to do this, the motor system integrates motor commands
generated in the central nervous system with ongoing sensory information to control the
complex mechanical machinery of the musculoskeletal system. This is achieved by
coordinating three levels of motor control: the spinal cord, the descending systems of
the brainstem, and the interconnected motor areas of the cerebral cortex, cerebellum
and basal ganglia. These different components are organized hierarchically and in
parallel. The hierarchical organization enables higher centers to give relatively general
commands without having to specify the details of the motor action. By means of their
parallel organization the higher centers of the motor system can issue commands that
can act directly on the spinal cord, the lowest level of the chain, or can affect spinal
circuits indirectly through other parallel descending systems. For example, the
corticospinal tract controls spinal circuit indirectly through motor pathways originated
in brainstem nuclei (for example, rubrospinal and pontine and medullary reticulospinal
projections) but, it also controls, directly, spinal INs and in some cases the
5

motoneurons. Direct monosynaptic corticospinal influence on spinal motoneurons is
largely restricted to upper limb musculature involved in fine manipulation in human
and non-human primates (Kuypers, 1962, 1964; Porter and Lemon, 1993). Initially,
each of these areas develops independently and later become interconnected.
Descending system connections with the spinal cord is the last step in the maturation of
the motor system and is mostly a postnatal process manifested behaviorally mainly in
the increased postural control with age of pups and babies (reviewed in Altman and
Bayer, 2001; Vinay et al., 2005). The arrival of descending systems into the spinal cord
has been proposed to result in the reorganization of spinal segmental systems (reviewed
in Clowry, 2007), but initially the spinal cord circuits that control motor output develop
in isolation. Self-organization of basic circuitry capable of generating patterned motor
output is manifested in the isolated embryonic and neonatal spinal cord, which is
capable of generating rhythmic motor output that resembles locomotion in that there is
alternation between flexors and extensors and contralateral sides of the spinal cord
(Smith and Feldman, 1987; reviewed in Whelan, 2003; Vinay et al., 2002; Clarac et al.,
2004a, b).
The spinal cord is responsible for generating complex spatiotemporal patterns of
motor output that result in organized muscle activation during reflexes and rhythmic
motor patterns, such as locomotion. The spinal cord contains all necessary circuits to
mediate a variety of automatic and stereotyped reflexes and also locomotion. At the
beginning of the past century, Sherrington demonstrated that virtually all reflexes
involve the integrated activation and inhibition of activity in different muscle groups,
and these continue to function even if the cord is disconnected from the brain
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(Sherrington, 1910). He suggested that many of these actions are coordinated by spinal
INs. Ultimately, all interneuronal controls converge on the motoneurons that innervate
the skeletal muscles. To stress the importance of this convergence, Sherrington called
the motoneurons the final common path (Sherrington, 1947). Almost simultaneously,
Graham-Brown demonstrated that rhythmic locomotion can also be elicited in
spinalized cats that are positioned on a moving treadmill with or without sensory
afferents (Graham-Brown, 1911) and this lead to the proposition of spinal “centers” that
are interconnected in such a manner as to produce alternating stepping movements
(Graham-Brown, 1916). Nowadays, these spinal centers are called central pattern
generators (CPGs) and are believed to generate and control the basic rhythmicity and
pattern of motoneuron output during locomotion (Kiehn, 2006; Brownstone and Bui,
2010). Both, reflexes and CPGs, rely on local circuits formed by a large number of
spinal INs. Historically the naming of spinal INs involved in reflex pathways occurred
first (i.e., Ia inhibitory INs involved in reciprocal inhibition during monosynpatic
stretch reflexes, and others like Ib/Ia inhibitory INs, group II INs… etc; Jankowska,
1992). However, spinal INs are functionally versatile and the same interneuron can be
recruited by reflex pathways, descending systems and the spinal CPG to modulate
motoneuron activity (reviewed in Jankowska, 2001; McCrea, 2001). These basic
networks of INs are believed to outline the general principles of organization and
function in the vertebrate locomotor system. Unfortunately many elements of these
circuits are still unknown, for example the basic cellular components of the rhythmic
core have not yet been characterized. A developmental perspective that focuses on their
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initial development and wiring might generate important information not only about
their origins but also about their basic organization.

Basic organization of the spinal cord and its development
Rostro-caudal regions of the spinal cord
The spinal cord is the part of the central nervous system that extends caudal to
the medulla and is located within the vertebral column. It is longitudinally divided into
cervical, thoracic, lumbar, and sacral segments (Fig.1). Each region controls the
musculoskeletal system of a different part of the body. The cervical region controls the
neck muscles, respiration and upper arms, the thoracic region the axial musculature, the
lumbar region controls the hip and lower limbs and finally the sacral region controls
several visceral sphincters (i.e., bladder) and the tail. As a result there is diversity in the
motor pools located in each region, each controlled by different types of descending
systems and interneuronal circuits.
Most of our studies are mainly focused on the ventral horn of the lumbar area,
where the motor control of the lower limbs is organized. The lumbar spinal cord is
divided into 5 segments in humans and 6 in mice. These can be grouped in lower
lumbar segments (L4 through L6) that are biased towards extensor muscles and upper
lumbar segments (L1 to L3) which are biased towards flexor muscles (Fig.1). There are
also important differences in their capacity for rhythmic locomotion and usually upper
lumbar segments are considered to be more excitable and readily available to start
rhythmic motor output than lower segments (Kiehn, 2006; Bonnot and Morin, 1998;
Bonnot, et al., 2002). Another difference is that upper lumbar segments contain the
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Figure 1. Spinal column segmental divisions. Lumbar levels are further classified in
upper lumbar (L1 and L2) biased towards flexor muscles and lower lumbar (L4 and L5)
biased towards extensor muscles. Modified from Molander et al., 1984.

9

10

intermediolateral column of visceral motoneurons (preganglionic sympathetic neurons)
that is continuous with thoracic segments and has its own independent control. These
differences imply that the INs and circuits controlling motor output are not necessarily
identical in upper and lower lumbar segments.
Lumbar development lags slightly behind cervical development. Neurogenesis
and differentiation begins rostrally and progresses caudally in both rodents and humans.
In the rat, most cervical motoneurons are generated between embryonic day 11 (E11)
and E12 while most lumbar motoneurons appear between E12 and E13 (Barber et al.,
1991; Altman and Bayer, 1974; note that in the mouse similar developmental stages are
reached 24-36 hours earlier, see later). The same rostrocaudal pattern of cell generation
was noted in dorsal root ganglion (DRG) neurons (at cervical levels most cells are
generated at E11.5 and at E12.5 at lumbar levels; Lawson and Biscoe, 1979). Later,
there is also a rostrocaudal progression in the functional maturation of locomotion due
to the earlier development of descending connections in the cervical region compared
to lumbar. For example, a report from Clarac et al. (1998) explains the early bias in
neonatal rodents towards favoring forelimbs for initial crawling as a result of the lack
of enough postural tonus provided by descending systems in the lumbar region
controlling the hindlimbs. Nevertheless, both cervical and lumbar spinal cord have
functional CPGs at birth and each can drive robust locomotion-like activity in both
regions and also interact between them (Ballion et al., 2001; Gordon et al., 2008). Thus,
neonatal rodents and humans can display coordinated locomotor activity between
cervical and lumbar regions in situations in which weight-bearing postural control is
not necessary, for example during air-stepping and swimming. In summary, there could
11

be developmental differences in between different rostrocaudal regions because of
differences in motor pool composition and also because the existence of rostrocaudal
gradients in neurogenesis and functional maturation.

Dorso-ventral organization of the spinal cord.
Besides rostro-caudal differences, the spinal cord is also organized dorsoventrally. Transversally, the spinal cord is divided in all segments into two halves: the
dorsal and ventral horns. The dorsal horn receives sensory inputs through the dorsal
root and most dorsal horn neurons are functionally involved in the relay of cutaneous
sensory information to higher centers in the brain or integrating proprioceptive or
cutaneous input to be sent to the ventral horn (Fig.2). The ventral horn contains the
motoneurons and all the INs that control their activity (Fig.2 and 3). Motor output is
transmitted through the motor axons that exit through the ventral roots. Dorsal and
ventral horns are divided in different laminae based on the size, morphology and
density of neurons. Rexed (1952, 1954), divided the gray matter of the cat spinal cord
into nine layers or laminae and a tenth region around the central canal. The ventral horn
consists of laminae VI to IX. Lamina IX is defined as the region containing the motor
pools; lamina VIII occupies the medial ventral horn and contains many large INs which
send projections to the contralateral side of the spinal cord. The remainder of the
ventral horn is defined as lamina VII and contains medium to small size INs, many of
which are believed to form part of motor circuits. Finally, lamina VI is an ill-defined
region between the ventral-most dorsal horn lamina V and lamina VII. This lamina
occurs only in the cervical and lumbar enlargements, the regions that control the
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Figure 2. Basic structure and organization of the spinal cord. Top, shows a diagram
of the spinal cord in cross-section. Bottom, low magnification confocal image of a P40
mouse spinal cord transverse section immunostained for NeuN (red). This section
corresponds to the lumbar 4 segment. NeuN is a neuronal marker of differentiated
neurons. Neurons are contained within the gray matter (the core of the spinal cord) and
are surrounded by white matter (unstained). The central canal is what remains from the
original ventricle in the neural tube and is in the center of the spinal cord. The dotted
line separates the gray matter from the outside white matter. The white matter contains
all the axons from ascending, descending and propriospinal systems. Neuronal density
is higher in the dorsal horn than in the ventral horn. The ventral horn is divided in
basically three laminae: lamina IX containing the large NeuN-IR cell bodies of
motoneurons; lamina VIII contains relatively large interneurons most of which are
known to project to the contralateral side of the cord; lamina VII contains most of the
interneurons that control the function of ipsilateral motoneurons.
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Figure 3. Distribution of NeuN-immunoreactive and choline acetyltranferaseimmunoreactive neurons in spinal cord sections from lower thoracic to lower
lumbar segments of the mouse spinal cord at postnatal day 15 (P15). Low
magnification confocal images of spinal cord sections 50 μm thick. Motoneurons are
labeled in lamina IX, using an antibody against Choline Acetyltransferase (left column,
green neurons at the bottom of the section). All motoneurons and interneurons are
labeled in red, using and antibody against NeuN that labels differentiated neurons (right
column). A and B) Thoracic level; C and D) Lumbar 2; E and F) Lumbar 3; G and H)
Lumbar 5; I and J) Lumbar 6. Note the different organization and cell numbers of
motoneuron groups at different segmental levels.
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extremities (Rexed, 1952 in cat; Molander et al., 1984; Molander et al., 1989 in
rodents).
It has been known since the time of Cajal (Cajal, 1995) that at any particular
spinal cord segment, neurogenesis always starts ventrally with the motoneurons and
then proceeds dorsally generating different types of INs. Embryological studies
pioneered by His (1886, reviewed in Altman and Bayer, 2001) distinguished between
an alar and a basal plate based on the presence of an invagination in the ventricle,
known as sulcus limitans. The alar plate gives rise to the dorsal horn and the basal plate
to the ventral horn (Fig.4). The idea that motoneurons were generated ventrally from
ventral progenitors and earlier than alar plate cells was based on the early thinning of
the ventral progenitor area and the simultaneous appearance of differentiating
motoneurons with motor axons in the ventral root before INs could be detected in the
alar plate (Cajal, 1995). This was then corroborated using more modern “birth-dating”
techniques (Nornes and Das, 1974; Nornes and Carry, 1978; Altman and Bayer, 2001).
In addition, a ventral to dorsal gradient in the generation of spinal INs was also found.
One exception is a population of dorsal commissural INs that are among the first spinal
INs to start differentiating and send their axons towards the ventral commissure (Cajal,
1995; Altman and Bayer, 2001).

Spinal cord development and neural specification
A better knowledge of IN development is key to understand the normal and
pathological development of motor circuits. However, there is very little information
about how and when INs mature within the ventral horn motor circuits. More is known
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about the specification of motoneurons and the regionalization of the spinal cord in
different rostro-caudal and ventro-dorsal regions. This knowledge is reviewed here and
could serve as guiding principles to better understand IN development.

Neural tube formation and neurogenesis and gliogenesis in the early spinal cord
Despite the variety of vertebrate nervous system organizations, the underlying
principles of neural induction are maintained throughout evolution (Sanes et al. 2006).
The nervous system originates from the neural plate, a region of specialized ectoderm
on the upper surface of the embryo. The neural plate is already pre-patterned into
forebrain, midbrain, hindbrain and spinal cord regions. This rostro-caudal specialization
is reflected in the expression of different combinations of transcription factors in each
of these major regions. This regionalization is imposed by morphogenetic molecules
released from the underlying and paraxial mesoderm. After its induction, the neural
plate undergoes a complex series of morphogenetic movements, known as neurulation,
to produce a neural tube. In the spinal cord region the neural tube is located just above
the notochord which is a source of important inductors for the differentiation of this
region along the dorso-ventral axis.
The neural tube is initially a single layer of pseudostratified epithelium, which
then proliferates rapidly. In the spinal cord, the region where the ventral folding
occurred becomes the floor plate, while the dorsal region where fusion occurred during
neural tube closure becomes the roof plate. Both are specialized regions that release
molecules that induce dorso-ventral patterns of genetic expression in the progenitor
cells located in between (Placzek, 1995; Lee et al., 2000). Later in development they
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also serve to guide or repel axons, distinguishing between commissural and ipsilateral
interneuronal axons (Colamarino and Tessier-Lavigne, 1995). In between the floor and
roof plates, lining the ventricular zone, are the progenitor cells which are actively
dividing multipotent cells (Fig.4). Waves of proliferation from progenitor cells give rise
to both neurons and glia. As in other brain regions the nuclei of progenitor cells move
during the cell cycle. The nuclei are close to the ventricle during mitosis and move
laterally during S-phase (Sauer, 1935). Despite these nuclear movements the progenitor
cells themselves do not move. Clonally related progenitors labeled in embryonic chick
spinal cords with retroviruses are always found in tight dorso-ventrally restricted bands,
two to three cell layers thick, within the progenitor ventricular zone (Leber and Sanes,
1995). Daughter cells that become differentiating postmitotic neurons and glia do move
and migrate away from the ventricular zone and form the mantle layer while expanding
laterally the thickness of the neural tube (Wentworth, 1984). The cells in the mantle
layer cells undergo specific programs of differentiation and migration before acquiring
their final form and connections.
The progenitor cells and early generated neurons extend initially processes that
expand all the way from the ventricular to the lateral surfaces. Some progenitors
become radial glial cells and keep these processes. Most cells, however, lose these
processes with development. Detachment occurs because of expansion of the thickness
of the spinal cord and also because neurons and glia retract these process during
differentiation (Cajal, 1995; Wentworth, 1984; Fogarty et al., 2005). Most axons, with
the exception of commissural axons, extend initially towards the lateral edge of the
spinal cord. Motor axons exit the neural tube and extend into mesodermal layers, but
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Figure 4. Anatomy of the embryonic neural tube. Top image: An E10.5 spinal cord
immunostained for Tuj1 a marker of immature neurons. In this image differentiating
neurons and their axons are labeled, but not the progenitor area in the middle. The
outline of the spinal cord is marked with a continuous line and the border between the
precursor cells in the ventricular zone and the differentiating cells in the mantle is
indicated with a dashed line. Around the mantle is the marginal layer that will form the
white matter and already contains a few axons at this age. DRG refers to the developing
Dorsal Root Ganglia. In this particular picture it can be appreciated the axons from the
DRG travelling toward the spinal cord (dorsal roots) and the exit of motor axons in the
ventral roots. Ventral roots join the axons from the DRG in the periphery to form the
spinal nerve. At this particular age the alar plate is rather small compared to the basal
plate because the early proliferation and differentiation of motoneurons in the basal
plate. Bottom diagram. Schematic of the early neural tube. At this early age is divided
into the alar (dorsal) and basal (ventral) plates by the sulcus limitans. The dotted line on
the left image indicates the border of the ventricular zone (VZ) which contains the
progenitor cells. Differentiating cells migrate out of the ventricular zone into the mantle
layer, future gray matter. The marginal layer, which develops into the white matter,
contains the axons of the differentiating neurons. The spinal cord is divided into dorsal,
where the sensory input enters the spinal cord and the ventral horn, where the motor
output exits the spinal cord.
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axons from INs become restricted to the neural tube and form the external marginal
layer, which is the precursor of the white matter. Interneuron axons turn in the marginal
layer and form either ascending or descending projections.
Early studies in chick and mice found that motoneurons in the basal plate
differentiate first (Cajal, 1995; Wentworth, 1984). In the mouse the neural tube at
lumbar regions closes around embryonic day 8 (E8). At this age the neural tube
contains only ventricular progenitor cells. At E9 a few ventral neuroblasts migrate
laterally and start differentiation, forming the early basal plate. These neuroblasts are
motoneuron precursors and the majority of them display bipolar or unipolar
morphologies and send axons away of the ventral tube through the ventral roots. By
E10 many motoneurons have differentiated in the ventrolateral cord and are
transitioning from bipolar to multipolar morphologies. At E11, medial and lateral
subdivisions within the motor pools become obvious and there are many welldifferentiated multipolar motoneurons (Fig.5, Wentworth, 1984).
The ventral proliferative regions are thinned as daughter cells become
postmitotic motoneurons and leave this region to settle laterally. Proliferative zones
dorsal to the motoneuron region diminish in size later. The reduction in the size of
proliferative regions is always paralleled by an increase in the number of differentiating
neurons in the mantle layer at the same dorso-ventral level. This observation suggested
early neuroanatomists that different types of neurons arise from specific dorsal-ventral
regions of the proliferative area and that different neurons are generated at different
developmental times (Cajal, 1995). Different classes of neurons are therefore added
sequentially in the developing spinal cord.
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Figure 5. Motoneuron differentiation during very early embryonic development in
the mouse. At E8 the neural tube has just closed and is composed of undifferentiated
progenitors that extend processes from the ventricle to the external surface. At E9 a few
postmitotic neuroblasts have emigrated from the progenitor zone and start
differentiating acquiring unipolar or bipolar morphologies at the same time that one of
the processes (axon) exit the spinal cord. At E10 the motoneurons display more
differentiated multipolar morphologies and by E11 medial and lateral motoneurons
pools start to be group together. Modified from Wentworth, 1984.
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Nowadays we know that the neural tube is molecularly regionalized along the
anterior-posterior and dorso-ventral axes such that each progenitor has a “molecular
address code” (reviewed below) that encodes its location and defines the time window
when it proliferates at the same time that restricts the types of cells that it can generate.
Therefore, spinal progenitor cells are not pluripotent stem cells but partially-restricted
multipotent cells from which specific subtypes of neurons and glia are generated in a
spatially and temporally restricted mode. Temporal mechanisms allow the generation of
different cell types over time. Cajal (1995) already suggested that spinal glial cells were
generated later than neurons from the same progenitor regions. This switch is now well
characterized at the molecular level for the progenitors of motoneurons and
oligodendrocytes. The ventral most progenitors, named pMN and p3 respectively, give
rise to motoneurons (from pMN) and a type of ventral interneuron known as V3 (from
p3) during the neurogenesis phase. Later these progenitors give rise to oligodendrocytes
(Soula et al., 2001; Richardson et al., 1997; Zhou et al., 2001; Lu et al., 2000). This
temporal switch in specification to oligodendrocytes is accompanied by a change in the
pattern of transcription factor expression in progenitors, which results in part from
changing levels of sonic hedgehog (Shh) expressed by the notochord and floor plate
during development. Olig2, a basic helix-loop-helix (bHLH) transcription factor, is
expressed in a restricted domain of the spinal cord ventricular zone that sequentially
generates motoneurons and oligodendrocytes. Just prior to oligodendrocyte generation,
the domains of Olig2 and Nkx2.2 expression switch from being mutually exclusive to
overlapping and the proneural Neurogenins 1 and 2 are extinguished within this region
promoting glial differentiation. Coexpression of Olig2 with Nkx2.2 in the spinal cord
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promotes oligodendrocyte differentiation. Olig2 therefore functions sequentially first in
motoneuron generation and then in oligodendrocyte fate specification. This dual action
is enabled by spatio-temporal changes in the expression of other transcription factors
with which Olig2 functionally interacts.
In conclusion, a major contributor to define cell fate in the embryonic spinal
cord is the position of its progenitors, being the type of cell derived from each
progenitor also regulated and influenced by the time of generation. Progenitor mitotic
activity peaks at different times in a ventro-dorsal sequence within the ventricular
proliferation area and these results in a parallel ventral to dorsal progression of
neurogenesis and differentiation. In this thesis we will ask whether time of generation,
from a single progenitor zone, is also important to define different neural phenotypes
within subgroups of ventral INs.

Time of neurogenesis and neuronal type specification
Timing of neurogenesis is an important factor in generating neuronal diversity
in other regions of the central nervous system. For example, different types of retinal
cells arise from the same progenitors in a temporally regulated manner (Cepko et al.,
1996). Similarly, it is well known that time of neurogenesis defines laminar location
and axonal projections of pyramidal cells in the cortex (Rakic, 2009). As will be
reviewed later, the time of “birth” is also correlated with columnar identity in
motoneurons. Little, however, is known about the importance of time of birth for
generating diversity within interneuronal groups. Different types of cortical INs arise
from different proliferative domains in the ganglionic eminences, but in addition a
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single region can give rise to multiple subtypes (Anderson et al., 1997; Wonders and
Anderson, 2006). For example, cortical INs classified as fast-spiking (parvalbuminexpressing basket and chandelier INs) and the regular burst-spiking somatostatin
expressing cells all arise from progenitors in the median eminence. Interestingly, the
period of neurogenesis of parvalbumin vs. somatostatin cells is different (Butt et al.,
2007). Within the spinal cord recent analyses in zebrafish suggested that within a single
class of excitatory ipsilateral INs sending descending connections to motoneurons, cells
generated at different times become located in different dorso-ventral regions, connect
with different classes of motoneurons and are differentially recruited depending on the
speed of swimming (Kimura et al., 2006; McLean and Fetcho, 2009). Our studies will
try to determine if time of generation is not only capable of imposing functional and
connectivity gradients within a single class of INs, but whether it can also generate
completely different types of adult INs.

Molecular mechanisms of cell specification along the dorso-ventral axis
Cellular specification along the dorso-ventral axis occurs by inductive
mechanisms that regulate expression of certain transcription factors that control the fate
and differentiation of neurons. These mechanisms are mediated by secreted factors
emanating from the ventral notochord and floor plate, and dorsally from the non-neural
ectoderm (Jessell, 2000; Poh et al., 2002; Melton et al., 2004). Diffusion of secreted
factors from these sources results in concentration gradients along the dorso-ventral
axis that are converted from graded signals into all-or-none distinctions in cell fate
(Fig.6, Briscoe et al., 2000). In addition, these gradients change with development and
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perhaps influence the temporal sequence of neuronal generation from each dorsoventral domain, although less is known about this possibility.
The differentiation of ventral cell types is triggered by signals from a gradient of
the protein Sonic hedgehog (Shh), secreted initially by the notochord and later by floor
plate cells (Placzek, 1995; Chiang et al., 1996). In addition, retinoids derived from the
paraxial mesoderm and possibly also from differentiating neural cells, provides a
parallel signaling pathway that aids in the specification of some IN subtypes (Zhao et
al., 1996; Sockanathan and Jessell, 1998, Pierani et al., 1999). Sonic hedgehog and
retinoids control the expression of different transcription factor combinations in
progenitors located at different dorso-ventral regions (Fig.6).
Briscoe et al. (2000) proposed that the ventral progenitor domains emerge in
three main stages. In the first stage, homeodomain proteins expressed by ventral
progenitors interpret the graded Shh signaling. This Shh gradient represses expression
of class I transcription factors (Pax7, Pax6, Irx3, Dbx1, and Dbx2) and induces class II
factors (Nkx6.1, and Nkx2.2) with each protein induced or repressed at different levels
by different Shh concentrations. As a result, a dorso-ventral gradient for the expression
for each transcription factor is established. In the second stage, the selective reciprocal
repression between class I and II proteins refines the progenitor domain boundaries
(reviewed in Price and Briscoe, 2004). Such repressive interactions occur at certain
expression thresholds and are all-or-none, that is one transcription factor in the pair is
completely repressed. They have three roles: First, they define the dorsoventral limits
of expression of class I and class II proteins. Second, they ensure the existence of sharp
boundaries between progenitor domains. Third, they relieve progenitor cells of a

28

Figure 6. Scheme of ventral progenitor domains giving rise to ventral interneurons
and motoneurons. Each ventral canonical class of interneuron is characterized by the
expression of a characteristic transcription factor (indicated) and originates in one
specific progenitor domain. These differences in progenitor domains are induced by
dorso-ventral concentration gradients of the proteins Shh and BMP as indicated in the
top right corner. Shh is released from notochord (N) and the floor plate (FP). BMPs are
released from the roof plate (RF).
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requirement for ongoing Shh signaling, consolidating progenitor domain identity. In the
third stage, the homeodomain protein code is translated into specific neuronal subtype
identity. As a consequence the combinatorial expression profile of these proteins leads
to five progenitor domains in the ventral neural tube. These are defined as pMN, which
gives rise to motoneurons and p0 to p3 giving rise to four classes of embryonic ventral
INs (Fig.6, Briscoe et al., 2000; Jessell, 2000; Poh et al., 2002; Goulding and Lamar,
2000).
For Shh-induced dorso-ventral progenitor domains to remain stable, it is
necessary to constrain cell movements within the ventricular zone as shown by the
retroviral experiments of Leber and Sanes (1995). Once these boundaries are
established, progenitor cells freely move within a given domain but are unable to cross
into adjacent domains, thereby establishing lineage-restricted compartments in the
ventral neural tube (Goulding and Lamar, 2000).

Anterior-posterior patterning
Similar induction and repression mechanisms of transcription factor expression
help to define the rostro-caudal organization of the spinal cord. The rostrocaudal pattern
is in part imposed by retinoic acid (RA) and fibroblast growth factor (FGF) signals. It
has also been described that early Wnt (Wingless Int, Wingless is a recessive mutation
affecting wing development in Drosophila melanogaster and Int is an homologus gene
of Wingless with common evolutionary origin) signaling provides a positional context
for the later actions of RA and FGF in specifying rostrocaudal regional identity in the
embryonic spinal cord (Nordström, et al., 2006; Dasen and Jessell, 2009). The
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differential expression of FGFs, RA and Wnts control the expression of the Hox gene
family, a class of transcription factors with an evolutionarily conserved role in
establishing differences in cell identity along the rostrocaudal axis (Melton et al., 2004).
Hox genes are localized in gene clusters and their position in the cluster defines its
expression pattern; genes located at the 3‟ end of the cluster are expressed more
anteriorly in the neural tube than genes at the 5‟ (Melton et al., 2004). Hox gene
expression in the spinal cord is closely aligned with their position within the Hox
cluster and this is further refined by cross-repressing mechanisms similar to those
between class I and class II proteins involve in dorso-ventral patterning (Dasen et al.,
2009). Hox genes are therefore informative markers of the rostrocaudal positional
identity of progenitor cells and are also determinants of motoneuron identity, both in
the hindbrain (cranial nerve motor nuclei) and spinal cord. For example, Hox9
expression in progenitors and cross-repressive interactions between Hox6 and Hox9
proteins in postmitotic motoneurons consolidate the distinct profile of the lateral motor
column (LMC) in the cervical enlargement and the Column of Terni (CT, i.e.
preganglionic sympathetic neurons) in the thoracic spinal cord. Hox6 activity in
brachial motoneurons directs RALDH2 (retinaldehyde dehydrogenase-2) expression
and induces late features of LMC identity, while Hox9 activity in thoracic motoneurons
directs BMP5 expression and the dorsal migration of “visceral” motoneurons (Dasen et
al., 2003). It is not known yet if similar mechanisms act on rostro-caudal specification
of IN identity.
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The “V code”
Dorso-ventral patterning results in 5 ventral progenitor domains that give rise to
motoneurons and 4 types of INs, known as V0, V1, V2, and V3. Postmitotic neurons
generated from each domain upregulate specific transcription factors that then define
the class. V0 cells are characterized by expression of Evx1/2 (Even-skipped
homeobox1), V1 cells by engrailed-1 expression (En1), V2 cells are divided in cells
that express GATA3 (V2b INs) or the CEH10 Homeodomain-Containing Homolog
(Chx10; V2a INs) and V3 cells express Sim1 (Single-minded homolog1). These celltype specific genes have been extensively used to direct the expression of reporter
genes like green fluorescent protein (GFP), yellow fluorescent protein (YFP), variants
of red fluorescent proteins, like tdTomato, and LacZ to specific subclasses of ventral
INs. They have also been used to direct genetic silencing or deletion of each of these
populations either in embryo or in the adult. Each type is considered a canonical cell
type with some basic common properties. Taking advantage of genetic labeling it was
found that each embryonic subgroup is characterized by a different migration and final
location, the direction of extension of the primary axon and frequently (but not always)
its neurotransmitter phenotype. These properties are conserved through evolution and
each cell type shares similar fundamental properties from fishes to mammals
(Goulding, 2009; Grillner and Jessell, 2009).
V0 INs take a ventro-medial migration and settle in the future LVIII extending
commissural projections that distribute for 1-4 segments rostrally in the contralateral
spinal cord. Most V0 INs display inhibitory phenotypes, but some are also excitatory
(Lanuza et al., 2004). These authors also used an in vitro spinal cord preparation to
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induce fictive locomotion by application of N-methyl-D-aspartic acid (NMDA) and 5hydoxytryptamine (5-HT, serotonin) and recorded alternating bursts of motor activity in
left lumbar 2 (lL2) and right lumbar 2 (rL2) ventral roots. After genetic deletion of V0
INs there was a loss of strict left-right alternance in motor output and sometimes ipsi
and contralateral roots fired synchronously. The authors concluded that V0‟s are
involved in stabilization of the left-right alternation of motor output. Recently, a
subclass of V0 INs (V0c) was defined according to the expression of the pitx2
transcription factor. V0c neurons are cholinergic and are located close to lamina X.
These cells are the origin of C-terminal synaptic boutons on motoneurons. Genetic
deletion of this group showed they control motoneuron excitability (Zagoraiou et al.,
2009).
V1 INs in contrast, migrate latero-ventrally and most end up located in LVII in
close apposition to the lateral motor pools (Matise and Joyner, 1997; Saueressig et al.,
1999; Alvarez et al., 2005). They project ascending axons that travel for short distances
in the ipsilateral ventro-lateral funiculus and project to ipsilateral motoneurons. So far,
only inhibitory phenotypes have been found in this subclass (Saueressig et al., 1999;
Sapir et al., 2004; Alvarez et al., 2005). V1 INs are therefore good candidates to
provide local inhibitory modulation to motoneurons. Both, Renshaw cells and IaINs
have been shown to derive from this group (Sapir et al., 2004; Alvarez et al., 2005).
Genetic silencing of V1 INs in embryo or postnatally did not affect left-right or flexorextensor coordination during NMDA/5-HT induced fictive locomotion in the in vitro
spinal cord preparation, but the step cycle duration was lengthened leading to the
conclusion that V1 INs regulate the speed of locomotion (Gosgnach et al., 2006). Later
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it was shown that reciprocal inhibition between quadriceps and biceps is not altered in
Pax6 knockout mutants in which V1 INs are not generated (Wang et al., 2008). Taken
together with the lack of effect of V1 deletions in fictive locomotion flexor-extensor
motor output alternance (Gosnach et al., 2006) and with more recent data describing
IaINs in the mature spinal cord that are not derived from V1 INs (Siembab et al., 2010)
the results suggest multiple origins for IaINs. In this thesis we will refer to the cells
under study as “V1-derived” IaINs.
V2 INs also follow a lateral migration but do not extend as ventrally as V1‟s,
they also project axons to the ventro-lateral funiculus, but these are mostly descending
axons (Lunfald et al., 2007; Al-Mosawie et al., 2007). Most V2 INs express Chx10 and
are excitatory (V2a subtype), however a smaller subgroup expresses GATA3 and these
are inhibitory (V2b subtype). Ablation of V2a INs using transgenic Chx10-DTA mice
(which express diphtheria toxin specifically in Chx10 expressing neurons) lead to
deficits in left-right coordination, similar to the observation after deletion of V0 INs, in
the in vitro fictive locomotion spinal preparation (Crone et al., 2008). These authors
then used genetic labeling to demonstrate a direct connection between Chx10 on V0
neurons. Interestingly, in the whole animal these deficits are more apparent at high
treadmill speeds and the mice switch from normal alternating running gaits to an
abnormal synchronous rabbit-like pattern (Crone et al., 2009). These results suggest
that similar to homologous zebrafish V2a (Alx) INs, mammalian V2a INs are
functionally diverse and their overall functional impact might change with locomotor
speed. Correspondingly, recent studies on the cellular properties of V2a cells
demonstrated a variety of morphologies, axonal projections, electrophysiological
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properties and coupling of their firing activity with rhythmic motor outputs (Zhong et
al., 2010; Dougherty and Kiehn, 2010).
Lastly, V3 INs are generated most ventrally and take a medio-dorsal migration
pathway that divides then into three different subgroups settling in different dorsoventral regions. V3‟s are excitatory and extend contralateral axons and therefore they
might be important in synchronizing motor activity between both sides of the spinal
cord (Zhang et al., 2008). Blocking neurotransmission from V3 INs using conditional
expression of Tetanus neurotoxin in these cells increased the duration of the step cycle
and made motor bursts more variable and labile. The authors concluded that V3 INs
stabilize locomotor network rhythmicity (Zhang et al., 2008). In a recent study of netrin
knockout mutants it was found that all V0 commissural INs (mostly inhibitory) fail to
cross axons to the other side of the spinal cord, however V3 axons (excitatory) were
netrin-independent and crossed normally (Rabe et al., 2009). These animals express a
necessary rabbit-like hopping gait with synchronous activation of left and right
motoneurons.
Although these experiments point to possible functions of the different classes
of embryonic INs, they are difficult to interpret because they are broad deletions that do
not take into account the diversity of functional subtypes within each class. Moreover,
none of the specific cell deletions seems able to eliminate locomotion rhythmicity. The
possibility of compensatory and redundant mechanisms cannot be overlooked but in
addition we need a better understanding of the variety of IN subclasses derived from
each class and their mechanism of differentiation to assess more precisely their
function. An important example is the V0c group which controls the excitability of
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ipsilateral motoneurons and therefore has a function quite different from most cells in
the generic V0 group (Zagoraiou et al., 2009).
Further refinement of approaches used to classify ventral INs will likely become
highly valuable as demonstrated in animals with simpler spinal circuits, such as the
zebrafish (Fetcho and Bhatt, 2004). In these animals there is a nice correlation between
canonical subtypes and one or a few types of well-defined INs in the mature spinal
cord, each of known morphology, neurotransmitter phenotype and functional action.
However, in mammals there are many more classes of ventral INs in the adult spinal
cord than canonical embryonic subtypes. It has been argued that this is the result of
evolutionary pressures towards greater diversification to allow the transition from
swimming to terrestrial locomotion and encode the more complex and larger number of
motor patterns displayed by terrestrial mammalian species (Alvarez et al., 2005;
Goulding and Pfaff, 2005; Goulding, 2009; Grillner and Jessell, 2010).
Although the mechanisms that lead to the diversification of the generic V0-V3
INs have not been defined, there is an interesting parallel in the specification of
motoneurons into classes (somatic vs. visceral), columns (lateral vs. medial) and
specific pools (reviewed in Jessell, 2000; Price and Briscoe, 2004). This diversification
of motoneuron phenotypes is characterized by the sequential expression of distinct
transcription factors driven by a combination of intrinsic and extrinsic signals. It is
possible that similar hierarchical specialization also occurs during IN development.
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Mechanisms of motoneuron diversification
The process by which motoneurons develop unique identities depends on a
hierarchical and sequential expression of transcription factors that increasingly restrict
motoneuron differentiation based on cell body position, axonal projections and gene
expression. The specification of generic motoneuron identity leads into the generation
of motoneuron subtypes located at specific positions in the spinal cord. The soma of
functionally related groups of motoneurons that are destined to share common
projection targets settle in longitudinally oriented columns as their axons project
towards their target regions. Finally, motoneurons that innervate the same muscle form
clusters known as motor pools and at this time is when pre- and post-synaptic
connections are made. Each step involves extracellular signals that regulate intrinsic
cell-autonomous determinants of motor identity (reviewed in Price and Briscoe, 2004).
Generic motoneuron identity is specified by the combinatorial action of three
homeodomain proteins, Nkx2.2, Nkx6.1, and Irx3 expressed in three adjacent ventrodorsal progenitor domains induced by the graded action of Shh. Ventrally Nkx2.2 (in
the p3 domain) and dorsally Irx3 (in the p2 domain) repress motoneuron differentiation
and ensure that motoneuron generation is restricted to the pMN domain expressing
Nkx6.1. Within pMN, Nkx6.1 induces transcription factors that are essential for
motoneuron specification, such as Olig2 and MNR2 (the chick homolog of mammalian
Hb9). Initially, Olig2, a bHLH protein, induces proneural genes like neurogenin 2
(Ngn2) and favors the acquisition of motoneuron properties by repressing Irx3. Later,
when Nkx2.2 expression moves dorsally into the pMN domain, Olig2 represses
proneural genes and oligodendrocytes are generated (reviewed before, pag. 27). In the
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abscence of Nkx2.2, Olig2 induces MNR2 (chick) and Hb9 (mammals) in the
progenitors during their final cell division, and these determine motoneuron identity.
During early differentiation, motoneurons are also subdivided into subclasses
that innervate different muscles in the periphery. After leaving the spinal cord, motor
axons project either dorsally, towards axial muscles or ventrally towards body wall
muscles or limb muscles. Motoneurons innervating these distinct regions become
positioned into longitudinal columns. Motoneurons located medially in a subcolumn
called MMCm innervate axial muscles. This column is present throughout the rostrocaudal extent of the spinal cord. More laterally in the spinal cord are the subcolumns
that project to body wall muscles (MMCl) and to limb muscles (LMC). LMC
motoneurons are present only at cervical and lumbar levels while MMCl motoneurons
are present only at thoracic levels. LMC axons face a second choice at the base of the
limb where they project to dorsal or ventral limb muscles. The lateral LMC subcolumn
projects to dorsally derived muscles and the medial LMC subcolumn projects to
ventrally derived muscles. Each of these subcolumns can be identified by the
combinatorial expression of LIM homeodomain transcription factors, like Isl1, Isl2,
Lim1, and Lim3, prior to the innervation of muscle (reviewed in Price and Briscoe,
2004). The formation of subcolumns within the LMC is related to time of birth and an
inside-out migration that has a critical influence on their identity. Isl1 and Lim1
distinguish medial from lateral LMC motoneurons. Isl1 is initially expressed by all
LMC neurons just after they are generated but then is rapidly downregulated from
lateral LMC neurons at which time Lim1 is induced. The switch in LMC subtype
depends on retinoid signals provided by earlier-born LMC motoneurons. Early born
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LMC motoneurons form a medially located column and later born LMC motoneurons
pass through them to reach more lateral positions. LMC neurons upregulate the retinoid
synthesizing enzyme RALDH2 and exposure of later-born naïve LMC neurons to
retinoids represses Isl1 and promotes Lim1 expression (Sockanathan and Jessell, 1998).
Later, motoneurons differentiate into pools dependent on expression patterns of
a different family of transcription factors named E-twenty six or ETS (Lin et al., 1998).
The onset of ETS gene expression occurs at late developmental stages and coincides
with limb innervation. Recently, many other genes related to specific adhesion and
recognition mechanisms, like ephrins, cadherins, semaphorins, have been found
expressed in specific motor pools, sometimes under the control of specific transcription
factor combinations (reviewed in Price and Briscoe, 2004).
In summary, motoneuron diversification suggest progressive acquisition of
properties from the more general column specification to specific motor pool identity
influenced by extrinsic signals that trigger intrinsic programs of differentiation. It is
possible that similar principles can be transferred to IN diversification.

V1-derived interneurons in the mature spinal cord: basic control of motoneurons
As mentioned before, inactivation or deletion of V1 INs results in a marked
prolongation of the step cycle and slows the motor rhythm, suggesting they are crucial
for setting the speed of locomotion (Gosgnach et al., 2006). Core features of V1-INs,
like their inhibitory nature and ipsilateral projections, are conserved between the
aquatic vertebrates and mammals. The seemingly evolutionary conserved role of V1
neurons in regulating the speed of the locomotor rhythm suggests that certain functions
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may have been preserved between the swimming and walking CPG and reflects the
close phylogenetic relationship between spinal neurons in swimming vertebrates and
their terrestrial counterparts. This is particularly apparent in the embryonic spinal cord.
Although it was initially suggested that V1-INs form a homogenous population of
inhibitory interneurons in mice embryos (Sauressig et al., 1999), it was quickly shown
that at least in the chick embryo they express heterogenous electrophysiological
properties (Wenner et al. 2000). However, in “simpler” vertebrates (fish and tadpoles)
V1 INs remain a homogenous population of ipsilaterally projecting, glycinergic
inhibitory INs that exert motor control by limiting firing of motoneuron and INs and
gating sensory information during swimming (Higashijima et al., 2004; Li et al., 2004).
Interestingly, these two functions are provided in the mammalian spinal cord by two
different classes of adult INs, Renshaw cells and IaINs, and both were found to be
derived from embryonic V1 INs in the mouse (Sapir et al., 2004; Alvarez et al., 2005).
V1 INs in the mammalian embryonic spinal cord therefore represent a primitive ground
state that undergoes diversification during development and gives rise to specialized
INs with more restricted functions.

Renshaw cells: recurrent inhibition
Physiology and function
Renshaw cells mediate recurrent inhibition (Fig.7). Recurrent inhibition was the
first inhibitory spinal pathway identified due to the simplicity of its organization and its
unique feature of being activated by motor axons. In 1941, Renshaw discovered that in
animals with dorsal roots sectioned, antidromic impulses in motor axons decrease the
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excitability of α-motoneurons projecting to the same or synergistic muscles. Renshaw
named this effect recurrent inhibition and in 1946 identified a group of INs that he
proposed mediated the inhibitory effects of motor axon activation on motoneurons. A
few years later Eccles and colleagues (1954) discovered that the spinal recurrent
inhibitory pathway was disynaptic, involving a cholinergic synapse from motor axon
collaterals onto an IN located in the ventromedial portion of the ventral horn and a
strychnine-sensitive hyperpolarizing synapse from this IN onto the motoneurons. He
named this IN the Renshaw cell. Later it was found that Renshaw cells also control
IaINs and therefore reciprocal inhibition and the amount of co-contraction between
antagonistic muscles (Hultborn et al., 1971) (see schematic in Fig.7). Renshaw cells
and recurrent inhibition are thought to play a variety of different roles in fine-tuning
motor output by modulating motoneuron recruitment and proprioceptive reflex circuits
(reviewed in Windhorst, 1996).

Location, anatomy and morphological identification
The „Renshaw cell area‟ was identified in ventral lamina VII (Thomas and
Wilson, 1965). The location, morphology and glycinergic/GABAergic nature of
Renshaw cells was confirmed by combining intracellular recording and labeling with
immunolabeling (Fyffe, 1990; 1991a,b). Renshaw cells are small size INs located in the
exit region of motor axons in ventral lamina VII and IX and extend relatively small
dendritic arbors. Their axons extend rostro-caudally through a few ipsilateral spinal
segments and make local arborizations preferentially in lamina IX.
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Later it was found that Renshaw cells uniquely display a high density of
proximal inhibitory synapses with uncommonly large postsynaptic densities that can be
labeled by gephyrin, a glycine receptor and GABAA receptor clustering protein
(Alvarez et al., 1997). Using this criteria for identification Carr and colleagues (Carr et
al., 1998) confirmed an earlier suggestion that primate Renshaw cells express high
levels of the calcium-buffering protein calbindin (Ardvisson et al., 1992). Developing
Renshaw cells can also be distinguished as a distinct cluster of ventrally located
calbindin-IR cells in neonates (Geiman et al., 2000) and embryos (Sapir et al., 2004).
Moreover, it appears that many other ventral spinal INs express calbindin initially, but
then it is downregulated during postnatal development in most, except in the Renshaw
cells (Zhang et al., 1990; Siembab et al., 2010). Thus, calbindin expression appears to
be an intrinsic feature of the Renshaw cell phenotype but it‟s function and the
difference in the regulation of its expression in Renshaw cells compared to other INs
have not been studied.

Ia inhibitory interneurons (IaINs): reciprocal inhibition
Physiology and function
In 1897, Sherrington demonstrated that the contraction of a muscle is
accompanied by the relaxation of its antagonist and denominated this effect “reciprocal
inhibition”. Lloyd (1941) postulated that reciprocal inhibition was mediated by Ia
afferents directly affecting motoneurons, however, more than a decade later, Eccles
demonstrated in 1956 that an IN was interpolated in the reciprocal inhibitory pathway.
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This interneuron was called “Ia intermediate interneuron”, which evolved into its
current name, “Ia inhibitory interneuron” (Fig.8).
The reciprocal inhibitory circuit as we know it today involves Ia afferents
originated in the muscle spindle primary endings that exert monosynaptic excitatory
action onto homonymous motoneurons and activate IaINs inhibiting the motoneurons
of the antagonistic muscle. IaINs have been also shown to inhibit other IaINs (Hultborn
et al., 1976) and to be modulated by Renshaw cells (Hultborn et al., 1971).

Location, anatomy and morphological identification
IaINs ventral horn position was determined first from electrophysiological
recordings (Hultborn et al., 1971). More specific information on exact location came
from intracellular labelings of IaINs. They were found in lamina VII (LVII) dorsal or
medial to lamina IX (Burke et al., 1971). IaINs are always located in the same spinal
cord segment as the Ia afferents that excite them and therefore to exert reciprocal
inhibition between pools of motoneurons located segments away the axons of IaINs
need to travel into the lateral and ventral funiculi where they ascend or descend sending
collaterals to motor pools locally or several segments away (Jankowska and Lindstron,
1972). A thorough investigation of IaIN locations, morphologies, dendritic arbors and
axon trajectories demonstrated considerable variability within this population (Rastad et
al., 1990). IaINs were located in all regions of lamina VII, could exhibit large or small
cell bodies and dendritic arbors and their axons could be preferentially descending or
ascending or bifurcating, some being quite local and others long range propriospinal.
Histological identification of IaINs is more complicated than for Renshaw cells,
since synaptic connectivity needs to be identified and IaINs seem very heterogeneous.
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A few years ago our lab found that some INs in the ventral horn receive a dense
innervation in the cell body and proximal dendrites from Renshaw cells (labeled with
calbindin antibodies) and Ia afferents (labeled with the proprioceptive synaptic marker
VGLUT1; Todd et al., 2003; Alvarez et al., 2004). In parallel with electrophysiological
criteria (see Alvarez and Fyffe, 2007) these INs were identified as IaINs (Alvarez et al.
2005; Siembab et al., 2010). We don‟t know the proportion of IaINs identified using
this criteria or whether cells with such high density of Renshaw cell and Ia afferent
inputs represent a subpopulation of IaINs. These criteria, however permit the
identification of some cells that with very high probability are IaINs. Up to date there
are no other histological or genetic markers to label this population. Developmental
analyses will hopefully aid in the discovery of specific genes more specifically
expressed in IaINs and perhaps these will subdivide the IaIN population in to further
subgroups each having more homogenous morphological and functional properties.
The basic question pursued in this thesis is when and by what possible
mechanisms Renshaw cells and IaINs differentiate from each other within the V1
population. The results should be always interpreted considering that it is unlikely we
identified all V1-derived IaINs throughout our studies. The IaIN population we can
identify, however, might give important information on the mechanisms of
differentiation and in comparison to Renshaw cells. Based on previous analyses we
believe that recognition of the Renshaw cell population is quite complete (Alvarez and
Fyffe, 2007). The starting point for generating our hypothesis is the observation that
both cell types can be recognized in the neonatal spinal cord (Siembab et al., 2010).
This information together with studies in human newborns and mice pups, showing that
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recurrent and reciprocal inhibition are functional at birth (Mc Donough et al., 2001;
Wang et al., 2008) strongly suggest that the main cellular elements and connections are
preformed and specified in the embryo. Up-to-date there is no information about the
mechanisms that specify any of the INs found in the adult spinal cord and classically
defined according to their function (as reviewed in Jankowska et al., 1992).
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Figure 7. Diagram of basic connections between IaINs, motoneurons, Ia afferents
and Renshaw cells.
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Figure 8. Diagram of the basic connections of reciprocal inhibition through IaINs.
IaINs receive inputs from Ia afferents that innervate muscle antagonists of the motor
pools they inhibit. Reciprocal inhibition is extensive for excitatory inputs from other
sources like descending inputs. Descending pathways are represented in a discontinued
line. Descending pathways co-activate α-MNs and corresponding IaINs. In general,
IaINs receive the same excitatory input than the motor pools receiving input from
common Ia afferents. In this way reciprocal inhibition is not limited to the Ia afferent
mediated stretch reflex but also to all excitatory inputs allowing reciprocal excitationinhibition of flexors and extensors. In addition, extensor-coupled IaINs inhibit
antagonist flexor-coupled IaINs, and vice versa. Further modulation of the IaIN is
through Renshaw cell inputs.
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III. HYPOTHESIS AND SPECIFIC AIMS
Hypothesis: Differentiation of V1-INs into Renshaw cells and IaINs occurs early in
mouse embryos and depends on birth-date, early expression of specific
transcription factors and different spatial relationships during early migration.

Aim 1: Determination of birthdates of different populations of V1-derived INs.
Hypothesis 1: Renshaw cells and V1-derived IaINs differ in their time of generation
from p1 progenitors.
Previous studies suggested that V1 INs exit the progenitor zone between E9 and
E12 (Matise and Joyner, 1997; Saueressig, et al., 1999). We tested the possibility that
different classes of V1-INs have different birthdates within this period by pulselabeling with bromodeoxyuridine (BrdU) newly generated cells at different embryonic
times. Embryos from animals encoding reporters for V1-IN identification, either LacZ
(En1Cre/Tau-LacZ) or YFP (En1Cre/Thy1-YFP), were injected with BrdU at
embryonic ages E9.5 to E12.5. BrdU incorporation into Renshaw cells and V1-derived
IaINs was analyzed postnatally at P15, an age in which each cell type has differentiated
most of their characteristics (Siembab et al., 2010).

Aim 2: Characterization of transcription factor expression of Renshaw cells and
IaINs in the embryonic and postnatal spinal cord.
Hypothesis 2: Renshaw cells and V1-derived IaINs start their differentiation
immediately after being generated by expressing cell-type specific transcription factors.
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In a previous preliminary study it was suggested that subpopulations of V1 INs
could be differentiated based on the expression of the transcription factors FoxP2 and
MafB (Geiman et al., 2007). We tested in this aim whether these transcription factors
are specifically expressed in Renshaw cells and V1-derived IaINs. Because these
transcription factors are quickly downregulated after birth we analyzed using
immunohistochemistry their expression in Renshaw cells and IaINs at P0 and P5. Then
we analyzed the upregulation of their expression in early embryos. To obtain early
expression in embryo of V1 genetically encoded reporters we used a new reporter
mouse (En1-Cre/Rosa26-tdTomato).

Aim 3: Characterization of the migratory pathway of Renshaw cells as distinct to
that of other V1-INs.
Hypothesis 3: Early Renshaw cells follow a unique migratory path that influences their
unique relationship with motor axons.
The analyses in embryonic spinal cord performed in Aim2 suggested calbindin
is an early marker of newly born Renshaw cells and that specific transcription factors in
these cells are expressed only after they have settled in their final positions. We
therefore hypothesized that the migration pathway has implications for Renshaw cell
differentiation and could explain their unique relationship with motor axons. To
analyze migrating Renshaw cells in relation to motoneurons and ventral root axons we
labeled motoneurons with the transcription factor islet1 and ventral roots with a
monoclonal antibody against a class III beta-tubulin isoform (Tuj1) characteristic of
immature neurons and axons.
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IV. GENERAL METHODS

Animal models for V1-interneuron identification
Three animal models were used in this study to identify V1-interneurons (V1INs) in embryonic or postnatal tissue sections. A Cre/lox recombination strategy was
used to direct expression of reporter genes (LacZ, YFP, and tdTomato) in cells derived
from engrailed-1 expressing V1-INs (Sapir et al., 2004). All animals were obtained by
crossing En1Cre/+ heterozygotes (Sapir et al., 2004) with three different reporter mouse
lines. All reporter lines contain a transcriptional stop cassette flanked by two loxp sites
just upstream of the reporter gene. In the driver line, the cre recombinase gene was
inserted into the first coding exon of engrailed-1 (en1), a transcription factor expressed
by V1-INs during development. In this manner only V1-INs express Cre in the spinal
cord. Cre is a type I topoisomerase from P1 bacteriophage, that catalizes site-specific
recombination of DNA between loxp sites. Cre recombination of loxp sites removes the
stop signal and allows transcription to proceed onto the reporter gene (Fig.9).
Expression is continuous through the life of the V1-derived neuron due to the activity
of the promoters that control the reporter genes expression. The three reporter lines we
used are described below.

- Tau-lox-STOP-lox-mEGFP-IRES-NLS-LacZ:
Tau-lox-STOP-lox-mEGFP-IRES-NLS-LacZ mice (Tau-LacZ, Hippenmeyer et
al., 2005) contain one copy of the reporter transgene knocked-in by targeted
recombination in the tau gene. The Tau promoter is reportedly active in embryonic and
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adult neurons (although we noted when using this line that is not active in some
neurons at the earliest embryonic ages: see results Aim 2). The reporter gene contains a
bicistronic element with an internal ribosomal entry site (IRES) that allows expression
of multiple proteins from a single mRNA transcript as ribosomes bind to the IRES in a
5‟-cap-independent manner to initiate translation. The bicistronic element is a single
transcript with open reading frames encoding for two different proteins separated by the
IRES sequence. The first coding sequence generates a modified myristoylated EGFP
(mEGFP) designed to bind to the plasma membrane and label entire cell surfaces.
However, in our tissue sections it only labels the axons. The second coding sequence
(NLS-LacZ) translates a modified bacterial β-galactosidase with a nuclear signal,
meaning the localization of the reporter will be restricted to the nuclei of the cells. We
used immunodetection of NLS-LacZ to identify the location of V1 cells (Fig.10).
mEGFP remained undetected in our experiments and since immunocytochemical
amplification is necessary for revealing axonal mEGFP in these animals, we were able
to reserve the green channel for other immunomarkers.

- Thy1-lox-STOP-lox-EYFP:
The Thy1-lox-STOP-lox-EYFP mouse line (Thy1-YFP, Feng et al., 2000;
Buffelli et al., 2003) contains multiple copies of a transgene that will produce Enhanced
Yellow Fluorescent Protein (EYFP) after Cre/lox recombination. EYFP is a yellowshifted Green Fluorescent Protein (GFP). In this line YFP expression fills the cell
bodies, dendritic arbors and axons of V1-derived INs (Fig.11). The Thy1 promoter is
robustly expressed in postnatal neurons (but not in embryo), however one significant
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property of Thy1 lines is expression “mosaicism” (Feng et al., 2000). This refers to the
characteristic of Thy1 reporters to become active in only a percentage of neurons in the
target population. We chose the Thy1 line 15 because it labels a large percentage
(~75%) of all V1-derived INs (Siembab et al., 2010). Complete cellular filling, as
provided by YFP expression in this line, is advantageous in experiments trying to
identify V1-derived IaINs. This is because our criteria are based on synaptic contacts
and good definition of the cell body and dendrites is necessary for this.

- CAG-Rosa26-lox-STOP-loxp-tdTomato-WPRE:
These mice harbor a targeted mutation of the Gt(Rosa)26Sor locus with a loxPflanked STOP cassette preventing transcription of a CAG promoter-driven red
fluorescent protein variant (tdTomato) that is expressed only after Cre recombination.
tdTomato is a modification of the Red Fluorescent Protein (RFP) of marine invertebrate
organisms such as the soft coral and reef coral (Madisen et al., 2010). The wild type
RFP protein, which is an obligate tetramer, is not well tolerated in mammalian systems.
The original molecule was modified to optimize expression in mammalian cells. The
modified tdTomato is among the brightest fluorescent proteins available. The CAG
promoter is a combination of the cytomegalovirus and chicken beta-actin promoter and
induces high gene expression in mammalian cells while the Rosa26 locus is a site that
permits reliable and efficient expression of transgenes targeted to that locus. As a result
tdTomato expression in these animals is strong and was always visualized “naked” in
our studies using epifluorescence or confocal microscopy (Fig. 12).
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Figure 9. Conditional cre/lox recombination used to label V1-interneurons. The
reporter lines contain a reporter cassette in which a loxp-STOP-loxp sequence is
upstream of the reporter gene. This stop signal prevents transcription of the reporter in
most cells. Loxp sites recombine in the presence of Cre, such that the DNA fragment in
between (in this case a transcriptional STOP signal) is deleted. Cre is expressed
specifically in engrailed-1 expressing V1 neurons and therefore reporter expression is
only allowed in these cells.
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Figure 10. Labeling in En1-Cre / Tau-LacZ mice. Low magnification images of a
P15 spinal cord hemisection from the En1-Cre / Tau-LacZ animal. The sections were
triple immunolabeled for LacZ (β-galactosidase, 405, blue), calbindinimmunoreactivity (CB-IR, FITC, green) and parvalbumin-immunoreactivity (PV-IR,
Cy5, white). A) LacZ-IR labels the nuclei of V1-derived INs. V1-derived INs are
distributed through the ventral horn of the spinal cord mostly concentrated medial to
lumbar motor pools. B) Calbindin-IR distinguishes a group of ventrally located neurons
that correspond with Renshaw cells (RC area). In addition, a few other ventral
calbindin-IR cells are located more dorsally. These are more frequent in upper lumbar
regions and were divided into large (see big CB) and small cells according to soma
size. Many other calbindin-IR cells are located in the dorsal horn. Dorsal horn
calbindin-IR cells do no belong to the V1-derived population. C) Parvalbumin-IR is
present in the axons of proprioceptive afferents and in many dorsal and ventral horn
INs. By difference to CB, Parvalbumin-IR cells are more varied being distributed in all
dorso-ventral and medio-lateral regions of the ventral horn, including a proportion of
the RCs. D) Calbindin-IR and LacZ staining shows Renshaw cells are labeled with
LacZ confirming they are V1-derived interneurons. E) Parvalbumin-IR and LacZ
staining shows that same populations of parvalbumin-IR cells are V1-derived
interneurons. F) Superimposition of calbindin, parvalbumin, and LacZ (V1)
immunostaining.
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Figure 11. Labeling in En1-Cre / Thy1-YFP mice. Low magnification images of a
P15 spinal cord section from the En1-Cre / Thy1-YFP animal (line 15). YFP-expressing
V1 INs appear in green and the section was also immunostained for calbindinimmunoreactivity (CB-IR, Cy5, white). A) Distribution of YFP V1 cells. B) Higher
magnification of YFP labeled V1 INs showing filling of the cell body, dendrites and
axons. C) Calbindin-IR cells in the same section as in A. Note the Renshaw cells at the
ventral most border. D) Superimposition of calbindin-IR and YFP cells.
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Figure 12. Labeling in En1-Cre / R26-tdTomato mice. Low magnification images of
a spinal cord section from the R26/tdTomato animal. The tdTomato transgenic mouse
line shows V1 cells in red. The section was dual immunolabeled for calbindinimmunoreactivity (CB-IR, Cy5, white) and NeuN-immunoreactivity (NeuN-IR, FITC,
green). A) The distribution of tdTomato labeled V1 cells is identical to that of the other
reporter lines. B) Calbindin-immunoreactivity show the ventral cluster Renshaw cells at
the ventral border. C) NeuN-IR is a generalized marker of most spinal cord neuron cell
bodies. Note the location of the large motoneuron cell bodies delimiting the extent of
the motor pools in this lumbar segment. D) Merge of calbindin-IR and tdTomato
labeling of V1-INs. All calbindin-IR Renshaw cells are V1 derived and thus tdTomato
positive. E) Merge of NeuN and V1-INs. F) Superimposition of the three
fluorochromes. Scale bars; 200μm (all images have same magnification).
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Animals
All animal procedures were performed according to NIH guidelines and
reviewed by the local Laboratory Animal Use Committee at Wright State University
under protocol numbers 736 and 738. All transgenic lines were bred at Wright State.
Pups were tail clipped for genotyping and feet tattooed before P5 for identification.

Genotyping
All genotyping was carried out with help from Mrs. Maria Berrocal. DNA from
tail clips were extracted using Qiagen‟s DNeasy® kit. Genotypes were determined by
Polymerase Chain Reaction (PCR) with primers reported in the table below. The PCR
was carried out using a MyCycler™ Bio Rad thermocycler with HotMaster™ Taq
DNA Polymerase (Eppendorf Brinkmann Instruments, Inc) under the following
condition: 5 min 95ºC pre-melt step, followed by 35 cycles of 30 sec 95ºC melt, 30 sec
60ºC anneal, and 7 min 72ºC extension. PCR products were analyzed using 2% agarose
gel electrophoresis in 1X TBE buffer with ethidium bromide staining.

Table 1. Primer sequences used for PCR and expected PCR products.
PCR
product
1Kb

Primer

Primer sequence

Cre

Cre 3: (5‟ to 3‟) TAA TCG CCA TCT TCC AGC AG
Cre 4: (5‟ to 3‟) CAA TTT ACT GAC CGT ACA C

GFP/YFP

EGFP-1: (5‟ to 3‟) GAC GTA AAC GGC CAC AAG TT
EGFP-2: (5‟ to 3‟) GAA CTC CAG CAG GAC CAT GT

600bp

R26tdTomato

oMIR9020: (5‟ to 3‟) AAG GGA GCT GCA GTG GAG TA
oIMR9021: (5‟ to 3‟) CCG AAA ATC TGT GGG AAG TC
oIMR9103: (5‟ to 3‟) GGC ATT AAA GCA GCG TAT CC
oIMR9104: (5‟ to 3‟) CTG TTC CTG TAC GGC ATG G

200bp300bp

Genotype
WT: No band
Mutant: 1kbp
WT: No band
Mutant: 500600bp
WT: 297bp
Mutant: 196bp
Heterozygous:
297 and 196bp
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Timed pregnancies: hormonal treatment
To determine embryonic ages with less than a 12 hour error, pregnancies were
facilitated using hormonal injections in females and restricting the mating timeschedules. Hormonal treatment also maximized the number of pregnant females by
increasing the number of ova released. Two hormones were injected, Pregnant Mare
Serum Gonadotropin (PMSG, Calbiochem, LaJolla, CA, USA), which induces
follicular development on day 1, and 48 hours later, Human Chorionic Gonadotropin
(HCG, Sigma, CG-10., St Louise, MO, USA) which induces ovulation. Both were
intraperitoneally injected (5.0 IU) at 12 pm with a 48 hour delay between them. The
females were caged with the males 6 hours after the last hormone injection (beginning
of the dark period) to ensure fertilization. The following morning, at 8 am, we checked
for vaginal plugs. A positive plug was considered E0.5. Females were weighed daily to
confirm successful pregnancy.

Tissue preparation and immunohistochemistry
Mice of different postnatal ages (P0, P5 and P15) were anesthetized with
Euthasol (2.0 μg/g i.p.) and perfused transcardially with 4% paraformaldehyde in 0.1M
phosphate buffer (PB). After perfusion, spinal cords were dissected, postfixed in 4%
paraformaldehyde overnight and cryoprotected in 0.1M PB (pH 7.4) with 30% sucrose
and 0.01% sodium azide. Mouse embryos were extracted from similarly perfused
pregnant mothers and fixed in toto overnight and then cryoprotected in 30% sucrose.
Embryonic developmental stages were confirmed using the Atlas of Mouse
Development (Kaufman, 2005). Histological sections from postnatal spinal cord or
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embryos were obtained using a freezing sliding microtome, a vibratome or a cryostat
depending on section thickness and age of the preparation. We always used indirect
immunofluorescence methods to reveal the proteins of interest. The exact method and
antibodies used are detailed in each of the specific aims.

Analyses
Immunolabeled sections were analyzed using a Olympus FV 1000 confocal
microscope or with epifluorescence in a Neurolucida system. Image analysis of
confocal images was done with Fluoview (Olympus), ImagePro (Media Cybernetics)
and Neurolucida software (Microbrightfield), a neuron tracing and neuron plotting
system. Cell counts and plots were done on “live” epifluorescence in an Olympus
BX51 microscope equipped with a motorized stage (Luld electronics, Harborne, NY)
and coupled to a digital camera (Microfire, Optronics, Goleta, CA). Statistical analyses
were performed using SigmaStat (version 3.1, Jandel).

Figure composition
Figures were composed using CorelDraw (ver. 12.0) and graphs in Sigma Plot
(ver. 9.0, Jandel). Image modifications for presentation such as, adjusting contrast and
brightness were done in Image Pro Plus (ver. 5.0 Media Cybernetics, Bethesda, MD)
and preserved all the information content in the original images. Some images were
sharpened using a “high gauss” filter. Quantification was always carried out in original
unprocessed images.
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AIM 1
DETERMINATION OF BIRTHDATES OF
DIFFERENT POPULATIONS OF V1DERIVED INTERNEURONS
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INTRODUCTION
The development of spinal cord locomotor circuits depends on the
differentiation of the many types of ventral horn interneurons (INs) that modulate
motor output (reviewed in Jankowska, 1992; 2008; Brownstone and Bui, 2010). These
derive from just a few embryonic subtypes classified according to their early
transcription factor expression and origins from specific groups of progenitor cells
(Goulding and Lamar, 2000; Briscoe et al., 2000; Goulding and Pfaff, 2005; Goulding,
2009). The mechanisms by which the variety of adult interneuronal circuits emerge
from just a few progenitors and subclasses of INs in the embryo are unknown.
Spinal cord INs derive from ten progenitor domains. Six dorsal (pd1 to pd6) and
four ventral (p0, p1, p2, and p3) that give rise respectively to dl1 to dl6 dorsal and V0,
V1, V2, and V3 ventral embryonic INs, respectively (Goulding, 2009). Motoneurons
are generated in an independent ventral domain (pMN), located between p2 and the
ventral most p3. Although some premotor INs can be originated from dorsal domains
(for example medial laminae V/VI GABAergic neurons, Wilson et al., 2010), many INs
that target monosynaptically motoneurons are derived from ventral groups.
V1-derived interneurons (V1-INs) are characterized by the expression of the
transcription factor engrailed-1 (En1). Their differentiation potential seems restricted to
development of ventrally and laterally located inhibitory INs that extend axons that
project ipsilaterally (and that initially take an ascending course). V1 axons frequently
make synapses directly onto motoneurons, in addition to other lamina VII neurons
(Saueressig et al., 1999; Alvarez et al., 2005). In the adult, all Renshaw cells and some
IaINs derive from V1-INs (Sapir et al., 2004; Alvarez et al., 2005; Siembab et al.,
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2010). Although Renshaw cells and IaINs share some common properties (they are
inhibitory INs with ipsilateral projections), their functionality, connectivity and
properties are very different in the adult. In the neonate, V1-derived Renshaw cells and
IaINs also display different neurochemical phenotypes and connectivity with
motoneurons, primary afferents and in between them (Wang et al., 2008; Siembab et
al., 2010). This prompts the question of when they start to differentiate within the V1
group and what factors are involved in determining their fate.
One mechanism of differentiation that is relatively widespread in brain regions
with laminar organization (cortex, retina) is based on the time in which cells become
postmitotic (reviewed in the background section). Within a single group of neurons
their time of generation influences their migration and final location not only in laminar
structures but also in brain nuclei (eg. rostral vs. caudal hypothalamic gonadotropinreleasing hormone neurons: Jasoni et al., 2009). Birth-date can also influence
neurochemical phenotype and connections (e.g., different types of amacrine cells in the
retina: Voinescu et al., 2009). In the spinal cord it is known that motoneuron birth-date
influences their columnar localization and axonal projections (Hollyday and
Hamburger, 1977; Sockanathan and Jessell, 1998).
Less is known on the role of birth-dates for the specification of spinal INs. Early
birth-dating studies using tritiated thymidine suggested that IN neurogenesis from
ventral progenitors occurs earlier than from dorsal progenitors (Nornes and Das, 1974;
Nornes and Carry, 1978), but it is not clear if birth-date is of any relevance for the
differentiation of different subclasses of INs from single progenitor domains. Recent
studies in zebrafish and in mouse analyzed the derivation of IN subtypes from the p2
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domain (V2). In the adult zebrafish spinal cord, there are fewer IN subtypes than in
mammals, and these are more closely related to their embryonic counterparts
(Goulding, 2009). One class of excitatory IN (CiD) corresponds to V2a INs according
to transcription factor expression (Alx the homolog of mammalian Chx10). This group
is divided into early and late born cells, and each respectively ends up being located
more dorsally or more ventrally in the spinal cord and becomes recruited during fast or
slow movements (Kimura et al., 2006). Thus, within a single class of adult INs (CiDs)
birthdate can impose a gradient of connectivity and function. However, the p2 domain
is also known to generate different classes of INs, the V2a excitatory and the V2b
inhibitory groups, each characterized by a different transcription factor. This division of
the V2 lineage seems to occur in both mice and zebrafish at the time of neurogenesis
and involves a notch-delta lateral signaling mechanism that does not necessitate of
temporal differences in V2a and V2b generation (Peng et al., 2007; Kimura et al.,
2008). In this thesis, which is contemporary to all these recent studies, we will test the
hypothesis that a different mechanism is at work in the p1 progenitor domain, that is
that Renshaw cells and IaINs derived from this domain have different birth-dates.
A suitable method to monitor the „birth-date” of neurons, meaning the time they
exit the cell cycle and become postmitotic, is to inject in pregnant females at different
stages during pregnancy bromodeoxyuridine (BrdU). BrdU incorporates during S-phase
in the DNA of dividing cells and remains at high concentration in the nucleus only if
the cell becomes postmitotic immediately after (Miller and Nowakowski, 1988;
reviewed in Taupin, 2007). To find the specific “birth-dates” of V1-derived Renshaw
cells and IaINs we pulse-labeled embryos in pregnant females with BrdU at embryonic

70

ages from E9.5 to E12.5. Previous studies suggested that V1-INs exit the progenitor
zone and start to differentiate between E9 and E12 (Matise & Joyner, 1997; Saueressig
et al., 1999). Analyses were carried out in P15 spinal cords from these animals because
at this postnatal age, the phenotypic features that distinguish subgroups of V1-derived
INs are already well established (Siembab et al., 2010). We used two different
transgenic mouse lines expressing genetic markers for the V1 lineage combined with a
number of histochemical criteria to distinguish Renshaw cells from IaINs (Alvarez et
al., 2005; Siembab et al., 2010). In the Tau-LacZ line we distinguished timing of BrdU
incorporation between calbindin-IR and parvalbumin-IR V1-derived INs, while in the
Thy1-YFP line we distinguished between Renshaw cells and IaINs according to their
distinct synaptic inputs at P15 (see Siembab et al., 2010).

MATERIALS AND METHODS
Animals
Timed-pregnant females were obtained as explained before. All procedures
were carried out according to NIH guidelines and were approved by WSU LACUC.

BrdU injections
Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) is a thymidine analog that
incorporates into dividing cells during S-phase (Fig.13). BrdU has to be administered in
the right dose to avoid lethal effects or morphological or functional alterations (Taupin
et al., 2007; Kolb et al., 1999). NeuN-labeling of P15 spinal cords indicated that the
dose chosen for this study (60 mg per Kg weight) did not produce alterations in the size

71

of the gray matter or cell numbers, suggesting that this dose of BrdU does not affect
spinal cord neurogenesis or morphogenesis.
Knowledge of the time course of BrdU incorporation in tissues is important for
correct interpretation. Injected BrdU is metabolized through dehalogenation if not
integrated into DNA. In the adult, BrdU is available for labeling new born neurons with
a half-life of around 2 hours, after which there is an abrupt drop in concentration. If we
assume similar availability in fetal tissue and consider that the cell cycle length is of
approximately 12-14 hours and the S-phase lasts around 4 hours, a single injection will
label only cells that enter S-phase during the 2 hours of BrdU availability after the
injection (Taupin, 2007; Packard et al., 1973). Therefore, pulse labeling with a single
injection increases timing accuracy, but only labels a small percentage of cells.
The animals were injected with BrdU (Sigma Aldrich, St. Louis, MO, 15mg/ml,
60mg/kg of body weight) diluted in 0.9% NaCl and 0.007% NaOH. BrdU injections
were made at five different ages, E9.5, E10.5, E11.5, E12.0, and E12.5. E9.5 is just
after neural tube closure in the lumbar region. Previous studies from our laboratory
(Maria Berrocal and Francisco J. Alvarez, unpublished) have shown that that after
E12.5 there is no BrdU incorporation in V1-INs. All BrdU injections were administered
intraperitoneally to pregnant females at 12 pm. Fourteen En1-Cre/Tau-LacZ and ten
En1-Cre/Thy1-YFP pregnant females were injected at different embryonic ages.

Tissue preparation
Mice pups from litters treated with BrdU in embryo were anesthetized at P15
with Euthasol (2.0 μg/g i.p.) and perfused transcardially with 4% paraformaldehyde in
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0.1M phosphate buffer (PB). After perfusion the spinal cords were dissected, postfixed
overnight in 4% paraformaldehyde and cryoprotected in 0.1M PB (pH 7.4) with 30%
sucrose and 0.01% sodium azide. The spinal cords were stored in this solution at 4°C.

Immunolabeling and analysis of V1-INs pulse-labeled with BrdU.
Fourteen En1-Cre/Tau-LacZ and ten En1-Cre/Thy1-YFP P15 animals were used
to study the distribution of BrdU pulse-labeled V1-INs at five different ages (E9.5,
E10.5, E11.5, E12.0 and E12.5). For each line/age one timed-pregnant female was
injected and all animals in the litter expressing genetic markers for V1 INs analyzed.
One exception was E10.5 in which two females were injected with BrdU. From these
litters we analyzed 3 animals per age in the En1-Cre/Tau-LacZ line (except for E12.5 in
which two animals were analyzed) and 2 animals per age in the En1-Cre/Thy1-YFP.
Fifty micron thick sections were obtained in a freezing sliding microtome from
the upper (2 and 3) and lower (4 and 5) lumbar segments and processed free-floating.
Sections from En1-Cre/Tau-LacZ animals were quadruple immunolabeled for
calbindin, parvalbumin, β-galactosidase and BrdU. Sections from En1-Cre/Thy1-YFP
were triple immunolabeled for calbindin, YFP and BrdU. All spinal cord sections were
blocked with normal donkey serum diluted 1:10 in 0.01 M PB saline (pH 7.4) with
0.1% or 0.3% Triton X-100 (PBS/Tx) and then incubated overnight with primary
antibodies diluted in PBS/Tx. LacZ expression in the En1-Cre/ Tau-LacZ was revealed
with chicken polyclonal antibodies against β-galactosidase (β-gal, 1:500, AbCam Inc.,
Cambridge, MA). Yellow Fluorescent Protein (YFP-IR) in the En1-Cre/Thy1-YFP was
enhanced using an antibody against Green Fluorescent Protein (anti-GFP polyclonal
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sheep diluted 1:800, Biogenesis, Brentwood, NH or chicken polyclonal diluted 1:5000,
Aves Labs, Tigard, OR). The anti-β-gal antibody was combined with rabbit polyclonal
antibodies against calbindin (calbindin D28-K, 1:500, Swant, Bellinzona, Switzerland)
and a mouse monoclonal against parvalbumin (1:500, Chemicon, Temecula, CA). The
anti-GFP antibody was combined only with rabbit anti-calbindin antibodies (to
determine Renshaw cell contacts on YFP labeled V1-INs). The primary antibodies used
and their specificity are summarized in Table 2 below.

Table 2. Antibodies used in aim 1 and labeling specificity.
Antibody
name
Calbindin
D28K

Type

Hostspecies

Dilution

Company

Specificity

Polyclonal

Rabbit

1:500

Swant,
Bellinzona

Parvalbumin

Monoclonal

Mouse

1:500

Chemicon

β-gal

Polyclonal

Chicken

1:1000

Abcam Inc.

GFP

Polyclonal

Chicken

1:5000

Aves Labs

BrdU

Monoclonal

Rat

1:5000

Sigma
Aldrich

No labeling in KO
tissue
No labeling in KO
tissue
No labeling in
animals with no
reporter expression
No labeling in
animals with no
reporter expression
No labeling in
untreated animals

Immunoreactive sites for β-gal were revealed with a biotinylated donkey antichicken antibody (1:100, Jackson InmunoResearch, West Grove, PA) followed by
Alexa-405

conjugated

streptavidin

(Invitrogen,

Carlsbad,

CA)

and

YFP-

immunoreactive sites were revealed using secondary antibodies conjugated to
fluorescein-isothiocyanate (FITC, 1:100; Jackson InmunoResearch). Calbindin was
revealed with FITC-conjugated antibodies and parvalbumin using cyanine-5 (Cy5)
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conjugated secondary antibodies (all donkey raised and diluted 1:100 in PBS/Tx;
Jackson InmunoResearch) in combination with Alexa 405 β-gal immunofluorescence.
Calbindin was revealed with Cy5-conjugated antibodies in combination with FITC
YFP-immunofluorescence. The Cy3 red channel was reserved to immunodetect BrdU
in all preparations in a follow-up second immunostain. In preliminary experiments we
found that treatments to reveal BrdU-immunoreactivity damage the antigenicity for
calbindin, parvalbumin, β-gal and YFP and therefore these immunostains were
performed before BrdU immunostaining.
For BrdU immunolocalization the DNA was denatured with increasing
concentrations (1 to 2N) of hydrochloric acid (HCl) at increasing temperatures (4°C to
37°C). The acid was washed immediately at room temperature with borate buffer
(0.1M) and then 0.1M PBS/Tx. Finally the sections were incubated overnight with a rat
anti-BrdU monoclonal antibody (dilution 1:5,000; AbCam Inc. Cambridge, UK). BrdU
immunoreactivity was revealed with secondary antibodies against rat IgGs coupled to
cyanine 3 (Cy3; dilution 1:50 to 1:100 in PBS/Tx, Jackson ImmunoResearch). After all
immunoreactions were done the tissue sections were washed in 0.01 M PBS and
mounted on gelatin-coated or Histobond (VWR, West Chester, PA, USA) slides and
cover-slipped with Vectashield (Vector, Burlingame, CA).

Classification of BrdU cells
BrdU was detected using immunohistochemistry and we distinguished strong
and weak nuclear labeling (Fig. 14E, F). In strongly labeled cells, two-thirds or more of
the nuclear area was stained homogeneously and these cells were interpreted as cells
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that exited the cell cycle immediately after BrdU incorporation (Fig.13). In this case,
BrdU was not diluted by further divisions as nuclei of these cells were almost fully
covered with strong staining. In contrast, weakly labeled cells appeared to have
speckled labeling within the nuclei. Weakly labeled cells can result from: 1) Dilution of
BrdU content through further divisions and DNA replication cycles, 2) DNA repair
mechanism in some cells, 3) weak incorporation of BrdU during the pulse, for example
if a cell enters S-phase at the end of the period of BrdU availability when BrdU
concentration diminishes, 4) BrdU incorporation at different phases of S-phase with
different chromatin organization (Ferreira et al., 1997). Thus, it is difficult to be certain
about the exact significance of weakly labeled cells. We analyzed strong and weakly
labeled cells in all our analyses, but we only present data for strongly BrdU labeled
cells.
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Figure 13. BrdU incorporation into DNA during S-phase of the cell cycle. BrdU is
only incorporated during DNA replication. If the cell leaves the cell cycle right after
BrdU incorporation the nuclei appears strongly labeled, while if the cells goes through
further divisions or there was not enough BrdU available in the system it appeared as
weakly labeled with BrdU.
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Analysis
The numbers and positions of V1-INs with or without calbindin or parvalbumin
that incorporated BrdU at each embryonic age were plotted on a Neurolucida system
(MicroBrightField, Colchester, VT) coupled to an epifluorescence BX50 Olympus
microscope with a motorized stage (Luld electronics, Harborne, NY) and z-axis
encoder and imaged “live” with a digital color camera (Microfire CCD, Optronics,
Goleta, CA). V1-INs with and without BrdU labeling were counted and their positions
plotted on outlines of the spinal cord sections obtained first at low magnification. To
identify YFP-V1 INs receiving calbindin contacts (i.e., IaINs) we obtained higher
resolution confocal images (at 10X, 20X and 60X) using an Olympus FV100 system.
Image confocal stacks were obtained through the whole tissue section and fed into
Neurolucida for counting and plotting. We analyzed 10 ventral horns per animal in
lower and upper lumbar levels. Three animals were analyzed per age in the En1Cre/Tau-LacZ line (with the exception of E12.5 in which only two animals were
studied) and two animals per age in the En1-Cre/Thy1-YFP. From the Neurolucida
cellular plots we estimated: 1) the percentage of V1 INs labeled with nuclear BrdU in
the En1-Cre/Tau-LacZ and En1-Cre/Thy1-YFP lines, 2) the percentage of calbindin- or
parvalbumin-immunoreactive V1 INs that incorporated BrdU at each embryonic age
using the En1-Cre/Tau-LacZ line and 3) the percentage of V1-derived Renshaw cells
and IaINs with BrdU in the En1-Cre/Thy1-YFP line.
The data is presented for individual animals as well as average percentages
obtained by pooling together the animal averages from each line or the two animal lines
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when possible (n = 4 to 5 animals). Pooled averages were compared using one-way
ANOVA (SigmaStat ver. 2.0, Jandel). Significance was set at p<0.05.

Dorso-ventral distribution of BrdU labeled V1-derived interneurons.
The thoracic segments of 12 spinal cords from P15 En1-Cre/ Tau-LacZ animals
were used to analyze possible differences in dorso-ventral location of BrdU labeled V1INs. The animals were pulsed labeled with BrdU at E9.5, E10.5, E11.5 and E12.5 (n=3
animals per age). Thoracic segments were used in this analysis because in this region
the ventral horns preserve better the original embryonic orientation of the grey matter.
Spinal cord sections were double immunostained as previously described. The cells
were counted and plotted in the Neurolucida system. The positions of BrdU labeled V1INs were analyzed in a grid of five dorso-ventral 100 μm bins dividing the ventral horn
in different dorso-ventral regions. We analyzed 10 ventral horns per animal.

Internal controls for the timing of BrdU injections and BrdU incorporation.
The spinal cord at thoracic levels contains five groups of cholinergic neurons
that can be immunolabeleld with antibodies against choline acetlytransferase (ChAT)
and have known birth-dates (Barber et al., 1984; Phelps et al., 1988; Phelps et al., 1991;
Barber et al., 1991). To confirm that BrdU injections were delivered at the correct
estimated times in pregnant females, we first analyzed the dorso-ventral distribution of
all BrdU labeling and then the labeling in different groups of ChAT-immunoreactive
neurons. Thoracic spinal cord sections from all the animals used in the study were
double immunolabeled with a goat polyclonal ChAT antibody (diluted 1:500, Milipore,
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Billerica, USA) and the rat monoclonal BrdU antibody (1:5000, AbCam Inc.
Cambridge, MS, USA) using the same method described before. Immunolabeling for
ChAT using FITC conjugated secondary antibodies was followed by DNA denaturation
and BrDU immunohistochemistry revealed with Cy3-conjugated antibodies. The
percentage of strongly BrdU-immunolabeled in each cholinergic group was estimated
using the Neurolucida plotting system. We analyzed 10 to 20 ventral horns in all the
En1-Cre/Tau-LacZ and En1-Cre/Thy1-YFP animals prepared for study. Litters in which
BrdU was preferentially incorporated into the inappropriate cholinergic group
according to time of embryonic injection were discarded. We only discarded 2 animals
for one litter of the En1-Cre/ Tau-LacZ line and 3 animals from one litter in the En1Cre/Thy1-YFP line. This represents an 80-85% success rate with our method of timing
pregnancies. However, given that males and females are caged together for 12 hours
before checking plugs we should expect ±0.5 day error in our estimated times.

Figure composition
All images for presentation were obtained with an Olympus FV1000 confocal
microscope. Triple or quadruple color immunofluorescent preparations were first
imaged at low magnification (10x1 or 20x1). Representative cells were selected for
obtaining series of confocal optical sections throughout their cells bodies and dendrites
at high magnifications using a 60x1 oil objective (N.A. 1.35) and a z-step of 0.5μm.
Figures were composed using CorelDraw (ver. 12.0) and graphs in Sigma Plot (ver. 9.0,
Jandel).
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RESULTS
BrdU pulse-labeled neurons in the spinal cord from E9.5 to E12.5
In P15 mouse spinal cords, we found overall a ventral to dorsal and lateral to
medial pattern of IN labeling with BrdU delivered at increasingly older ages from E9.5
to E12.5 (Fig. 14). This pattern is similar to that described before using 3H-thymidine
injections in the mouse (Nornes and Das, 1974; Nornes and Cary, 1978). In the lumbar
cord at E9.5, mostly motoneurons in LIX together with a few ventral INs clustered
around motor pools incorporated strong BrdU labeling (Fig. 14A). At E10.5 (Fig. 14B),
there were fewer motoneurons strongly labeled with BrdU and the number of INs
increased. BrdU-labeled INs are mostly located ventrally in LVII and LVIII. From
E11.5 to E12.5 (Fig. 14C and D) strongly labeled INs were found in more medial and
dorsal locations. At E11.5 and later, we found no BrdU in motoneurons and at E12.5,
strongly labeled INs were restricted to the dorsal horn. These distributions of BrdUlabeled cells in the spinal cord agrees well with the known gradient in cell generation
indicating a correct estimate of timed pregnancies and embryonic injections.

Analysis of BrdU incorporation in cholinergic groups
To ensure that the estimated embryonic times for BrdU injections were correct,
we further analyzed BrdU labeling of cholinergic neurons in thoracic segments in all
litters that generated. There are five types of ChAT-immunoreactive neurons at thoracic
levels. These include ventrally located somatic motoneurons (MN), intermedio lateral
horn motoneurons (IML), partition cells (PC), central canal cluster cells (CC) and
dorsal horn INs (DH) (Barber et al., 1984). Each group exhibits a characteristic birth-

82

Figure 14. Distribution of Bromo-deoxyuridine (BrdU) labeled nuclei in spinal
cord hemisections at four different ages. Low magnification (A, B, C, D) and high
magnification (E, F) confocal images of lumbar spinal cord hemi-sections
immunolabeled with BrdU (Cy3, red) and either β-galactosidase (β-gal; 405, E) or
Yellow Fluorescent Protein (YFP; FITC, F) in En1-Cre/Tau-lacZ (E) and En1Cre/Thy1-YFP (F) P15 animals. Pregnant females were injected with BrdU at gestation
days 9.5, 10.5, 11.5, and 12.5. The dotted white lines delineate the border between the
white and grey matter and continuous white lines outline the spinal cord. The border
between lateral lamina IX and the rest of the spinal cord is also indicated. A)
Distribution of BrdU-immunoreactive (BrdU-IR) nuclei in animals injected at E9.5.
Both motoneurons (solid white arrows) and some ventral interneurons display strongly
labeled nuclei. B) Distribution of BrdU-IR in animals injected at E10.5. The BrdU
pattern is restricted to a few very ventral interneurons and some more lateral and dorsal
interneurons. C) BrdU-IR in animals injected at E11.5 showing almost no ventral
labeling. Most labeled nuclei are located close to the central canal and dorsally. D)
Distribution of BrdU-IR nuclei in an animal injected at E12.5 showing only dorsally
labeled nuclei. E) High magnification confocal image of BrdU-IR nuclei in cells from
an En1-Cre/Tau-lacZ animal. Some nuclei of V1 cells (β-gal positive in blue) show
strong (solid white arrows) or weak (open arrow) immunolabeling. F) BrdU-IR nuclei
in En1-Cre/Thy1-YFP animal injected at E10.5 (solid white arrows, strong labeling;
open white arrows, weak BrdU-IR). Scale bars; 200μm in A (B, C, and D have same
magnification); 10μm in E (F has same magnification).
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date peak in rats tested with 3H-thymidine (Phelps et al., 1988); MN and IML are
generated simultaneously around E11, while PC, CC, and DH peak respectively at E12,
E13 and E14. Thus, we expected that the proportions of strongly labeled BrdU cells in
each cholinergic group should confirm the sequence of embryonic BrdU injections.
Direct comparison of exact ages with the rat is not possible since spinal cord
neurogenesis occurs slightly earlier in the mouse. In the mouse, 90% of MNs are
generated between E9 and E10.5 (Sims and Vaughn, 1979; Holley et al., 1982;
Wentworth, 1984). This suggests that generation of other cholinergic neurons in the
mouse might also occur 2 days earlier. Consistent with this most animals pulse-labeled
with BrdU at E9.5 displayed labeling mostly in somatic (MNs) and visceral
motoneurons (IMLs), while at E10.5 MN labeling had decreased and BrdU
incorporation was predominant in PC cells (Figs. 15 and 17). At E11.5, the largest
BrdU labeled group were CC cells and at E12 many CC cells were still labeled while
the proportion of DH cells increases (Figs 15, 16 and 17). Finally, at E12.5 only DH
INs incorporated BrdU (Figs. 16 and 17). Thus, the generation sequence of thoracic
cholinergic INs in the mouse spinal cord is in good agreement with the pattern
described in the rat with a 24-36 hour difference in different cholinergic subgroups.
Moreover, the labeling patterns confirmed estimated embryonic times for BrdU pulselabeling in the majority of animals. Two out of twelve BrdU injected litters in the En1Cre/Thy1-YFP and one out of sixteen in the En1-Cre/Tau-LacZ were discarded because
the pattern of incorporation of BrdU in cholinergic cells did not match the timing of the
BrdU injections. This error was most likely due to pregnancy dating errors and these
animals were not analyzed further.
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Figure 15. Distribution of BrdU-labeling in cholinergic neurons in thoracic
segments after BrdU injections (E9.5, E10.5 and E11.5). A, C, and E) Low
magnification and B, D, and F) high magnification confocal images of P15 mouse
thoracic spinal cord sections dual immunolabeled from BrdU (Cy3, red) and ChAT
(Choline Acetyltransferase, green, FITC). BrdU injections were done at E9.5 (A and
B), E10.5 (C and D) and E11.5 (E and F). Yellow boxes in A, C and E indicate the
areas shown at higher magnification in B, D and F. Dotted lines delineate the border
between the white and grey matter. The central canal is also indicated in the center. In
the high magnification images (B, D and F) solid white arrows indicate cells strongly
labeled with BrdU, while open arrows point to weakly labeled cells. A, B) At E9.5
strong BrdU-labeling appears mostly on motoneurons and intermedio-lateral
motoneurons (IML). C, D) At E10.5 fewer motoneurons are strongly labeled with BrdU
and mostly partition cells are strongly labeled (PCs, large cholinergic interneurons
close to the central canal). E, F) At E11.5, we can still detect some PC cells strongly
labeled; however, the smaller central canal cells (CC) are the predominant group
labeled at this age. Scale bars; 200μm in A (C and E have the same magnification);
100μm in B (D and F have the same magnification).
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Figure 16. Continuation on the distribution of BrdU-labeling in cholinergic
neurons in thoracic segments after BrdU injections (E12.0 and E12.5). G and I)
Low magnification and H and J) high magnification confocal images of P15 mouse
thoracic spinal cord sections dual immunolabeled from BrdU (Cy3, red) and ChAT
(Choline Acetyltransferase, green, FITC). BrdU injections at E12.0 (G and H) and
E12.5 (I and J). Labeling is as in Figure 15. At these ages most BrdU-IR cells are
located in the dorsal horn. However, at E12.0 (G and H) we can still detect some CC
cells generated near the central canal, while none of the CC cells at E12.5 are labeled.
Scale bars; 200μm in G (I has the same magnification); 100μm in H (J has the same
magnification).
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Figure 17. Quantification of BrdU incorporation in thoracic cholinergic neurons.
A) Diagram of the thoracic spinal cord showing the location of the five different types
of cholinergic neurons described previously in the rat (dotted rectangles). B) Low
magnification confocal image of a P15 mouse thoracic spinal cord section
immunolabeled for ChAT (green, FITC). Yellow dotted line delineates the border
between the white and grey matter. White dotted boxes indicate the locations of the
cholinergic cells. C and D) Percentage of ChAT positive interneurons of each type
strongly labeled with BrdU at the different ages in the litters obtained from En1Cre/Tau-lacZ (C) or form En1-Cre/Thy1-YFP (D) mouse lines. Each bar shows the
average value of all the animals analyzed at each age. Data sample in C: N=5 animals at
E9.5, N=7 animals at E10.5 and N=4 animals at E11.5 and E12.5. In each animal 10
ventral horns were counted at thoracic level. Error bars indicate S.E.M. Data sample in
D, two animals were analyzed at each embryonic age. Bars indicate the average
between these two animals. No error bars are shown. In both cases, we can observe that
at E9.5 motoneurons (MN and IML) are the most predominant labeled group. The most
abundant group born at E10.5 are the partition cells; while at E11.5 are the central canal
cells followed by the dorsal horn cells at E12.0 and E12.5. However, while at E12.0 we
can still detect CC, at E12.5 there is no other cell type generated besides the dorsal horn
cells. Note: error bars increase when the number of cells sampled per section is very
low (1 or 2 cells), that is the case for the relatively rare dorsal horn cholinergic neurons.
E) Cell type distribution according to age. Grey boxes represent the cell type most
abundant at each age studied. White boxes indicate fewer strongly BrdU labeled cells.
A dash indicates no cells were found strongly labeled with BrdU. This pattern of BrdU
incorporation in our litters confirms the expected birth-dates of cholinergic neurons and
demonstrates that injections times correspond with the expected values
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Distribution of BrdU labeling in the V1 population
V1-derived INs were identified in each transgenic line by either nuclear β-gal or
YFP labeling (Fig. 14E and F). BrdU labeling was confined to the cell nucleus.
Sometimes most of the cell nucleus was covered with BrdU immunoreactivity, another
times only a few speckles were found. Only data on strongly labeled cells (>75%
nuclear coverage) is presented below. V1-derived INs were located ventrally (Figs. 10,
11, and 12). As previously reported (Siembab et al., 2010) there were approximately
25% less V1 cells in En1-Cre/Thy1-YFP animals compared to En1-Cre/Tau-LacZ (Fig.
18A). We compared upper lumbar (L2 and L3) segments to lower lumbar (L4 and L5)
regions because the possibility of rostro-caudal differences in cell number and/or
generation time. No differences between upper and lower lumbar regions were noted in
total number of V1 INs in the Tau/LacZ and Thy1/YFP lines (Fig. 18A). Similarly
there was little variation in the number of V1-derived INs expressing calbindin or
parvalbumin (Fig. 18B), or classified as Renshaw cells or IaINs (Fig. 18B and 18C; this
is more likely because analysis in upper lumbar segments were biased towards lumbar 3
sections). The only exception was a dorsally located calbindin-IR V1 IN characterized
by a very large size soma and dendrites (“Big calbindin”). This cell type was only
found in lumbar 2 and 3 levels (Fig. 18B).
Analyses of BrdU incorporation confirmed that V1-INs incorporate BrdU from
E9.5 to E12, with almost no V1 cells pulse-labeled by BrdU at E12.5 (Figs. 19 and 20).
Quantitative analyses suggested that there are two peaks of V1-IN generation, one at
E10.5 and the other at E12.0 with lower BrdU labeling at E9.5 and E.11.5. This result
was consistent in different animals, lines and in different lumbar segments (Figs. 21 and
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Figure 18. Comparison of V1-INs number examined in En1-Cre/Tau-lacZ and
En1-Cre/Thy1-YFP animals and at different lumbar levels. A) Average total number
of V1-derived interneurons sampled per ventral horn in different animals from each
mouse line and lumbar region. Fourteen animals were analyzed in the En1-Cre/TauLacZ lines. Ten animals were analyzed in the Thy1-YFP line. Ten ventral horns were
counted per animal in each lumbar segment, lower (L4/L5) and upper (L2/L3). No
significant differences were detected in cell numbers per ventral horn between lower
and upper lumbar segments within each line (t-test, P>0.05). However, between lines
there is a significant 25% decrease in the number of V1-INs detected per ventral horn in
the En1-Cre/Thy1-YPF line (t-test, P<0.05). B) Average numbers of different V1 cell
types detected in En1-Cre/Tau-LacZ animals: V1-derived calbindin-IR (V1-CB),
Renshaw cells (RC), V1 big-calbindin-IR (V1-big CB), and V1-derived parvalbumin
cells that are not Renshaw cells (non-Renshaw cells, V1-PV). Differences in between
lumbar segments are not significant except in the case of big CB-IR cells that are not
found in lumbar 4 and 5 segments. C) In the Thy1-YFP line only two cell types were
distinguished: Renshaw cells (RC) versus Ia inhibitory interneurons (IaINs). Similar
numbers were detected in different lumbar segments (t-test, P>0.05). All error bars
indicate standard error of the mean (S.E.M).
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Figure 19. Distribution of BrdU-immunoreactivity in V1-derived interneurons in
En1-Cre/Tau-lacZ P15 mice pulse-labeled with BrdU at 4 different ages. A, D, G,
and J) Distribution of V1-derived interneurons in the P15 ventral horn immunolabeled
against β-gal (Alexa 405, blue). B, E, H, and K) Pattern of BrdU labeling in the same
sections (Cy3, red). Solid white arrows point to V1-derived interneurons strongly
labeled with BrdU while open arrows point to non-V1 interneurons cells strongly
labeled with BrdU. C, F, I, and L) Superimposition of BrdU and nuclear LacZ
labeling. Females were injected at 4 embryonic ages. A-C: E9.5; D-F: E10.5; G-I:
E11.5; J-L: E12.5. The dotted lines indicate the border between the white and grey
matter in the ventral spinal cord. The images clearly show how the BrdU labeling starts
laterally and ventrally and moves medially and dorsally as the development progresses.
By E12.5 there are very few ventral V1 neurons strongly labeled with BrdU. Scale bar;
100 μm in A (all images have the same magnification).
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Figure 20. Distribution of BrdU-immunoreactivity in V1-derived interneurons in
En1-Cre/ Thy1-YFP P15 mice pulse-labeled with BrdU at 4 different ages. A, D, G,
and J) Distribution of YFP-labeled V1-derived interneurons (green, FITC + YFP) in
the P15 ventral horn. B, E, H, and K) Pattern of BrdU labeling in the same sections
(Cy3, red). Solid white arrows point to V1-derived interneurons strongly labeled with
BrdU while open arrows point to non-V1 interneurons cells strongly labeled with BrdU.
C, F, I, and L) Superimposition of BrdU and YFP labeling. Females were injected at 4
embryonic ages. A-C: E9.5; D-F: E10.5; G-I: E11.5; J-L: E12.5. The dotted lines
indicate the border between the white and grey matter in the ventral spinal cord. The
images show how the BrdU labeling starts laterally and ventrally and moves medially
and dorsally in animals injected with BrdU at older ages. By E12.5 there are very few
ventral V1 neurons strongly labeled with BrdU. Scale bar; 100 μm in A (all images
have the same magnification).
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22). We did not observe differences between the two mouse lines, other than the
number of BrdU strongly labeled V1 cells was higher in En1-Cre/Tau-LacZ animals
due to the higher number of labeled V1-INs compared to the En1-Cre/Thy1-YFP. When
pooling data from both lines together (Fig. 22 E, F), it appears that there are two waves
of S-phase BrdU incorporation in V1 INs. One starting at E9.5 and peaking at E10.5
and the second starting at E11.5 and peaking at E12.

Thoracic distribution of V1-derived interneurons labeled with BrdU at different ages.
Kimura et al. (2006) demonstrated in the zebrafish spinal cord that V2a INs
generated at different times become located at different dorso-ventral positions in the
spinal cord. To test the possibility of a dorso-ventral pattern in V1-derived INs in the
mammalian spinal cord we analyzed the position of V1-INs that incorporated BrdU at
different embryonic ages using Neurolucida cell plots. Analyses were performed in
thoracic segments of En1-Cre/Tau-LacZ animals (Fig. 23). In these animals we labeled
all possible V1 INs and we chose thoracic levels because the embryonic dorso-ventral
organization seems best preserved at this level in the mature spinal cord. We divided
the ventral horn in 5 dorso-ventral bins of 100 μm thickness starting at the central canal
level (Fig. 24A), and calculated the percentage of V1-INs strongly labeled with BrdU in
each bin. We could not detect a clear pattern consistent with a dorso-ventral sequence
of V1-INs generated at different times in the middle bins (Fig. 24B). V1-INs located in
the ventral most bin (400-500 m) were, however, generated only at E9.5 and at E12.5
most V1-INs with BrdU were located in the more dorsal bin.
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Figure 21. Quantitative analysis of strong BrdU-immunoreactivity in V1-derived
interneurons (data from individual animals). Histograms show the percentage of V1INs strongly labeled with BrdU in individual En1-Cre/Tau-lacZ (A and B) and En1Cre/Thy1-YFP (C and D) animal lines divided in lower (L4/L5; A and C) and upper
(L2/L3; B and D) lumbar segments. BrdU injections were made at the 5 embryonic
ages indicated in the x-axis. The first three digits correspond with litter number (as per
our full colony at WSU). After the dot the number represents the animal number in the
litter. These numbers were for identification purposes and it allows determination of
litters of origin. Variations in the number of labeled cells in each animal were always
consistent between upper and lower lumbar segments, suggesting that these differences
are intrinsic inter-animal differences perhaps due to slightly more or less advance
stages of development of individual animals within litters. Note that in a single litter
some animals will contain low and others relatively high BrdU labeling. Despite this
variation among animals we can observe among different litters, lines and lumbar
segments a consistent increase in the number of BrdU labeled V1 interneurons at E10.5
and E12.0. At E12.5 very few V1-INs were strongly labeled.
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Figure 22. Percentages of strong BrdU incorporation in V1-derived interneurons
at different embryonic ages (pooled data). A and B) Percentage of V1-INs strongly
labeled with BrdU in the En1-Cre/Tau-lacZ mouse. Data sample: N=3 animals at E9.5,
E10.5 and E11.5; N=2 animals at E12.5. Error bars in this and following histograms
indicate S.E.M. C and D) Similar analysis in the En1-Cre/Thy1-YFP mouse line. Each
bar represents the average of 2 animals. E and F) Percentage of V1-INs strongly
labeled with BrdU in both mouse lines pooled together. Each bar represents the average
of 5 animals, except for E12.5 where the average comes from 4 animals. In all cases
ANOVA analyses showed significant differences among the ages (p<0.001). Post-hoc
analyses consistently showed significant differences (p<0.05; asterisks) at all ages with
E12.5 and differences between E11.5 and E12. Fewer BrdU V1-interneurons were
always detected at E9.5 compared to E10.5, but significant differences were only
detected by the post-hoc analysis in the lower lumbar segments. We conclude that these
histograms strongly suggest two waves of BrdU incorporation. The first one starts at
E9.5 and peaks at E10.5 and the second one starts at E11.5 and peaks at E12.0. The
consistency and repeatability of the result among animals (Fig. 21), lines and lumbar
segments gives confidence in the strength of this conclusion.
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Figure 23. Distribution of strong BrdU labeling in thoracic V1-derived
interneurons. P15 thoracic spinal cord sections of En1-Cre/Tau-LacZ animals injected
with BrdU at E9.5, E10.5, E11.5 and E12.5 were immunostained with LacZ (green,
FITC) and BrdU (red, Cy3). Arrows indicate V1-INs strongly labeled with BrdU. A)
Spinal cord section of an animal injected at E9.5 showing BrdU labeling of V1-INs
throughout the entire ventral horn. B) At E10.5 we detected the same dorso-ventral
pattern of labeling. C) By E11.5 BrdU labeled cells start moving more dorsally
however, we can still detect few V1-INs strongly labeled for BrdU in the ventral horn.
D) At E12.5 we detected few V1-INs strongly labeled for BrdU and this were generally
located relatively dorsal within the V1 population.
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Figure 24. Analysis of dorso-ventral distributions of BrdU-labeled V1-derived
interneurons in the thoracic spinal cord. Analyses were done in 10 ventral horns of
P15 En1-Cre/Tau-LacZ animals injected at 4 embryonic ages with BrdU (E9.5, E10.5,
E11.5, and E12.5). A) The ventral horn of the spinal cord was divided in five 100 µm
bins and the number of V1-interneurons with or without strong BrdU labeling counted
in each bin. The bins were generated from the central canal, starting at the same level of
the central canal the first one was denominated 0-100 and from there 100-200 bin, 200300 bin, 300-400 bin, and 400-500 the most ventral bin. B) Percentages of strongly
labeled BrdU V1 cells found in each bin over the total number of BrdU-labeled V1
interneurons. At early embryonic ages, V1-INs strongly labeled with BrdU are
distributed in all bins. However, after E9.5 there are no V1-INs labeled with BrdU in
the most ventral bin and the percentage of cells labeled in more dorsal bins increased.
By E12.5 there are no V1s labeled in the two most ventral bins and the number of cells
of the most dorsal bin has considerably increased. Thus, although we do not observe a
clear pattern in the middle bins, we can detect a tendency of cells located more
ventrally being labeled earlier and cell located more dorsally being labeled with BrdU
at later embryonic ages.
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V1-derived interneurons expressing different calcium binding.
Two calcium binding proteins, calbindin and parvalbumin, distinguish
subclasses of V1-derived INs, namely Renshaw cells and IaINs (Alvarez et al., 2005).
In order to analyze BrdU incorporation in calbindin and parvalbumin V1-INs we
performed triple and quadruple immunolabeling of spinal cord sections (Fig. 25). For
these analyses we used the En1-Cre/Tau-LacZ mouse line. Calbindin-immunoreactivity
distinguished two groups of V1-INs based on location and morphology. Renshaw cells
are small cells located ventrally in the region where motor axons exit from the spinal
cord and are found in all lumbar segments analyzed. A proportion of Renshaw cells
also express parvalbumin (Fig. 26). A novel group of calbindin-IR V1 cells was found
in upper lumbar segments (these segments have not been analyzed in previous studies
of V1-derived INs, Alvarez et al., 2005). These cells have large cell bodies extensive
dendrites and are located relatively dorsal in LVII within the distribution area of the V1
population (Fig. 27). This novel V1 cell type and their BrdU incorporation was
confirmed in En1-Cre/Thy1-YFP animals (Figs. 28, 29, 30). Parvalbumin-IR V1-INs
were located at all dorso-ventral locations and we excluded from this group Renshaw
cells (some also express parvalbumin). Parvalbumin-IR V1-INs were generally large
and displayed extensive dendritic trees (Fig. 31).
Quantitative analyses showed that calbindin-IR V1-derived INs were mostly
generated between E9.5 and E10.5 (Fig. 32), with the largest percentage generated at
E9.5 in both upper and lower lumbar segments. Renshaw cells and big V1 calbindin-IR
neurons were labeled with BrdU at E9.5 and E10.5. No BrdU incorporation was
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detected in these cells at E11.5, E12.0 or E12.5. A few V1-INs of small size with very
weak calbindin and that did not correspond to any of the former groups incorporated
BrdU at E11.5 and E12. These cells appear to correspond with groups of V1 INs that
are in the process of downregulating calbindin expression in the postnatal spinal cord
(Siembab et al., 2010). Parvalbumin-IR V1-derived INs different from Renshaw cells
showed a broader generation time window from E9.5 to E12.5 in both lumbar regions
(Fig. 32). The percentage and number of parvalbumin-IR V1-INs generated at E9.5 is,
however, much lower than the percentage of calbindin-IR V1-INs at that same
embryonic age.
In conclusion, V1-derived INs expressing different types of calcium buffering
proteins are generated at different embryonic times.

Renshaw cells are generated first, followed by Ia inhibitory interneurons during much
broader window generation times
The above results suggest that V1-derived Renshaw cells might be generated
earlier than V1-derived IaINs. To confirm this hypothesis we directly analyzed BrdU
labeling in V1-derived IaINs and compared them to Renshaw cells in the same sections
using the En1-Cre/Thy1-YFP model. In this model the cell bodies, dendrites and axons
of V1-derived cells are labeled with YFP and this allowed us to define V1-derived
IaINs as those V1‟s receiving inputs from Renshaw cells (Alvarez et al., 2005; Siembab
et al., 2010). Renshaw cell axonal inputs were visualized as baskets of axons labeled
with YFP and calbindin and profusely contacting the cell soma and proximal dendrites
of putative V1-derived IaINs (Fig. 33). In these animals we confirmed that most
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Figure 25. BrdU labeling of V1-derived interneurons expressing different calciumbinding proteins in En1-Cre/Tau-lacZ mice spinal cords at P15. The dotted lines
delineate the borders between the white and grey matter. CC, indicates the central canal
position. A, B, C, D) Low magnification confocal images of lumbar spinal cord
hemisections immunolabeled for β-gal (Alexa-405, blue, A), BrdU (Cy3, red, B),
calbindin (CB; FITC, green, C) and parvalbumin (PV; Cy5, white, D). This particular
animal was exposed to BrdU at E10.5. Ventrally located calbindin-IR V1-derived
interneurons correspond with Renshaw cells (RC area). In addition, a few V1-derived
calbindin-IR cells were located more dorsally and do not correspond with Renshaw
cells. These were more frequent in upper lumbar regions and were divided into large
and small cells according to soma size. Large V1 calbindin-IR cells (Big CB) were only
detected in upper lumbar regions. Parvalbumin immunostaining is in a population of
V1-INs but it also labels many other non-V1-INs. E, F, G, H) Higher magnification
confocal images of ventral spinal cord sections showing V1 interneurons with BrdU
labeling (E), calbindin-immunoreactivity (F), parvalbumin-immunoreactivity (G) and
superimposition of all four fluorochromes (H). Scale bars; 200 μm in A and E (B, C
and D same magnification as A; F, G and H same magnification as E).
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Figure 26. BrdU incorporation in Renshaw cells. High magnification images of
Renshaw cells from a P15 En1-Cre/Tau-lacZ animal injected with BrdU at E10.5. The
section was quadruple immunolabeled for LacZ (blue, Alexa-405), calbindin (CB;
green, FITC), parvalbumin (PV; white, Cy5), and BrdU (red, Cy3). A to I) Show
images of these four fluorochromes in different combinations. Solid arrow (in C)
indicates strong BrdU labeling, while the open arrow points to a weakly labeled
nucleus. Calbindin-IR cells in general and Renshaw cells in particular incorporated
BrdU at E9.5 and E10.5. These particular images show two Renshaw cells. One of
them strongly labeled by BrdU injected at E10.5. The other cell is weakly labeled.
These two Renshaw cells expressed various levels of parvalbumin-immunoreactivity
(G-I). Scale bars; 10 μm in A (all images have the same magnification).
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Figure 27. BrdU incorporation in dorsal and large calbindin-immunoreactive V1INs in an En1-Cre/Tau-LacZ animal injected with BrdU at E10.5. Medium
magnification confocal images of two big calbindin-IR cells immunostained for LacZ
(blue, Alexa-405), calbindin (green, FITC) and BrdU (red, Cy3). A-F) Show images of
the same microscopic field with each of these three fluorochromes in different
combinations. Big calbindin-IR V1 cells are strongly labeled with BrdU at early
embryonic ages, between E9.5 and E10.5. This section contains two big calbindin-IR
V1 cells, however only one of them is strongly labeled with BrdU. Scale bar; 20μm in
A (all images have the same magnification).
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Figure 28. BrdU labeling of calbindin-IR V1-derived interneurons in an En1Cre/Thy1-YFP animal injected with BrdU at E9.5. A, B) Low magnification
confocal images of the spinal cord immunolabeled with calbindin (CB; Alexa-405,
white; A) and Yellow Fluorescent Protein (YFP; FITC, green; B). The dotted line
indicates the boundary between the grey and white matter. C, D, E, F) Higher
magnification confocal images of the ventral horn; Calbindin (C), YFP (D), BrdU (Cy3,
red; E) injected at E9.5 and superimposition of CB and BrdU (F). Some Renshaw cells
and the more dorsal calbindin-IR cell show strong BrdU labeling in their nuclei. G, H,
I, J, K, L) High magnification confocal image of the dorsal calbindin-IR V1
interneuron immunolabeled for YFP (G), calbindin (H) and BrdU (I). BrdU labeling is
shown superimposed to YFP (J) and calbindin (K), and calbindin and YFP labeling are
superimposed in L. Scale bars; 200μm in A (B has the same magnification); 100μm in
C (D, E, and F are at the same magnification); 30μm in G (H, I, J, K, L are at the same
magnification).
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Figure 29. BrdU labeling of calbindin-IR V1-derived interneurons in an En1Cre/Thy1-YFP animal injected with BrdU at E10.5. A, B) Low magnification
confocal image of a P15 spinal cord immunolabeled for calbindin (Alexa-405, white;
A) and BrdU (Cy3, red; B) injected at E10.5. The dotted line indicates the boundary
between the grey and white matter. Yellow boxes indicate the areas displayed below at
higher magnifications (C, D, E and F). The white box (A) indicates two big-calbindinIR V1 interneurons that are more dorsally located. C, D, E, F) Higher magnification
confocal images of the ventral horn labeled with YFP (FITC, green; C), calbindin (D),
BrdU (E) and superimposition of YFP and BrdU (F). The dotted line indicates the
boundary between the grey and white matter. G, H, I, J, K, L) High magnification
confocal image of two big calbindin-IR V1 interneurons (arrows) expressing YFP (G),
calbindin-immunoreactivity (H) and containing BrdU (I). Superimposed images of YFP
and calbindin-IR (J), YFP and BrdU-IR (K), and calbindin and BrdU (L). Scale bars;
200μm in A (B is at the same magnification); 100 μm in C (D, E, and F are at the same
magnification); 30 μm in G (H, I, J, K, and L are at the same magnification).
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Figure 30. BrdU labeling of calbindin-IR V1-derived interneurons in an En1Cre/Thy1-YFP animal injected with BrdU at E12.5. A, B, C) Low magnification
confocal images of spinal cord hemi-section immunolabeled with calbindin (CB; 405,
white; A), Yellow Fluorescent Protein (YFP; FITC, green; B), and BrdU (Cy3, red; C).
The dotted line indicates the boundary between the grey and white matter. D, E, F, G,
H, I) Higher magnification confocal images of the ventral horn labeled with calbindin
(D), YFP (E), and BrdU (F) injected at E12.5 and superimposition of calbindin and
BrdU (G). No calbindin-IR V1 cells are labeled with BrdU at this age. H) V1
interneurons superimposed to BrdU labeling at E12.5 shows only a few V1
interneurons with strong BrdU labeling on their nuclei. I) Superimposition of calbindin
and YFP shows that none of these were calbindin-immunoreactive. J, K, L, M, N, O)
High magnification confocal images of a dorsal CB-IR V1 interneuron immunolabeled
for YFP (G), calbindin (H) and BrdU (I) showing lack of labeling at this invention ages
of the large big calbindin-IR V1 cells. Superimposed images of BrdU and YFP (M),
BrdU and calbindin (N), and CB and YFP (O). Scale bars; 200 μm in A (B and C are at
the same magnification); 100 μm in D (E, F, G, H, and I are at the same magnification);
30 μm in J (K, L, M, N, and O have the same magnification).
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Figure 31. BrdU labeling of parvalbumin-IR V1-INs in an En1-Cre/Tau-lacZ
animals injected with BrdU at E12.0. A, B, C D, E and F) High magnification
images of cells in the Lumbar 2 ventral horn immunolabeled for parvalbumin (white,
Cy5, A), nuclear LacZ expression (blue, Alexa-405, B) and BrdU (red, Cy3, D)
injected at E12.0. Parvalbumin-immunoreactivity and BrdU are superimposed in E
while all three fluorochromes are superimposed in F. In E the solid arrow points to a
parvalbumin-IR V1 cell with strong BrdU labeling and the open arrow to the adjacent
V1 cell that contains only weak labeling in its nuclei. Parvalbumin-IR V1-derived
interneurons have variable cell sizes and locations, most frequently dorsal to the
Renshaw cell group. At P15 they represent 8.7% of all V1-derived interneurons at
lower lumbar levels and 6.8% at upper lumbar levels. Scale bars; 20 μm in A (all
images are at the same magnification).

122

123

Figure 32. Percentages of calbindin and parvalbumin immunoreactive V1
interneurons that incorporated BrdU at different ages in En1-Cre/Tau-LacZ
animals. A and B) Percentages of calbindin-IR (black bars) and parvalbumin-IR (grey
bars) V1 cells that were strongly labeled with BrdU at five different embryonic ages.
Lower (A) and upper (B) lumbar segments were analyzed separately. Each bar
represents an individual animal. The numbers above each column represent the animal
identification code (as in Figure 21). We analyzed three animals at E9.5, E10.5, E11.5,
and E12.0 and two animals at E12.5. In each animal 10 ventral horns were counted at
each level. In all animals the largest percentage of calbindin-IR V1 cells incorporated
BrdU at E9.5, very few incorporated BrdU at E11.5 and E12 and none at E12.5. In
contrast, parvalbumin-IR V1 cells are generated from E9.5 to E12.5, but very few
incorporate BrdU at E9.5 or E12.5, while peak incorporation occurs at E10.5 and
E12.0. C and D) Percentages of cells with strong BrdU labeling in the overall
calbindin-IR population (black bars), the Renshaw cell group (light grey), and the bigcalbindin-IR V1 cells (dark grey, only in upper lumbar segments). Each average
represents the average of three animals, except for E12.5 in which only two animals
were analyzed. Error bars represent the S.E.M. Most calbindin-IR V1 cells are
generated at E9.5 and E10.5 but there are some generated at E11.5 and E12, however
these are not Renshaw cells or big-calbindin-IR V1 cells. Most V1-calbindin-IR
neurons generated late were located more dorsally and were not considered Renshaw
cells. Renshaw cells and big calbindin V1 cells incorporate BrdU exclusively at E9.5
and E10.5. The percentage of Renshaw cells that incorporated BrdU at E9.5 was
significantly higher than at any other age (ANOVA, P<0.05). Differences between E9.5
and E10.5 in the overall calbindin-IR population and the big calbindin cell group did
not reach statistical significance. E and F) Pooled animal averages comparing BrdU
incorporation in calbindin (black bars) and parvalbumin (grey bars) immunoreactive V1
cells. Same sample size as above. Error bars also indicate S.E.M. At E9.5 the
percentage of calbindin-IR V1 cells was much larger than parvalbumin-IR V1 cells in
both upper and lower lumbar segments (t-tests, p<0.05). At E11.5 and E12.0 the reverse
was true. There were significantly more parvalbumin-IR than calbindin-IR V1 cells
with BrdU in both lumbar regions (t-tests, p<0.05). At E10.5 there was no significant
difference in BrdU incorporation between V1 cells expressing calbindin or
parvalbumin.
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Figure 33. BrdU incorporation in Renshaw cells and V1-derived IaINs in En1Cre/Thy1-YFP P15 mice. A, B, and C) High magnification confocal images of
Renshaw cells from lumbar spinal cord sections immunolabeled for YFP (FITC, green,
A, B and C), BrdU (Cy3, red, A and C) and calbindin (CB, Cy5, white, B and C) from a
P15 animal that was injected with BrdU at E9.5. Many Renshaw cells show strong
BrdU labeling at this age. D, E, F, G, H and I) High magnification confocal images of
ventral spinal cord sections showing V1-derived IaINs in a P15 animal injected with
BrdU at E12.0. D) V1-derived IaINs immunolabeled with YFP (FITC, green). E) BrdU
labeling of V1-derived IaINs nuclei. F) Calbindin-IR processes and boutons in the same
field. G) Superimposition of YFP and BrdU, showing some V1-derived IaINs strongly
labeled for BrdU. H) Superimposition of YFP and calbindin. I) Superimposition of the
three fluorochromes. V1 derived IaINs are defines as such because they are innervated
by perisomatic baskets of Renshaw cell axons recognized by dual labeling with YFP
and calbindin. Scale bars; 20 μm in A and D (B and C are at the same magnification as
in A; E, F, G, H, I are at the same magnification as H).
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Figure 34. Renshaw cells are born first while V1-derived IaINs are born later in
En1-Cre/Thy1-YFP. A and B) Percentage of strongly labeled BrdU cells in Renshaw
cells (black bar) and V1-derived IaINs (grey bar) in individual animals. Each bar
represents an individual animal coded as in Figure 21. Two animals were analyzed at
each BrdU injection time. As before there were no differences between lower (A) and
upper (B) lumbar segments and the results were consistent among the two animals and
in the two different segmental levels. Also consistent with previous analyses, Renshaw
cells in this different independent sample are also labeled by BrdU when injected at
E9.5 and E10.5. V1-derived IaINs incorporate BrdU matching the pattern of
parvalbumin-IR V1 cells as described in the En1-Cre/Tau-LacZ line (see Figure 32).
Almost no cells were labeled with BrdU at E12.5. C and D) Average percentage of
strongly labeled cells for both animals showed in histograms A and B. Graphs at both
lumbar segments show that Renshaw cells are generated in the first two days (E9.5 and
E10.5) while V1-derived IaINs are mostly generated from E10.5 to E12.0.
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Renshaw cells are generated at E9.5 and a few at E10.5 (Fig. 34). Almost no V1-IaINs
were BrdU-labeled at E9.5 or E12.5. Most IaINs were generated between E10.5 and
E12.0, with a maximum at E12 (Fig. 34). The results were consistent in the two animals
per age that were used in the quantitative analyses.
In conclusion, V1-derived IaINs are generated later and with a broader
generation time frame than Renshaw cells.

DISCUSSION
Methodological considerations of the BrdU birthdating method.
BrdU was detected using immunohistochemistry in the cell‟s nuclei and we
distinguished strong and weak nuclear labeling. Strongly labeled cells were interpreted
as cells that leave the cell cycle immediately after BrdU incorporation. In this case
BrdU is not diluted by further divisions and their nuclei are almost fully covered with
strong staining. In contrast, weakly labeled cells appear as spotted labeling within the
nuclei and can result from a number of different situations (see explanation in
Methods). One possible source of weakly labeled cells is worth discussing further:
BrdU might appear spotted because chromatin rearrangements during S-phase. For
example at the end of the S-phase the DNA-replication appears punctuated and not
uniform and can give raise to speckled staining (Ferreira et al., 1997; Walter et al.,
2003) meaning that some cells labeled at the correct time in our study would have been
consider weak and discarded. If this is the case we will have underestimated the
percentages of cells in S-phase at each injection time, however, this error should be
consistent through all ages and animals and overall relationships should be preserved.
130

Another problem with this technique is the relative low number of cells labeled
with BrdU. Injected BrdU is available for only around 2 hours (see Methods). Thus
single injections results in relative small percentages of cells labeled. Some authors
using 3H-thymidine overcame this problem by repeated injections after a few hours
(Altman and Bayer, 2001). This method resulted in a larger number of labeled cells but
with a loss in time resolution. Differences in generation times of different cell types in
the spinal cord might be too fast to be well resolved by multiple injections; therefore we
chose to use single injections at the expense of labeling just relatively small percentages
of V1 cells. Nevertheless, by analyzing large numbers of sections in several lines and
animals we were able to recognize very consistent patterns.
A final problem is that with current methods for setting mates and timing
pregnancies it is difficult to estimate embryonic stages more accurately than with ±0.5
day of error. Moreover in the embryonic studies described in Aim 2 it was clear that
within a single litter different embryos might be at slightly different developmental
stages. These uncontrollable variables introduce some error in estimating the exact
developmental stage at which BrdU injections were delivered. To minimize errors we
used two controls, the overall BrdU pattern in the spinal cord and the thoracic analysis
of BrdU-incorporation in cholinergic neurons of known birth-date. Using these controls
we are confident that BrdU injections were delivered at the appropriate times of
gestation of the animals that were later studied at P15. The problem remains, however,
that if the sequence of generation of different types of cells from the p1 domain is faster
than ±12 hours, then our methods will not be discriminating enough to detect these
differences. In addition, since we expect ±12 hours error estimate, it is possible that
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some of the overlap in BrdU incorporation in adjacent dates is due to this error. In this
sense it is noteworthy that the studies with different markers were done in the same
animals and that for any single marker the study was repeated in different litters and
lines. However, it is interesting that the analysis of V1 cells exiting the progenitor area
described later in Aim2, suggest a lesser amount of overlap in the production of
different cell types than the one we obtained with BrdU labeling.

Differences in Renshaw cells and IaIN generation from p1 progenitors
These results support the hypothesis that Renshaw cells and IaINs are generated
at different times from the p1 progenitor domain. Renshaw cells are the first cells
generated and their time-window for neurogenesis greatly overlaps with that of the
motoneurons. These could explain their close relationship. Not only Renshaw cells
seem to be generated at early stages, this is also the case for the big-calbindin-IR cells.
This could suggest that V1-derived calbindin-IR neurons, in general, exit the cell cycle
before other V1-INs (this point is then confirmed in Aim 2). Regarding V1-derived
parvalbumin-IR neurons, their peak of generation at E12.0 matches with the one for
V1-derived IaINs, suggesting that they are highly overlapping population. In fact,
parvalbumin was found expressed in large numbers of V1-derived IaINs at P15 and P20
(Alvarez et al., 2005; Siembab et al., 2010). Overall, Renshaw cells seem to have a
much narrower window of generation compared to IaINs. This might suggest that
Renshaw cells are a more homogenous population than IaINs. Renshaw cells and IaINs
are defined by their function, recurrent and reciprocal inhibition, but whether these
functions are mediated by more or less homogeneous subclasses of INs could not be
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adequately tested in previous electrophysiological characterizations. In fact, early
studies already suggested that reciprocal IaINs could be located at different dorsoventral regions of LVII, display a variety of sizes and dendritic arborizations, extend
axons of different length and orientation and different populations could receive a
diversity of inputs from descending systems (reviewed in Jankowska, 1992; Rastad et
al., 1990). In contrast, Renshaw cells display a more homogeneous location,
morphology and electrophysiological properties (Alvarez and Fyffe, 2007). Recently,
our lab revealed, unexpectedly, further diversity among IaINs characterized by
histological definition of inputs (Siembab et al., 2010). In this study, IaINs were found
to be diverse in regards to their origins from V1‟s or non-V1 derived populations and in
parvalbumin content (parvalbumin positive and negative populations). Therefore, it is
possible that a number of INs with different embryonic development become later
incorporated into reciprocal inhibitory circuits. It is possible that if the IaIN populations
is composed of different subpopulations and these might be generated at different
times.
In conclusion, our studies suggest that different subtypes of V1 INs are
generated from p1 progenitors in a temporally regulated manner. This is not always the
mechanism followed by ventral INs to generate diversity. For instance, V2-derived INs
are generated by asymmetric divisions and through a Notch/Delta lateral signaling
pathway that plays a critical role in fating excitatory V2a versus inhibitory V2b INs
from the p2 domain. In this case, cell fate is controlled by Delta4 activation of Notch
receptors together with MAML factors (Peng et al., 2007). Interestingly, V2a INs
display then subpopulations with gradations of function that are generated in a time-
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dependent manner. In zebrafish, Alx is the transcription factor analog to Chx10 and
defines excitatory V2a INs in the fish (Kimura et al., 2006). Alx V2a INs are
glutamatergic INs that correspond with a type of adult INs known as CiD
(circumferential ipsilateral descending INs). CiDs are activated during swimming and
make monosynaptic excitatory connections with motoneurons (Kimura et al., 2006).
Within this population, there are functional differences according to cell size and this is
in turn related to their birth-date. Early born neurons are larger, more dorsally located
and active during stronger movements such as escapes or fast swimming, while later
born neurons are smaller more ventrally located and are preferentially active during
slower and weaker sustained swimming episodes (Kimura et al., 2006). Further
analyses demonstrated that small and large CiDs are not recruited by addition with
stronger movements but that the INs involved in the weaker movements are silenced
during fast movements that recruit INs involved in stronger movements (McLean et al,
2008). This implies not a simple difference according to cell size but also different
connectivity for each type of neuron. There are clear differences in our study with this
pattern, Renshaw cells are first generated but smaller and more ventrally located than
later born V1-IaINs, but nevertheless we wanted to test the possibility of a dorsoventral gradient of cell generation within the V1 group, overall. Even though we
analyzed thoracic segments that seem to preserve a dorso-ventral organization better
than in other segments, we could not see a clear dorso-ventral pattern of generation,
except that the ventral most cells were generated earlier and the dorsal most V1 cells
incorporated BrdU the latest. Thus, we conclude that the dorso-ventral position of
mammalian V1 adult INs are related only very weakly to differences in cell generation
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(with the exception of course of the most ventral Renshaw cell group). It could be
expected that a larger variety of IN subtypes generated from each progenitor domain in
mammals might exhibit a larger variety of migratory patterns, ending in different
positions and acquiring different phenotypes. The mechanisms that impose location and
connectivity gradients within a single class of INs in zebrafish (CiD) could now be used
in mammals to generate distinct subtypes from single progenitors.

Possible mechanism that could regulate V1 phenotype according to time of
neurogenesis
The differences in birth-date between Renshaw cells and IaINs within the V1
group suggest two possible mechanisms to define cell type. First their fate could be
determined cell autonomously depending on cell cycle number. This mechanism will be
akin of generation of neural diversity in Drosophila neuroblasts in which after each cell
cycle there is an alteration in transcription factor expression in the progenitor cell
altering the fate of daughter cells produced in successive cell cycles (Isshiki et al.,
2001). More recently a similar mechanism was discovered for pyramidal cells in the
neocortex. As reviewed before corticofugal pyramidal cells located in deep laminae
(layer 5 and 6) are generated before pyramidal cells with cortico-cortico projections and
located in upper laminae (layer 2 and 3). Transplantation studies using heterochronic or
isochronic cells found that the developmental potential of cells becomes narrower with
time. For example, early progenitors, which normally produce deep pyramidal cells,
will generate superficial laminae cells if transplanted in an older cortex, but late
progenitors will generate layer2/3 pyramidal cells even if transplanted to an earlier
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environment (McConnell and Kaznowski, 1991). More recent studies based on clonal
analyses suggested that the progenitors sequentially generate lower and upper
pyramidal cells by restricting their fate potential over time (Shen et al., 2006). These
changes are accompanied by changes in transcription factor expression in the
progenitors and even translocation of the progenitors from the ventricular to the
subventricular zone (reviewed by Leone et al., 2008).
Are there similar mechanism operating in the p1 domain? At present this is
unclear. First, our data cannot address the question of whether early and late generated
V1 INs are clonally related or not. This means whether they arise from different cell
cycles of the same progenitor or by different progenitor subdomains within the p1
domain. Second, we do not know if the sequence we observed is due to a restriction of
progenitor potential with cell cycle divisions or to complete different cell type
specifications. It is however, intriguing that some regions in the p1 domain
downregulate expression of the transcription factor Dbx1 after E10 (Pierani et al.,
2001), that is after Renshaw cells have been generated. Levels of Sonic hedgehog and
retinoic acid vary with development (Ericson et al., 1995; Ulloa and Briscoe, 2007;
Maden, 2001) and these changes could modify transcription factor expression at the
level of the ventral progenitors as it occurs when the pMN domain switches form
generating motoneurons to oligodendrocytes (reviewed in background). These
mechanisms are not necessarily exclusive since changes in genetic determination
established by a time-clock at the progenitor level could determine competences to
respond to temporally regulated environmental influences in the differentiating
neurons.
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Future experiments should address these more specific issues but before that we
need to know first at what time these cells start differentiation. Our birth-dating study
does not provide information on the exact timing of differentiation for each of these
two cell populations; however, given their different birth dates it is possible that these
cells start to differentiate just after they are born. If this is true, they should
differentially regulate gene expression at a very early stage and this should be reflected
in the expression of different markers. Alternatively, V1 cells generated at different
times could remain relatively undifferentiated until the expression of different cues later
in development. In aim 2 we will test the hypothesis that there is an early differentiation
and that Renshaw cells and IaINs can be distinguished in early embryos within the V1
population by their expression of different transcription factors or phenotypic markers.
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AIM 2
CHARACTERIZATION OF
TRANSCRIPTION FACTOR EXPRESSION
IN RENSHAW CELLS AND V1-DERIVED
IA INHIBITORY INTERNEURONS IN THE
EMBRYONIC AND POSTNATAL SPINAL
CORD
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INTRODUCTION
The results in aim 1 suggest that Renshaw cells and V1-derived IaINs are
generated sequentially and therefore start development at different embryonic times.
Their different birth dates could imply that differentiation from each other begins early,
perhaps just at the time they exit from the progenitor cell cycle. If this was the case they
might be fated by their differential birth date and each cell type would follow different
mechanisms of differentiation and integration into the ventral horn spinal cord circuits.
An alternative possibility is that although their time of generation is different, they
could remain as undifferentiated postmitotic cells in the early embryonic spinal cord
and split into Renshaw cell and IaIN phenotypes at later times, for example at the time
of early synaptogenesis, which in the mouse embryo occurs between E12 and E13
(Vaughn et al., 1975). In this case the early embryonic cord could contain precursors of
Renshaw cells and IaINs with similar properties and functionality until the start of
spinal circuit assembly.
Analyses of the diversification of other ventral spinal cord neurons suggest that
an early specification is the more likely possibility, although later signals might add
further phenotypic complexity or even impose switches in development, for example
from one neurotransmitter to another (reviewed in Edlund and Jessell, 1999). In
motoneurons, specific transcription factor expression is regulated hierarchically in a
temporal manner such that motoneurons express them in different combinations while
they become sequentially restricted into different classes, columns, divisions and pools
(reviewed in Jessell, 2000; Price and Briscoe, 2004; Poh et al., 2002; Ji et al., 2009).
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Transcriptional codes that restrict the class, columnar and divisional identity of
motoneurons occur very early in development, while ETS transcription factors that
define pool identity are expressed later, simultaneously with muscle innervation and are
in part controlled by the periphery (Jessell, 2000; Price and Briscoe, 2004). It is
possible that IN lineages undergo a similar diversification process starting just at the
time that the progenitor becomes postmitotic. One such example is the division of the
p2 progeny into excitatory V2a INs that express the transcription factor Chx10 and V2b
INs that express GATA3 (Peng et al., 2007). V2a and V2b INs develop simultaneously
from genetically identical p2 progenitors through a lateral delta4-Notch signaling
mechanism that produces daughter cells of different phenotypes. Early differentiation
would also agree with the existence of discrete groups of INs expressing unique
combinations of transcription factors in the very early spinal cord. One such example
are the cholinergic INs that form partition cells (PC) in the mature spinal cord and give
raise to C-terminal synapses on the motoneurons. These cells arise from a subgroup of
V0 INs that expresses the transcription factor pitx2 from the early embryo (E12) to
adult (Zagoraiou et al., 2009). An early differentiation of V1 INs giving rise to
Renshaw cells or V1-derived IaINs would indicate that they belong to different
branches within a possible hierarchical organization for the specification of V1
subtypes. Since transcription factors have the intrinsic ability to translate transient
extrinsic signals into long-lived cellular responses and early differentiation is almost
always reflected in the expression of different transcription factors we searched for
potential transcription factors that could define subgroups within the V1 population.
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In a previous preliminary study it was suggested that subpopulations of
embryonic V1-INs could be differentiated based on the expression of two transcription
factors, MafB and FoxP2 (Geiman et al., 2007). MafB expressing V1 INs were
described in the Renshaw cell area and FoxP2 expressing V1 INs were more dorsally
located, in a region where we might expect to find developing IaIN precursors.
Therefore we analyzed whether these transcription factors divide the V1 population in
early born Renshaw cells and late born V1-derived IaINs and at what stage they are
first expressed in the embryonic spinal cord.
MafB belongs to the MAF family of genes that are widely expressed at varying
levels and in distinct spatiotemporal patterns. The MAF proteins are important during
neurogenesis and exert transcriptional control over gene expression, development and
differentiation. The role of MAF proteins in development and differentiation and their
importance in neurogenesis makes MafB a good candidate to be involved in the control
of V1 differentiation (Wang et al., 1999). FoxP2 is a transcription factor that belongs to
a family of genes named FOX that are conserved from fungi to mammals and that have
been associated in humans with articulation of complex speech sounds, since mutations
of this gene are associated with language deficits (Fisher and Scharff, 2009). FoxP2 is
also involved in various early embryogenesis processes, including neural differentiation
(Bonkowsky and Chien, 2005; French et al., 2007). Furthermore, FoxP2 is expressed in
a subpopulation of V1-INs in mouse embryos. FoxP2 was detected from E11.5 to P0
mostly in the ventral spinal cord (Morikawa et al., 2009), suggesting very early
expression.

141

We hypothesized that MafB and FoxP2 could be early markers of Renshaw
cells and IaINs, respectively. Furthermore, we hypothesized that since Renshaw cells
are among the first V1 INs generated, expression of the MafB transcription factor in
V1-INs should precede expression of FoxP2 in the embryonic spinal cord and within
the V1 population. To test these ideas we first compared the expression of MafB and
FoxP2 in characterized subpopulations of V1-INs in the postnatal spinal cord. Given
the fast downregulation of these transcription factors after birth the studies were
constrained to P0 and P5. Then, we analyzed their distribution and onset of expression
in the embryonic spinal cord.

MATERIALS AND METHODS

Animals
We used for postnatal analyses En1-Cre/Thy1-YFP and En1-Cre/Tau-LacZ
animals. However we noted that in these animals upregulation of reporter expression
occurs late during embryogenesis in the V1 population. In particular Renshaw cell are
among the last cell populations to express these reporters within V1 INs. Therefore, for
embryo studies we crossed En1Cre/+ heterozygotes with the CAG-Rosa26-lox-STOPloxp-tdTomato-WPRE reporter line (stock#007909; Jackson labs, Bar Harbor, Maine).
We will refer to these animals as En1-Cre/R26-tdTomato. Initially we purchased this
line as heterozygotes and therefore only 25% of the litter expressed tdTomato in V1
cells. All transgenic animals were bred at Wright State University. Pups were tail
clipped for genotyping using Polymerase Chain Reaction (PCR) and the feet tattooed
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before P5 for identification as before. All animal procedures were performed according
to NIH guidelines and reviewed by the local Laboratory Animal Use Committee at
Wright State University.

Tissue extraction
Fourteen

En1-Cre/Thy1-YFP

or

En1-Cre/Tau-LacZ

mice

pups

were

anesthetized at either P0 or P5 with Euthasol (2.0 μg/g i.p.) and perfused transcardially
with 4% paraformaldehyde in 0.1M phosphate buffer (PB). After perfusion the spinal
cords were dissected and postfixed overnight in the same fixative and then
cryoprotected in 0.1M PB (pH 7.4) with 30% sucrose and 0.01% sodium azide. The
spinal cords were stored at 4°C in this solution until used.
In addition, 12 timed pregnant females were used to generate litters containing
En1-Cre/Tau-LacZ (4 litters) and En1-Cre/R26-tdTomato (8 litters). At the appropriate
gestation times (E.95 to E12.5) the pregnant females were anesthetized and perfused as
above and the embryos removed from the uterus and freed from their yolk sacs.
Embryos were fixed in toto overnight and then cryoprotected in 30% sucrose.
Embryonic developmental stages were confirmed using the Atlas of Mouse
Development (Kaufman, 2005). Embryos were cut in a cryostat at 20-30 µm thickness
and collected in subbed slides. Slides were stored at -20ºC until processed. In addition
we analyzed in a preliminary study a few slides containing sections from En1Cre/Thy1-YFP and En1-Cre/Tau-LacZ late embryos (E15.5, E17.5). These were
provided by Dr. Valerie Siembab in our lab.
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Expression of transcription factors in V1-INs postnatally
Six En1-Cre/Thy1-YFP animals at P5 and five at P0, as well as three En1Cre/Tau-LacZ P0 animals, were used for postnatal analysis of transcription factor
expression in V1-derived Renshaw cells and IaINs. Sections were triple or quadruple
immunolabeled for either polyclonal sheep antibody against GFP (1:800, Biogenesis,
Brentwood, NH) or chicken polyclonal antibodies against β-gal (1:500, AbCam Inc.,
Cambridge, MA) combined with polyclonal rabbit antibodies against calbindin (1:500,
Swant, Bellizona, Switzerland), polyclonal guinea pig antibodies against VGLUT1
(1:5000, Synaptic Systems, Goettingen, Germany), and goat polyclonal antibodies
against either MafB or FoxP2 (1:200, Santa Cruz biotechnology Inc., Santa Cruz, CA).
Immunoreactive sites were revealed with fluorochrome-conjugated (FITC, Cy3, and
Cy5) donkey species-specific secondary antibodies (1:50, Jackson Laboratories) or
Alexa-405 (Invitrogen) as previously described and all immunofluorescent preparations
were coverslipped with Vectashield (Vector Labs).

Analysis
Images were obtained in an Olympus FV1000 confocal microscope at 20x1 and
60x1. Images were analyzed and labeled cells identified counted using Fluoview
software (Olympus). Six P5 En1-Cre/Thy1-YFP animals were analyzed for FoxP2
expression and 6 P0 En1-Cre/Thy1-YFP and 3 P0 En1-Cre/Tau-LacZ animals were
studied to characterize MafB expression. Ten ventral horns per animal were sampled.
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The number of MafB and FoxP2 immunoreactive cells within the V1, Renshaw cell and
IaIN populations were calculated. Renshaw cells were identified due to their location
and calbindin-immunoreactivity as in Aim 1. V1-derived IaINs were identified as V1INs receiving convergent inputs from both Renshaw cells (YFP V1 labeled calbindinIR axonal contacts) and vesicular glutamate transporter 1 (VGLUT1) contacts from
sensory proprioceptors. We obtained percentages of expression in six En1-Cre/Thy1YFP animals for the FoxP2 study. Initially we also analyzed P0 En1-Cre/Thy1-YFP
animals for MafB expression but we noted that a large number of Renshaw cells did not
contain YFP at this age. Because of this reason the MafB analysis was repeated in three
En1-Cre/Tau-LacZ animals at P0. All calbindin-IR Renshaw cells express the LacZ
reporter at P0 in this line.

Expression of transcription factors during development at different embryonic ages
In preliminary studies we dual immunostained late embryos (E15.5 and E17.5)
of the En1-Cre/Thy1-YFP and En1-Cre/Tau-LacZ for the reporter and calbindin (as
above) and found that at this age reporter expression does not occur in the En1Cre/Thy1-YFP line. We focused then in the En1-Cre/Tau-LacZ line.
A total of 9 En1-Cre/Tau-LacZ embryos were used at three embryonic stages
(E10.5, n = 2, from one litter; E11.5, n = 2, from one litter; E12.5, n = 5, from two
litters) to analyze the developmental expression of MafB and FoxP2 in V1-INs.
Sections were triple immunolabeled with chicken polyclonal antibodies against β-gal
(1:500, AbCam Inc., Cambridge, MA) combined with rabbit polyclonal antibodies
against calbindin (1:500, Swant, Bellizona, Switzerland), and MafB or FoxP2 goat
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polyclonal antibodies (1:200, Santa Cruz biotechnology Inc., Santa Cruz, CA).
Immunoreactive sites were revealed with fluorochrome-conjugated (FITC, Cy3, and
Cy5) donkey species-specific secondary antibodies (1:50, Jackson Laboratories) and
cover slipped as previously described. In these animals we noted that putative
calbindin-IR Renshaw cell precursors did not express LacZ at E10.5 and that the
reporter was first observed in some Renshaw cells only by E11.5. As above this
suggests late upregulation of Tau promoter activity driving reporter expression in
embryonic Renshaw cells. Therefore we repeated the experiments in En1-Cre/R26tdTomato embryos at E9.5 (n = 3, from one litter), E10.5 (n = 4, from two litters),
E11.5 (n = 7, from two litters), E12 (n = 4, from two litters) and E12.5 (n = 3, from one
litter). In these animals tdTomato expression was visualized “naked” (without
immunocytochemical amplification) and the sections were dual immunolabeled for
calbindin (1:500, rabbit polyclonal antibody, Swant) combined with either MafB or
FoxP2 (1:200; goat polyclonal antibodies, Santa Cruz Biotechnology Inc).
Images were obtained with an Olympus FV1000 confocal microscope at 20x1
and 60x1. Unfortunately, even at 20 µm thickness and using confocal microscopy the
cellular density in these early embryos is too dense for reliable counting. Therefore the
materials are described qualitatively. Image composition was performed as in aim 1.
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Table 3. Antibodies used in Aim 2 and labeling specificity

Antibody
name
Calbindin
D28K

Type

Hostspecies

Dilution

Polyclonal

Rabbit

1:500

VGLUT1

Polyclonal

Guinea pig

1:5000

β-gal

Polyclonal

Chicken

1:1000

Abcam Inc.

GFP

Polyclonal

Chicken

1:5000

Aves Labs

MafB

Polyclonal

Goat

1:200

FoxP2

Polyclonal

Goat

1:200

NeuN

Monoclonal

Mouse

1:1000

Company

Specificity

Swant,
Bellinzona
Synaptic
Systems

No labeling in KO
tissue

Santa Cruz
Biotech.
Santa Cruz
Biotech.
Chemicon

No labeling in KO
No labeling in
animals with no
reporter expression
No labeling in
animals with no
reporter expression
Per Santa Cruz data
sheet
Per Santa Cruz data
sheet
Only antibody
available (ref. Kim
et al., 2009)

RESULTS
MafB and FoxP2 were found in the nuclei of many V1 and non V1-INs in the
postnatal spinal cord (Fig. 35). In preliminary analyses carried out in our lab by Mrs.
Maria Berrocal it was found that MafB was quickly downregulated after P0 and
immunolabelings became inconsistent by P5. In contrast, FoxP2 expression was similar
at P0 and P5 and downregulated more gradually. By P10 fewer cells were found and by
P15 there were very few FoxP2 positive neurons in the ventral spinal cord and these
were more weakly labeled (not shown). The studies described here in the postnatal
spinal cord therefore focused at P0 (MafB) and P5 (FoxP2).
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Figure 35. Distribution and expression of MafB and FoxP2 in V1-derived
interneurons of respectively, P0 En1-Cre/Tau-lacZ and P5 En1-Cre/Thy1-YPF
spinal cords. A to C) Low magnification confocal images of the lumbar spinal cord
from an En1-Cre/Tau-lacZ animal at P0 immunostained for MafB (Cy3, red, A-C),
LacZ (FITC, green, B) and calbindin (Cy5, white, C). A) In the P0 spinal cord MafB is
expressed in a ventrally located group located in the Renshaw cell area, a more lateral
group of cells in lamina IX and several dorsal populations. B) The most ventral group
of MafB-immunoreactive cells belong to the V1 group (LacZ positive). C) Merge of
calbindin and MafB immunoreactivities demonstrates that this ventral group
corresponds with Renshaw cells. D, E and F) High magnification confocal images of
Renshaw cells (arrows) immunostained for MafB (Cy3, red), LacZ (FITC, green), and
calbindin (Cy5, white). G to I) Low magnification confocal images of lumbar spinal
cord sections at P5 immunolabeled with FoxP2 (Alexa-405, blue, G, H, and I), YFP
(FITC, green, H), and calbindin (CB, Cy5, white, I). G) Distribution of FoxP2 in P5
lumbar segments. FoxP2-immunoreactive cells are for the most part localized in the
ventral horn. H) Some V1-INs (YFP positive) express FoxP2. I) FoxP2 is not expressed
by calbindin-IR V1 Renshaw cells. J, K and L) High magnification confocal images
of an YFP (FITC, green) V1-IN immunostained for FoxP2 (Alexa-405, blue, J). This
cell receives contacts from Renshaw cell axons that are both calbindin-immunoreactive
(Cy5, white) and YFP positive (K). It also receives contacts from VGLUT1 boutons
(Cy3, red, white arrows in L). This particular cell is therefore a V1-derived IaIN. M
and N) Percentages of cells of different groups of V1-INs with either MafB of FoxP2
in the En1-Cre/Tau-LacZ and En1-Cre/Thy1-YFP lines; 100% of V1 Renshaw cells
express MafB, while less than 10% of V1-INs express MafB. Six animals were
analyzed in the En1-Cre/Tau-lacZ line and three in the En1-cre/Thy1-YFP. In contrast,
around 70% of V1-derived IaINs express FoxP2 at P5 and 33% of V1 overall express
FoxP2. Scale bars; 200 µm in A and G (images B, C, H and I are at the same
magnification).
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MafB expression in V1-interneurons in at P0
Analysis of P0 spinal cords in En1-Cre/Thy1-YFP and En1-Cre/Tau-LacZ
spinal cords (Fig. 35A-F, M) proved that 100% of V1-derived calbindin-IR Renshaw
cells located in ventral lamina VII express MafB. However, YFP expression in P0
Renshaw cells in the En1-Cre/Thy1-YFP was variable. On average, 17 ±6% of
calbindin-IR neurons in the Renshaw cell area were YFP negative at P0 (n = 6
animals). Positive reporter expression varied in different animals from 98% of
calbindin-IR Renshaw cells to 62%. In contrast, there is 100% positive expression of
genetic markers in postnatal Renshaw cells when using a R26 reporter line (Sapir et al.,
2004) or the En1-Cre/Tau-LacZ line (Fig. 36E-H). At P5 and later ages (Aim 1) all
Renshaw cells consistently express YFP in the Thy1 line (Fig. 36M-P). This result
suggests late upregulation of YFP expression in Renshaw cells during postnatal
development.
Renshaw cells were not the only MafB expressing cell group in the spinal cord
(Fig. 35A-C). A dorsal horn group, unrelated to V1-INs also expressed mafB. These
cells were located throughout LIII, IV and particularly in lateral LV. More interestingly
a group of dorsal V1 INs (located in dorsal regions of LVII), that differs from Renshaw
cells and do not express calbindin, also expresses MafB. Quantitatively the dorsal V1
group was much smaller than the Renshaw cell group. Overall around 10% of V1-INs
expressed MafB. MafB-immunoreactivity was strongly downregulated after P0.
In conclusion, MafB expression is not unique to Renshaw cells, but all Renshaw
cells express this transcription factor at P0.
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Figure 36. Distribution and expression of reporters in V1-derived interneurons in
En1-Cre/Tau-lacZ and En1-Cre/Thy1-YFP animals during development. A-H) Low
magnification confocal images of spinal cords from E11.5 to P15 showing the
distribution of V1-INs in En1-Cre/Tau-lacZ animal. I to P) Similar confocal images but
in the En1-Cre/Thy1-YFP animals. V1-INs are shown in green (FITC, lacZ positive in
Tau-LacZ and YFP positive in Thy1-YFP). Calbindin-IR is shown in white (Cy5).
Expression of the LacZ reporter is first detected at E11.5 (A), however it is not very
strong and quite diffuse and is difficult to individualize to specific cell types, especially
the calbindin-IR cells (B). By E12.5 (C) LacZ expression is more defined in the nuclei
of the cells and brighter. However, not all V1-INs express the reporter at this age.
Specifically, upregulation of LacZ expression in Renshaw cells is delayed compared to
other V1-INs. LacZ is not detectable in a large number of calbindin-IR cells located in
the Renshaw cell area (C,D). By P0 all calbindin-IR Renshaw cells express the reporter
(E,F), but there many other calbindin-IR interneurons in the ventral horn. At P15
calbindin-immunoreactivity has become restricted to Renshaw cells in the ventral horn
and all Renshaw cells express lacZ (G,H). In contrast, YFP expression is not detected in
V1-INs until E15.5 (I) and it is extremely weak at this point. YFP expression becomes
stronger by E17.5 (K), but it is still not present in calbindin-IR Renshaw cells. By P5
(M), YFP seems to be upregulated in 75% of all V1-INs, including all Renshaw cells by
P5 (M,N). YFP expression is maintained in all calbindin-IR Renshaw cells at P15 (O,
P). These results indicate that upregulation of both reporters in Renshaw cells happens
later than in the rest of V1-INs. Scale bars; 100 µm in A (all images are at the same
magnification).
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FoxP2 expression in V1-interneurons in the postnatal spinal cord
These analyses were performed at P5 in En1-Cre/Thy1-YFP spinal cords to
optimize identification of V1-derived IaINs (Fig. 35G-L, N). Convergent inputs from
Renshaw cells (axons co-labeled with YFP and calbindin) and proprioceptive afferents
(VGLUT1 immunoreactive) were used as criteria for IaIN identification. Analyses
performed at P5 allowed clearer identification of primary afferent inputs given that
VGLUT1-immunoreactivity inside the central terminals of primary afferents undergo
considerable upregulation during postnatal development (Mentis et al., 2006; Siembab
et al., 2010). Also by P5 calbindin immunoreactivity has downregulated in most nonRenshaw V1-INs in lower lumbar regions (Siembab et al., 2010), becoming a more
specific marker of Renshaw axons.
FoxP2 is more widely expressed in the postnatal spinal cord ventral horns than
MafB (Fig. 35G). Fewer neurons express FoxP2 in the dorsal horn. In the P5 ventral
horn FoxP2 is present in several groups of V1 and non V1-derived INs (Fig. 35G-I) and
in cells that can be identified as V1-derived IaINs (Fig. 35J-L). FoxP2 cells are a
relatively large population and 40% were identified as V1-derived IaINs (Fig. 35N).
Thirty-three percent of YFP V1-INs expressed FoxP2 and around 66% of V1-derived
IaINs expressed FoxP2. FoxP2-IaINs were a relatively small population (11%) of all
V1-derived INs expressing FoxP2 and were a small percentage (5%) of all ventral horn
FoxP2 cells. Therefore we conclude that several classes of V1-INs in addition to IaINs
express FoxP2. FoxP2 was never expressed by Renshaw cells. Therefore, MafB and
FoxP2 are expressed in distinct subgroups of cells within V1-derived INs.
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In conclusion, MafB and FoxP2 cannot be regarded as specific of Renshaw cells
and IaINs, respectively, but they can be used as markers to label within the V1
population all Renshaw cells and a large number of IaINs. We therefore used these
markers to analyze the divergence of Renshaw cells from IaINs in the early embryonic
spinal cord.

Location and morphology of V1-interneurons in early embryos.
We first analyzed En1-Cre/Tau-LacZ embryos at E10.5, E11.5 and E12.5, but
we were unable to detect any labeling of V1 cells in these embryos at E10.5 (not
shown). Labeling was weak at E11.5 and increased by E12.5 (Figs. 36A-D). Many
putative V1 calbindin-IR Renshaw cells (identified based on location) lacked LacZ,
particularly at E11.5. LacZ expression is robust in Renshaw cells at P0 and P15 (Fig.
36E-H). To confirm whether lack of labeling was due to developmental regulation of
reporter expression in the Tau line or because late upregulation of En1 in some V1 INs,
we repeated the experiments in En1-Cre/R26-tdTomato mice. In these animals no V1cells were found at E9.5 (Fig. 37A, B) but we found labeled cells at E10.5 (Fig. 38A).
Given the ubiquitous expression of the CAG reporter and its location in the Rosa26
locus, which allows transcription from very early stages in the embryo, it is unlikely
that lack of reporter expression in the E9.5 spinal cord is due to inactivity of the
promoter. Indeed, tdTomato labeling is clearly visible in dorsal midbrain progenitors
known to express En1 by E9.5 (Fig. 37C, D). The differences in timing between birth
dates (Aim 1) and genetic labeling of embryonic V1-INs are therefore likely related to
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Figure 37. Lack of R26-tdTomato reporter and calbindin expression in the spinal
cord of E9.5 embryos. A to D) Low magnification confocal images spinal cord (A and
B) and midbrain (C and D) cross-section in E9.5 embryos. tdTomato expression (V1, in
red) is not visible in the spinal cord but it is strongly expressed by dorsal progenitors in
the neural tube at midbrain regions. E to F) Calbindin-immunoreactivity (CB in green)
is undetectable in the same fields shown in A-D of spinal cord and midbrain. Scale
bars; 100 µm in A, B, C and D (matching images in E, F, G and H are at the same
magnification). The early neural tube at the level of the spinal cord is outlined in A, B,
E and F.
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Figure 38. Location of V1-INs and calbindin-immunoreactivity from E10.5 to
E12.5 in the En1-Cre/R26-tdTomato mouse model. Solid lines indicate the boundaries
of the early spinal cord. Dotted lines indicate the ventricle in the midline of the spinal
cord. All images are low magnification confocal images immunostained for calbindin
(Cy5, white, B, E, H, and K) and showing genetically labeled V1-INs (tdTomato, red,
A, D, G, J). A to C) E10.5 spinal cord contains a small cluster of V1-INs leaving the
progenitor area and sending ventral projections (A). Most of these V1-INs express
calbindin-immunoreactivity (B,C). D to F) At E11.5 the numbers of V1-INs (D) and
calbindin-IR cells (E) increased. Most cells located laterally express both markers (F)
and are positioned either at the edge of the ventro-lateral spinal cord (arrows in E) or
medial to the motor pool. Another group of more weakly labeled V1-INs is at border of
the progenitor area. Many of these cells do no express calbindin and appear to be
migrating away from the progenitor area. G to I) V1-INs at E12 are still leaving the
progenitor area. The most lateral clusters of calbindin-IR V1 interneurons start to form
a Renshaw cell group, while medial V1-INs are either calbindin positive or negative.
At this age many V1-INs are seen exiting the progenitor zone and all of these are
without exception calbindin negative. J to L) At E12.5 no V1-INs are exiting the
progenitor area and the number of calbindin negative V1 interneurons in the ventral
horn has significantly increased. Scale bars; 100μm in all images.

157

158

the time necessary for cells to transfer from S-phase to cell division and then start of
V1-differentiation and upregulation of En1 (see discussion).
V1-INs detected at E10.5 are restricted to a very small group of cells located in
a single mid dorso-ventral plane and in between the ventricular zone and the lateral
external border of the spinal cord (Figs 38A, 39A, 40A, 44A). The more lateral cells
extend several neurites while the more medial cells are frequently bipolar and express
weaker tdTomato labeling. As previously suggested in motoneurons (Wentworth,
1984), this morphological changes might represent a medial to lateral progression in
maturation, being the morphology of lateral cells more mature than medial ones.
Medial cells are usually located in a transition zone between the ventricular progenitor
zone and the mantle layer. This space is small at this age and these cells seem to be the
first to occupy and form the mantle region at this dorso-ventral location. The number of
V1-INs increased at E11.5 and their area of distribution extended more ventrally
occupying positions both lateral and medial to presumptive motor pools in the ventral
horn (Figs. 38D, 40A, 44A). Further V1-INs are added at E12 and E12.5, mostly
medial to putative motor pools. The ventral horn grows in size by the addition of more
cells (Figs. 38G,J, 41A, 42A, 45A, 46A). At E11.5 and E12 many small V1-INs are
located medially, at the border of the ventricular zone. These cells form tight packets of
high cellular density and weak tdTomato labeling and likely represent newborn cells. In
our preparations is usually difficult to discern single cells within these packets. The
morphological complexity of V1-INs and tdTomato expression both increased in the
more lateral cells suggesting they have further progressed in their development. Higher
tdTomato expression permitted better cell definition in the lateral cells. At E12.5 we
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Figure 39. Expression of MafB in V1-INs in the early embryonic spinal cord
(E10.5). Low and high magnification confocal images of spinal cord sections obtained
from an En1-Cre/R26-tdTomato mouse. The solid line delineates the embryonic spinal
cord, while the dashed line marks the midline. The dotted line in G to I indicates the
edge of the progenitor area. V1-INs are labeled in red (tdTomato), MafBimmunoreactivity in green (FITC) and calbindin-IR in white (Cy5). A to F) Few V1INs have been generated at E10.5 (A) and the few that are present are located in
between the progenitor area and the external border of the spinal cord. At this age,
MafB expression is mostly present in motoneurons (B) and not in V1-INs (E, F H and
I). However, calbindin-IR (C) is present in most V1-INs at this age. G to I) Higher
magnification images with the boundary between progenitor area and mantle layer
indicated (dotted line). Calbindin-IR V1-INs are located either laterally (cells sending
projections ventrally) or medially. The medial cells are bipolar and seem to be
migrating away from the progenitor area. None of these cells express MafB. Scale bar;
100 µm in A (panels B to F at the same magnification); 50 µm in G (panels H to I are at
the same magnification).
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Figure 40. Expression of MafB in the E11.5 spinal cord. Low magnification confocal
images of the spinal cord from an En1-Cre/R26-tdTomato mouse. Markings as in
Figure 39. Sections were immunostained for MafB in green (FITC) and calbindin in
white (Cy5). V1-INs are labeled red (tdTomato). At E11.5 there appears to be
considerably more labeled V1-INs than at E10.5 (red, A). A group of V1-INs are
already ventrally located. MafB expression has been downregulated from motoneurons
(B) and it starts to be present in few V1-INs. Calbindin-IR is mostly located ventrally
(C and D) in the majority of laterally located V1-INs. Scale bar; 100 µm in A and
applies to all images.
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Figure 41. Expression of MafB in V1-INs in the E12.0 embryonic spinal cord. Low
magnification confocal images of the spinal cord from an En1-Cre/R26-tdTomato
mouse. Markings as in Figure 39. Sections were immunostained for MafB (green,
FITC) and calbindin (white, Cy5). V1-INs are visualized naked (red, tdTomato). V1INs can still be seen exiting the progenitor area (A) and some of the more ventrally
located now express MafB (B, E and F) and calbindin (C, D and E). Calbindin
expression is, at this age, located in the most ventral areas of the ventral horn (C), while
MafB expression has been almost completely downregulated from motoneuron pools
and it is present in V1-INs, mostly in the ones most ventrally situated. Scale bar; 100
µm in A and is applicable to all images.
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Figure 42. Expression of MafB in V1-INs in the E12.5 embryonic spinal cord. Low
magnification confocal images of the ventral spinal cord from En1-Cre/R26-tdTomato.
Markings as in Figure 39. Sections were immunostained for MafB (green, FITC) and
calbindin (white, Cy5). V1-INs are visualized naked (red). By E12.5 no more V1-INs
can be seen exiting the progenitor area (A) and most cells appear to be located in their
final positions with regard to the motor pools. MafB (B) is present in the more ventrally
located V1-INs that also express calbindin (C). These cells are likely developing
Renshaw cells. Bottom row shows superimpositions of two fluorochromes. Scale bar;
100 µm in A, applies to all images.
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could not detect cells exiting from the ventricular zone and the majority of V1-INs
appear relatively mature.

Calbindin expression in early embryos.
From E10.5 to E12.5 a proportion of V1-INs expressed calbindinimmunoreactivity (Fig. 38). No calbindin-IR cells were detected at E9.5 in the spinal
cord or midbrain (Fig. 37E-H), therefore the first calbindin-IR cells detected in the
spinal cord are V1-INs. The majority of V1-INs at E10.5 and most of the laterally
located and more mature V1-INs at E11.5 are calbindin-IR (Figs 38A,D, 39A,D,
40A,D, 43A,D, 44A,D). Calbindin seems to upregulate in these cells very early, being
frequently found in cells exiting the ventricular zone at E10.5 (Fig. 39). By E12 and
E12.5 a large number of the newly added V1-INs are calbindin negative and newborn
cells exiting the ventricular zone at E11.5 and E12 are also calbindin negative (Figs.
41A,D, 42A,D, 45A,D, 46A,D). Presumptive calbindin-IR V1-Renshaw cells are
located between motoneurons and the lateral edge of the spinal cord by E11.5, and
these cells remain more or less at a similar position at E12 and E12.5 (Fig. 38). In
conclusion, the first wave of V1-IN neurogenesis seem to correspond with cells that
rapidly upregulate calbindin in agreement with the conclusions from aim 1.
In addition, we found populations of calbindin-IR cells that are not V1-INs at
E12 and E12.5. Some are relatively large and could represent motoneurons based on the
fact that some calbindin-IR axons can be seen exiting the spinal cord though the ventral
roots. Motoneurons are known to downregulate calbindin expression by P0 (Zhang et
al., 1990).
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Expression of transcription factors in embryonic V1-interneurons
MafB expression in the embryonic spinal is detected prior to FoxP2, but
surprisingly most was found in motoneurons and not in V1-INs at E10.5 (Figs. 39). By
E11.5 MafB expression downregulates in motoneurons and starts to be upregulated in
some V1-INs (Fig. 40). At this age MafB expression is found in calbindin-IR V1-INs
that start to be located at the edge of the spinal cord lateral to motoneurons and also in
some dorsally located V1-INs some of which are calbindin negative. Not until E12.0,
could we detect MafB strongly expressed in most calbindin-IR V1-INs in the Renshaw
region (Fig. 41) and this expression is maintained at E12.5 (Fig. 42) and until P0 (see
above). In conclusion, MafB expression in Renshaw cells is delayed compared to
calbindin expression and upregulates only after the cells have reached their final
locations. MafB is therefore upregulated at a relatively advanced step in differentiation
in two groups of V1-INs (ventral Renshaw cells and dorsal non-calbindin V1-INs).
Both seem generated earlier than E11.5.
In contrast, there are no FoxP2 cells at E10.5 (Fig. 43). The first expression is
observed at E11.5 in a group of packed V1-INs located at the exit region of the
progenitor zone (Fig. 44). Similar newborn V1-INs expressing FoxP2 are found at E12,
but not at E12.5 (Figs. 45 and 46). E12 and E12.5 are characterized by the increase in
the number of FoxP2 expressing V1-INs that are located in the marginal region (Figs.
45 and 46). In conclusion, FoxP2 expression seems characteristic of late born V1-INs
but is upregulated in these cells as soon as they start differentiation.
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Figure 43. Expression of FoxP2 in V1-INs in the E10.5 spinal cord. Low
magnification confocal images of a spinal cord from an En1-Cre/R26-tdTomato mouse.
Markings as in Figure 39. Sections were immunostained for FoxP2 in green (FITC),
and calbindin in white (Cy5). V1-INs are visualized in red (tdTomato). The locations of
V1-INs and calbindin immunoreactivity is as previously described (Figure 39). No
FoxP2 immunoreactivity is visible at this age. Scale bar; 100 μm in A, applies all
images.
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Figure 44. Expression of FoxP2 in V1-INs in the E11.5 spinal cord. Low
magnification confocal images of spinal cords from an En1-Cre/R26-tdTomato mouse.
Markings as in Figure 39. Sections were immunostained for FoxP2 in green (FITC),
and calbindin in white (Cy5). V1-INs are visualized naked in red (tdTomato). At E11.5
we can first detect FoxP2 (B) expression in some V1-INs (A) that are just exiting the
progenitor area. None of these cells express calbindin-immunoreactivity (C). D to F
superimposition of different fluorochromes. Scale bar; 100μm in all images.
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Figure 45. Expression of FoxP2 in V1-INs in the E12.0 spinal cord. Low
magnification confocal images of spinal cords from an En1-Cre/R26-tdTomato mouse.
Markings as explained in Figure 39. Sections were immunostained for FoxP2 in green
(FITC), and calbindin in white (Cy5). V1-INs are visualized naked in red (tdTomato).
At E12.0 we detect many V1-INs (A) leaving the progenitor area and these cells also
express FoxP2 (B and F). In addition, many V1-INs that are FoxP2 positive have
already migrated ventrally and display more complex morphologies. Calbindin-IR (C)
at this age is mostly restricted to ventral locations in the spinal cord and colocalizes
with the most ventral V1-INs (D), but none of this are FoxP2-immunoreactive (E).
Scale bar; 100 μm in A, applies to all images.
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Figure 46. Expression of FoxP2 in V1-INs in the E12.5 spinal cord. Low
magnification confocal images of a ventral spinal cord from an En1-Cre/R26-tdTomato
mouse. Markings as in Figure 39. The sections were immunostained for FoxP2 in green
(FITC), and calbindin in white (Cy5). V1-INs are visualized naked in red (tdTomato).
At E12.5 there are no V1-INs (A) leaving the progenitor area. FoxP2 (B) and calbindinIR is present in more mature laterally located V1-INs. But there is little co-localization
and while calbindin-IR V1-INs are located ventro-laterally, FoxP2-IR V1-INs are
located more medio-dorsally. Bottom row contains superimpositions of various
immunoreactivities. Scale bar; 100 μm in A, applies to all images.

176

177

In summary, the results confirm the time windows of neurogenesis for all V1
INs and Renshaw cells in particular, estimated with BrdU pulse-labeling studies in
Aim1. It also suggests that MafB expression in Renshaw cells appears relatively late
and only after the cells are close to their final locations. In contrast, FoxP2 is found in
late born V1-INs from the moment they exit the cell cycle and before differentiation
and migration out of the ventricular zone. Interestingly, calbindin seems similarly very
early upregulated in V1-IN Renshaw cells and other early born V1-INs and therefore
precedes MafB expression and constitutes the first phenotypic marker of early born V1IN differentiation including the Renshaw cells. The results allow us to conclude that
both calbindin-IR Renshaw cells and FoxP2 expressing V1-INs (that includes IaINs)
start to phenotypically diverge from the moment they exit the cell cycle and start
migration.

DISCUSSION
The main results described in this aim are: 1) MafB and FoxP2 are expressed in
two distinct non-overlapping populations of V1-INs; 2) V1-INs expressing MafB
include all calbindin-IR Renshaw cells; 3) Calbindin expression defines Renshaw cell
precursors as they exit the progenitor zone while MafB expression is upregulated after a
certain delay and only after Renshaw cells have migrated to their final locations; 4)
FoxP2 is expressed in a population of late generated V1-INs that include a large
proportion of the V1-derived IaINs that we can identify with the present histological
criteria; 5) FoxP2 is expressed in late generated V1-INs as they exit the progenitor

178

zone. In conclusion, the V1-IN populations from which Renshaw cells and IaINs derive
start differentiation from the moment they become postmitotic.

Differences in reporter expression suggest early differences in the regulation of gene
expression in different subgroups of V1 INs.
Neither the En1-Cre/Tau-lacZ nor the En1-Cre/Thy1-YFP lines expressed the
reporters early enough to allow analyses of the early differentiation of V1 INs. The first
expression of the Tau-LacZ reporter was noted at E11.5 and for the Thy1-YFP reporter
this date was E15.5. In both cases reporter expression at these ages was very weak,
particularly in Renshaw cells. This lack of expression is most likely due to a
developmentally regulated control of activity in the Tau and Thy1 promoters. Although
it was not thoroughly quantified, the results also suggest that Renshaw cells are one of
the last groups of V1-INs to upregulate these promoters. In particular YFP expression
in the Thy1 line was not noted in Renshaw cells until relatively late (~E17) and only a
subgroup of Renshaw cells expressed YFP at birth (P0). YFP expression spreads to all
Renshaw cells by P5. The late upregulation of reporter expression in Renshaw cells
suggest that genetic expression control mechanisms in Renshaw cells already differ
from other V1-INs in the embryo. Thus, for analyses of E9.5 to E12.5 embryos we
switched to the R26-tdTomato reporter line that exhibits a wider temporal window of
reporter expression during development. We described only results from En1-Cre/R26tdTomato litters, however the observations were replicated and largely confirmed in
En1-Cre/Tau-LacZ litters from E11.5 age to E12.5 (not shown).
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The first evidence of reporter expression in the spinal cord using En1-Cre/R26tdTomato mice was E10.5. We confirmed that the genetic reporter expression system in
these animals is indeed active as early as E9.5. Engrailed-1 expression is upregulated
early in progenitor cells at the diencephalic/rhombecepahlic boundary, a region that
gives rise to the cerebellum. Progenitor cells in this area expressed abundant fluorescent
protein in E9.5 embryos. In the E10.5 spinal cord the reporter was found in cells
located at the border of the ventricular zone and in differentiating cells located more
laterally in the mantle. The positions of weakly labeled cells at the lateral edges of the
ventricular zone, exiting the progenitor zone, suggests upregulation of engrailed-1 in
V1 INs as soon as they become postmitotic. If we consider an approximately 10 hour
delay between S-phase BrdU labeling and the appearance of postmitotic neurons
expressing specific transcription factors (Peng et al., 2007), our results match well the
findings in Aim 1. BrdU was found to incorporate in V1-INs by E9.5. Following BrdU
incorporation the cell needs to enter M-phase, divide, become postmitotic and start
differentiation by expressing engrailed-1. Following steps include cre-recombination
and reporter expression. Therefore a 24 hour delay between BrdU labeling and the
appearance of the first reporter-labeled V1 INs is within the expected range. The results
confirm that engrailed-1 is upregulated in early postmitotic differentiating V1-INs, but
not in p1 progenitors (Matise and Joyner, 1997; Sauressig et al., 1999).

Transcription factor immunodetection in spinal cord neuronal subpopulations.
When analyzing the pattern of expression of transcription factors using
antibodies, we need to be aware of possible confounding effects caused by antibody
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specificity, temporal regulation of expression and possible epitope masking due to
chromatin reorganization. MafB and FoxP2 immunoreactivities were always confined
to the cell nuclei. This cellular localization is expected for transcription factors and
suggests specificity. An optimal specificity test would be to perform these
immunoreactions in mouse spinal cords lacking the proteins (i.e., expression
knockouts). MafB and FoxP2 knockouts have been generated (Blanchi et al., 2003; Shu
et al., 2005), but these animals are yet unavailable to us. Confirmation of the pattern of
expression of both transcription factors was therefore done comparing immunolabeled
cells in our sections with in situ hybridization genetic expression maps of the mouse
spinal cord (Allen Brain and Spinal Cord Atlas; http://www.brain-map.org/). This
expression maps contain data for the P4 and P56 mouse spinal cords.
The distribution of MafB mRNA expressing INs in this atlas is identical to the
pattern of MafB protein immunolocalization we described at P0. Interestingly, in situ
detection of MafB transcripts in the Atlas is described for both P4 and P56, while we
were unable to immunolocalize the protein at P5 or later. Fast downregulation of MafBexpression in the postnatal spinal cord agrees with data provided by Geiman and
colleagues in abstract form (Geiman et al., 2006). Mismatches between positive mRNA
detection and negative immunolocalization have been described before and do not
imply lack of antibody specificity. By contrast, the opposite situation in which positive
immunolocalization is not matched by mRNA expression would have raised concerns
about unspecific immunostaining, but this did not occur. Three explanations can be
proposed for the observed mismatch with MafB mRNA expression in older spinal
cords. First, high turn-over of MafB protein may result in a low steady-state
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concentration, below immunodetection threshold. Second, lack of translation of the
transcript into protein. Third, epitope masking obstructing access of the antibodies to
the protein. To resolve these issues, we will need to test a variety of DNA denaturing
and chromatin-unfolding methods before immunolocalization and corroborate the
presence and levels of protein in spinal cords of different ages using Western blots.
Alternatively, MafB expression could be followed by using a recently generated
transgenic mouse in which a mafB 5‟-upstream fragment directs expression of GFP
mimicking MafB expression in cells, including ventral spinal cord neurons (Hamada et
al., 2003). At present these experiments are beyond the objectives in this aim. It was
fortunate that enough antigenicity was preserved at P0 and that at this age the
immunolabelings correspond well with the distribution of cells expressing MafB
mRNA in the P4 spinal cord, giving confidence that the immunolocalizations described
herein accurately represent MafB-expressing INs in the spinal cord. However, we
cannot be completely sure that the observed developmental downregulation of MafB
immunoreactivity truly represents a downregulation of expression of this transcription
factor in more mature INs, including Renshaw cells. We can be more certain that
motoneurons express MafB early in development and then downregulate its expression.
MafB in situ hybridization signals are positive in the developing motor pools of the
chick embryo at day 4 (chick E4 corresponds roughly to E10 in mice as far as it relates
to motoneuron development) (Eichmann et al., 1997; Lecoin et al., 2004) and were also
detected from E10 to E13 in mouse spinal motoneurons (Eichmann et al., 1997;
Hamada et al., 2003). MafB mRNA is however undetectable in postnatal motoneurons
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(Allen Brain and Spinal Cord Atlas), in agreement with the lack of immunolocalization
signals in the postnatal spinal cord.
In conclusion, we identified four different cellular types that express MafB in
the embryonic spinal cord: 1) Early developing motoneurons that then quickly
downregulate MafB expression; 2) Ventral INs in which a majority are Renshaw cells
and remain clustered in the Renshaw cell region through development; 3) A few dorsal
V1-INs that do not express calbindin; 4) dorsal horn INs that arises from a dorsal
progenitor area and spread all over the postnatal spinal cord dorsal horn. These groups
match the MafB cells found at P0, except for motoneurons that seem to downregulate
MafB before P0.
The distribution of FoxP2 immunoreactive neurons was compared to previous
studies in the mouse embryonic spinal cord using both in situ hybridization (Shu et al.,
2001, Dasen et al., 2008) and immunolocalization (Dasen et al., 2008; Morikawa et al.,
2009). We found a similar onset of expression (at E11.5) and distribution of cells in
E12 and E12.5 mouse embryonic spinal cords. Morikawa et al (2009) indicated that all
ventral FoxP2 positive interneurons in E11 to E12.5 spinal cords also expressed En1immunoreactivity suggesting they belong to the V1 population. Moreover, the
proportion of V1-INs expressing FoxP2 increased from 18% at E11 to 59% at E12.5.
One possible explanation for this increase is that they correspond with a population
being added relatively late, as suggested in our studies. There are no previous studies
on the distribution of FoxP2 positive neurons in the postnatal spinal cord. We found
that at P5 only 33% of V1-derived INs express FoxP2, perhaps suggesting
downregulation of FoxP2 in some V1-derived INs. If this was the case, the partial

183

labeling of V1-derived IaINs (66% of V1-derived IaINs express FoxP2) could be
explained by downregulation before P5. Similar significant reductions in the number of
FoxP2 positive spinal INs was observed from E13.5 to P0 by Morikawa et al. (2009),
but the very significant growth of both spinal cord and neurons combined with the lack
of stereological methods make interpretation of these data difficult. Alternative
explanations are also possible. For example, the time course of En1 expression in
individual V1-INs is unknown, but this information is important to interpret the data in
temporal co-localization studies like the one described by Morikawa and colleagues. If
En1 downregulates shortly after the cell is born, this could explain the selective
enrichment of FoxP2 in En1 positive neurons at late developmental stages because
earlier V1-INs would have downregulated En1 expression at this stage. Another
difference between our estimates in postnatal spinal cords and those of Morikawa et al.
in embryos is that we found many FoxP2-immunoreactive INs in the ventral spinal cord
that do not belong to the V1 population. Given that ventral INs are largely generated
before E12.5 the appearance of ventral FoxP2 interneurons that are not V1 can only be
explained by late upregulation of this transcription factor in ventral non-V1 INs or by
migration of dorsal FoxP2 populations into the ventral horn. Indeed, Morikawa et al.
suggest that a population of dorsal dl2 INs express FoxP2 in early embryos and ends
been localized in ventromedial positions. The relatively poor cellular resolution
obtained with tdTomato fluorescent protein in tightly clustered early differentiating
cells, did not allow us to perform accurate co-localization quantitative analyses. In the
future thinner sections or immunocytochemical amplification of the reporter will need
to be used to generate preparations from where accurate estimates can be obtained.
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In summary, FoxP2 is expressed in a subpopulation of late generated V1-INs
that includes many V1-derived IaINs identified histologically in the postnatal cord.
Whether our results can be taken to suggest that FoxP2 is expressed by only a
subpopulation of V1-derived IaINs is more difficult to conclude given the possibility
that by P5 many V1-derived INs could have downregulated this transcription factor.
Alternatively, these analyses should be done earlier, but at present it is not possible to
identify IaINs at early developmental stages because the criteria we use for
identification is based on synaptic connectivity and synaptogenesis in the spinal cord
starts at embryonic ages later than the ones we studied here. On the other hand, if our
data at P5 truly indicates heterogeneity in FoxP2 expression in the IaIN population this
should not be too surprising given the diversity of IaINs in their origins (Siembab et al.,
2010), morphological characteristics (Rastad et al., 1990), trajectories of their axons
and electrophysiological properties and inputs (reviewed in Jankowska, 1992).
Therefore it is possible that our data at P5 indicates that FoxP2 expression is temporally
regulated in a different manner within different groups of V1-derived IaINs or not
expressed at all in some. Despite these interpretation caveats, FoxP2 does allow us to
investigate the early differentiation of a group of V1-INs that is distinct from Renshaw
cells/MafB-expressing V1 INs and includes, at minimum, a sizable proportion of V1derived IaINs.

Specifity of transcription factor expression in V1’s, Renshaw cells and IaINs
The results strongly suggest that neither FoxP2 nor MafB can be regarded as
transcription factors exclusively expressed by V1-INs, IaINs or Renshaw cells. Thus,
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we cannot conclude that these transcription factors alone control the differentiation of
each of these INs. It is more likely that a combination of these with other unknown
transcription factors expressed either simultaneously or sequentially might be
responsible for their specific differentiation as occurs during specification of
motoneuron subtypes (Jessell, 2000; Price and Briscoe, 2004). A “transcription code”
for the specification of adult IN subtypes is at present unknown for any spinal cord
population. What could then be the role of MafB and FoxP2?
Knockout MafB and FoxP2 animals display severe motor abnormalities, but this
cannot be ascribed solely to the loss of subgroups of V1 spinal INs since these
transcription factors are also important for the developmental of many other brain
regions. MafB is involved in the differentiation of monocytes and macrophages,
specification of rhombomeres 5 and 6 in the brainstem and the development of
rhytmogenic cells in the respiratory cells of the preBötzinger complex of the medulla.
An old X-ray induced mutation named Kreisler (Hertwig, 1942) is now known to
inactive MafB expression in some cells including those in the medulla, blood cells lines
and a number of other peripheral cells (but not in respiratory neurons). These animals
survive but have deformed vestibular apparatus and cochlea and are deaf, cannot swim,
run in circles with head tossing and also have a compromised immune system
(reviewed in Eichmann et al., 1997). In contrast, complete knockout of MafB results in
animals that die due to respiratory apnea just after birth because the deletion of critical
INs of the respiratory center in the preBötzinger complex (Blanchi et al., 2003). To our
knowledge there are no published analyses of spinal cord development in these animals.
One personal communication at a meeting (Symposium on Neurons and Networks in
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the Spinal Cord. University of Wisconsin – Madison. June 2009) from the lab of Dr.
Martyn Goulding (Salk Institute. San Diego, CA) suggested that Renshaw cells start
normal differentiation in early embryos but undergo apoptosis in late embryos in MafB
knockout animals. If these results are confirmed, MafB could be a critical factor for the
maintenance of Renshaw cells but not for their early specification and this would agree
with the timing of its expression, as described in here.
FoxP2 is also involved in many different developmental processes, and has now
gained fame due to its genetic linkage with human language deficits and with vocal
learning in other species (reviewed in Vargha-Khadem et al., 2005; Fisher and Scharff,
2009). However, FoxP2 is also widely expressed in many tissues and cells during
development and in the adult suggesting many different functional roles (Shu et al.,
2001). FoxP2 knockout mice express many severe motor deficits and an
underdeveloped cerebellum (Shu et al., 2005). These animals eventually die by P21,
although the cause of death was not fully investigated. Given the widespread functions
of FoxP2 it would be desirable to have better control for gene deletion in specific cells
and at specific times. This is now possible because the development of transgenic mice
carrying a conditional FoxP2 allele that can be removed upon Cre-mediated
recombination (French et al., 2007). To our knowledge there are no studies on the role
of FoxP2 in interneuronal development, however it is interesting that the related
transcription factor FoxP1 is highly express in motoneurons during development where
it controls pool specification and motoneuron spinal cord position and connectivity
(Dasen et al., 2008). If FoxP2 had a similar function in defining pools within IaINs, or
would explain the uneven distribution of FoxP2 in this population at P5.
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Differentiation of early and late V1 populations starts as soon as they are born.
The principal question we asked in this aim was whether or not early and late
generated V1-INs that include, respectively, Renshaw cells and IaINs start their
differentiation as soon as they are generated. The alternative possibility was that they
remain relatively undifferentiated until a later time, for example until the onset of
synaptogenesis. This second possibility could imply that integration into synaptic
circuits is a major factor in determining fate and differentiation. Our results falsify this
possibility and suggest that different groups of V1-INs commit to differentiation
pathways as soon as they start to leave the progenitor area and before synaptogenesis.
Interestingly, FoxP2 is expressed in late V1-INs very early, as they exit the progenitor
zone, while MafB is upregulated relatively late in earlier generated Renshaw cells, and
only after these cells have reached their final positions. This does not mean, however,
that Renshaw cells start differentiation relatively late. Early generated V1-INs express
calbindin as they exit the progenitor zone and calbindin expression seems unique to this
group of V1-INs not being replicated by late V1-INs expressing FoxP2. Therefore, the
first phenotypic marker we identified for early V1-INs is calbindin, while FoxP2
appears to be widely expressed in late generated V1-INs.
Within the early and late V1 populations it is likely that there are also
subdivisions. For example, calbindin-IR V1-INs also included the big upper lumbar
cells that according to aim 1 are generated overlapping with Renshaw cells. The early
calbindin expressing population is also likely to include other V1-IN groups that
downregulate calbindin during late embryo and early postnatal development (Siembab
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et al., 2010). Perhaps many of the calbindin V1-INs located medially to the motoneuron
pools belong to this group. It is interesting that MafB expression seems relatively
restricted to Renshaw cells within the calbindin-IR V1 group and that MafB is
upregulated only after Renshaw cells reach their final locations ventral and lateral to the
motor pools (during the morphogenetic movements related to the growth of the spinal
cord in late embryo this location will end being ventromedial to the motor pools in the
lumbar segments). In parallel with the known hierarchical organization of
transcriptional codes in motoneurons, MafB could represent a relatively late inductor of
properties that differentiate Renshaw cells from other groups of early generated V1-INs
that express calbindin in embryo. Interestingly this temporal regulation of MafB
expression appears to be specific to V1-INs because dorsal horn cells that also express
MafB upregulate its expression as they exit the progenitor zone.
Overall, the evidence in this aim suggests that differentiation of IN subtypes
from the canonical V1 group occurs very early, perhaps determined by geneticinductive processes before circuit formation. The mechanisms that trigger early
developmental programs that specify subgroups of V1-INs are unknown but it was
observed that MafB expression was not expressed in developing Renshaw cells until
they reached their final position. Therefore we speculate whether their migratory
behavior could provide insights into mechanisms of Renshaw cell differentiation. In
aim3 we investigated whether or not Renshaw cells follow a distinct migration
pathway that positions them among motor axons.
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AIM 3
CHARACTERIZATION OF THE
MIGRATORY PATHWAY OF RENSHAW
CELLS AS DISTINCT TO THAT OF OTHER
V1-INS
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INTRODUCTION
The migration route taken by newborn neurons can affect their development by
restricting their potential for differentiation or inducing certain characteristics as they
move through tissues. This influence of migration has been more thoroughly studied for
neural crest cells that are generated at the interface between the skin ectoderm and the
neural tube and migrate throughout the body giving raise to all the peripheral nervous
system, including the sensory ganglia and the autonomic nervous system. For example,
sympathetic neurons leave the neural crest and migrate towards the aorta where they
acquire a noradrenergic phenotype induced by aorta-released BMPs that upregulate the
expression in the migrating neurons of transcription factors that control noradrenergic
genes (Shah et al., 1996).
In the central nervous system, birth-date, migration, final position and
phenotype are closely interrelated as shown in the laminar segregations of retinal and
cerebral cortex neurons (in cortex McConnell and Kaznowski, 1991; McConnell, 1995;
Butt et al., 2007; Leone et al., 2008; Wonders and Anderson, 2006; in retina Watanabe
and Raff, 1990; Cepko et al., 1996; Voinescu et al., 2009). Although much is unknown
about the exact molecular mechanism, experiments with progenitor cells implanted in
tissues or co-cultured with cells of younger or older age suggest that they contain
internal cell programs regulated by internal clocks that make them more or less
susceptible to environmental influences that also change with time as the nervous
system develops. As a result the developmental potential of progenitor cells gets
restricted with time and they generate different cell types that become located at
different positions (see review: Leone et al., 2008; see in retina: Watanabe and Raff,
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1990). Many of the temporal changes that occur in progenitors are related to sequential
changes in transcription factor expression and some of these are known to directly
influence migration (Butt et al., 2007; Leone et al., 2008). In conclusion, the interaction
between migration and differentiation seem to be bidirectional, some cells are biased
towards certain migration routes and at the same time the route of migration and local
environment further specifies novel cellular properties.
Spinal cord LMC motoneurons exhibit similar relationships between birth-date,
migration, transcription factor expression and phenotype. As reviewed before, a
retinoid signal provided by one subset of early-born spinal motoneurons specifies
subcolumnar identity in later-born motoneurons as they migrate past each other
(Sockanathan and Jessell, 1998). Furthermore, visceral motoneurons of the
symphathetic preganglionic motor column settle in the intermediate horn at thoracic
levels and this position is determined by expression of the transcription factor Isl2,
which is key for their migration and future differentiation (Thaler et al., 2004). It is
possible that similar mechanisms are at work for differentiation of spinal ventral INs,
but this is yet unknown. In an early study a number of different directions of migration
were proposed for motoneurons and ventral INs, with most migrating in a lateral and
ventral direction (Leber and Sanes, 1995). It is now clear that cells from different
canonical subtypes (V0, V1, V2, V3) display preferential migration directions in the
spinal cord and end located in different positions (see review in background). However,
within these canonical groups, further subdivisions according to migratory pattern have
only been suggested for the V3 group and their significance is unknown (Zhang et al.,
2008). Within adult V1-derived INs, Renshaw cells display a unique position, known in
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the past as the “Renshaw cell area” located in ventral LVII and LIX (Thomas and
Wilson, 1965; Willis 1971; Alvarez and Fyffe, 2007). In Aim 2 we found that this
location is correlated with positioning at the ventro-lateral edge of the developing
embryonic spinal cord. We therefore asked in here whether this is related to a specific
migratory pathway for early-born Renshaw cell precursors that in addition could
explain their close relationship with motor axons and may be also important for further
development of Renshaw cell properties. For example, MafB expression seems
upregulated in Renshaw cells only after they reach their final position (Aim2).
Previous studies suggested that V1-derived INs leave the progenitor area as
soon as the last cell cycle division is completed (Saueressig et al., 1999) and therefore
early and late born V1-INs should start migration at different times. This implies
possible differences in routes and interactions within a developing neural tube that
changes with age. Based on Aim1 results we know that Renshaw cells leave the cell
cycle around E9.5 and E10.5, coinciding with the time in which motoneurons become
postmitotic in the mouse spinal cord (Sims and Vaughn, 1979; Holley et al., 1982;
Wentworth, 1984). The early expression of calbindin in Renshaw cell precursors
(Aim2), just as they migrate away from the ventricular zone, could suggest that they are
already at least partially differentiated towards some aspects of the Renshaw cell
phenotype and this could include a specific migration route. It has also been suggested
in the early spinal cords of the mouse (E9.5 to E11.0) and the chick (S18 to S23) that
cytoplasmic extensions from both motoneurons and radial glia connect the ventricular
zone with the external surface of the neural tube (Holley, 1982). Developing Renshaw
cells could use these pathways for lateral migratory guidance. Therefore, we suggest

193

that because motoneurons and Renshaw cells have similar birth dates, their migratory
timing and pathways might be related and in part responsible for some aspects of their
future differentiation. Indeed in an early study looking at V1 cells at different
embryonic stages it was suggested that V1 cells first move laterally within the neural
tube and then start to migrate ventrally positioning themselves medial to motor pools
(Matisse and Joyner, 1997). The results in aim 2 clearly suggest that developing
Renshaw cells are different in that their final position in the embryonic spinal cord is
ventro-lateral to motor pools, not medial. No previous study has directly analyzed these
migratory patterns or established differences among the different groups of V1-INs.
Moreover, there are a number of different pathways available for putative Renshaw
cells to settle into their final positions between motoneurons and the ventral root. These
include pathways around motoneurons dorsally or ventrally or even through the
motoneuron pools. Each migratory route could suggest different possible interactions
with the maturing motor pools.
We therefore hypothesize that a subset of early-generated V1-INs which will
become the Renshaw cell pool is attracted toward the motor axon exit and they could
interact with motoneurons during the migration process in a number of different
manners. In contrast, later born V1-INs stop their migration medial to motoneurons and
these could become other types of premotor inhibitory INs. We will test this hypothesis
by analyzing the relationships of migrating Renshaw cell precursors with motoneurons.
For these studies we used En1-Cre/R26-tdTomato embryos and combined V1 genetic
labeling with calbindin-immunoreactivity to distinguish Renshaw cell precursors within
the V1 group. The sections were also immunostained for either a motoneuron marker
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(the transcription factor, islet 1) or a marker of neurites in immature neurons (Tuj1
monoclonal antibodies against class III beta-tubulin, give ref) to label the developing
ventral roots.

MATERIAL AND METHODS
Animals and Tissue extraction
Time pregnant females were obtained as before to obtain embryos from E10.5
to E12.5. We analyzed E10.5 (n = 4 embryos from 2 litters), E11.5 (n = 7 embryos from
2 litters), E12 (n = 4 embryos from 2 litters) and E12.5 (n = 2 embryos from 1 litter),
embryos generated by crossing En1Cre/+ heterozygotes with the CAG-Rosa26-loxSTOP-loxp-tdTomato-WPRE reporter line. Timed pregnant females were perfused as
described in Aim 2 and the embryos removed and fixed in toto overnight and then
cryoprotected in 30% sucrose. Positive embryos (expressing tdTomato in En1+ cells)
could be easily identified by a large area of red fluorescence observed in the midbrain
region (see Aim 2). Embryos were cut in a cryostat at 20-30µm thickness and collected
in subbed slides. Slides were stored at -20ºC until processed.
All animal procedures were carried out according to NIH guidelines and were
approved by WSU LACUC.

Immunolabeling.
For these experiments rabbit polyclonal antibodies (1:500, Swant, Bellizona,
Switzerland), were combined with monoclonal mouse antibodies against Islet1 or Tuj1
Immunoreactive sites were revealed with fluorochrome-conjugated (FITC, Cy3, and
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Cy5) donkey species-specific secondary antibodies (1:50, Jackson Laboratories) or
Alexa-405 (Invitrogen) as previously described and all immunofluorescent preparations
were coverslipped with Vectashield (Vector Labs).

Table 4. Antibodies used in Aim 3 and labeling specificity

Antibody

Type

Host species

Dilution

Company

Calbindin
D28K

Polyclonal

Rabbit

1:500

Swant,

Islet1

Monoclonal

Mouse

1:100/1:50

Hybridoma
Bank, Iowa

Tuj1

Monoclonal

Mouse

1:500

Chemicon

Specificity
No labeling in KO
tissue
Only known
embryonic spinal
islet1 cells labeled
Only present at
early embryonic
stages

Analysis: Images were obtained in an Olympus FV1000 confocal microscope at
10X1, 20x1 and 60x1. Image composition and presentation were done as in aims 1 and
2.

RESULTS
Analysis of embryonic spinal cord sections from E10.5 to E12.5 helped us
generate a plausible scheme of V1 migratory pathways based on static images. At
E10.5 few tdTomato-labeled V1-INs are present in the embryonic spinal cord. Most are
calbindin-IR and located in close proximity to the spinal cord surface and just dorsal to
Islet1-IR motor pools (Fig. 47). At this age there are very few differentiating cells in the
mantle layer of the embryonic spinal cord and therefore these cells, although located in
apposition to the lateral surface they are not far from the ventricular zone where they
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Figure 47. Locations of calbindin-IR V1-INs with respect to Islet1-IR motoneurons
in the embryonic spinal cord at E10.5. Low (A to F) and high (G to L) magnification
confocal images of spinal cords from the En1-Cre/R26-tdTomato mouse line. The solid
line delineates the boundaries of the embryonic spinal cord, while the dotted line marks
the midline and progenitor area. Sections were immunolabeled for Islet1 in green
(FITC) and calbindin in white (Cy5). V1-INs were visualized naked (without any
antibody enhancement) in red. At E10.5 the V1-IN population (A and G) is located
right above the motoneuron pool (F and L). Motoneurons (Islet1 positive) are already
located ventrally at this age (B and H). In these images we also confirmed that at E10.5,
all V1-INs present are calbindin positive (D and J). Some calbindin-IR cells have
bipolar morphologies and some are oriented medio-laterally. However the most striking
groups are located most laterally, have unipolar morphologies send out projections
ventrally to a very specific area in the ventral horn (white arrow in I). Projections
follow the most external path or infiltrate the motor pools. Many end in growth cones
which are frequently clustered at this ventro-lateral location (J and K). Scale bar; 50μm
in A and G (B to F are at the same magnification as A; H to L are at the same
magnification as G).
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originated and they are at a similar dorso-ventral level. The simplest interpretation of
these images is that this early group of INs did not move much laterally but just exited
the proliferative zone and started the formation of the mantle layer just above the motor
pools, which are settling more ventrally. This might suggest that this early group of V1
INs is possibly one of the first IN cell groups that start differentiation in the early spinal
cord. At this age most are unipolar or bipolar neurons with short processes. The cells
located more medially are frequently bipolar and located at the transition zone between
the progenitor area and the mantle layer. The border between these two regions is better
visualized in sections immunostained against Tuj1 (Fig. 48). In these sections some
calbindin-IR V1-INs are clearly identified outside of the proliferative zone (i.e., Fig. 48
C, I, and F). In bipolar cells one process is oriented laterally, toward the surface of the
neural tube, and the other is shorter and directed medially, likely retracting from the
ventricular area. More laterally located cells are presumably more mature neurons
generated earlier. These cells are mostly unipolar with a clear process directed ventrally
(Figs. 47G-L, 48D-I). These ventral processes course in between the outer edge of the
spinal cord and the Islet1-immunoreactive motor pools or through the motor pools. In
Tuj1-labeled sections these processes seem to terminate in front of the motor root exit
area (Fig. 48D-I) and frequently end in bulbs that resemble growth cones (arrow in Fig.
47I).
At E11.5 there is a significant increase in the number of V1 INs (Figs. 49 and
50), but still the majority are calbindin-IR (as described in Aim 2). They are distributed
in two groups. The more striking population of calbindin-IR V1 INs are tightly
clustered in a thin layer surrounding the most lateral and ventral corner of the spinal
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Figure 48. Calbindin-IR V1-INs project ventrally to the area right next to the
motor axon exit zone in the E10.5 spinal cord. Low (A to C) and high (D to I)
magnification confocal images of an embryonic spinal cord from a wild-type animal.
Markings as in Figure 47. Sections were immunolabeled for Tuj1 (Neuron-specific
class III beta-tubulin, red, Cy3) and calbindin (green, FITC). A) Tuj1-IR targets
microtubules of undifferentiated neurons and labels mostly processes including the
axons. Dorsal roots and ventral roost are well defined in these preparations (see Figure
4). The progenitors are unlabeled by Tuj1 antibodies. B) Calbindin-IR cells (E and H)
send projections to the area in front of the motor axon exit as visualized with Tuj1
immunolabeling (C). D to I), High magnification images showing the relationship
between the ventral root exit zone and the ventrally directed processes sent by
calbindin-IR neurons in the E10.5 spinal cord. Scale bar; 50 μm in A and D (B and C
are at the same magnification as A; E to I are at the same magnification as D).
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Figure 49. Location of calbindin-IR V1-INs with respect to Islet1-IR motoneurons
in the embryonic spinal cord at E11.5. Low (A to F) and high (G to L) magnification
confocal images from an En1-Cre/R26-tdTomato mouse. Markings as in Figure 47.
Sections were immunostained for Islet1 (B and H, green, FITC) and calbindin (C and I,
white, Cy5). V1-INs (A and G) are shown in red due to the presence of a red
fluorescent protein in their cell bodies. By E11.5 calbindin-IR V1-INs are located in
two distinct areas. A more lateral group is at the very edge of the spinal cord and seems
to have followed the projections seen at E10.5. A second group is located medial or
intermingled with motoneurons. Scale bars; 50 μm in A and G (B to F at the same
magnification as A; E to I at the same magnification as D).
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cord. These cells appear to correspond to presumed developing V1 Renshaw cells that
were located more dorsally at E10.5. In Tuj1-labeled sections these lateral cells are
found in close relationship with the ventral root exit (Fig. 50). The medial group of V1
INs is located far from the ventral roots and positioned medial or intermingled with
islet1-immunoreactive motoneurons. A large proportion of these V1 cells are also
calbindin immunoreactive. At this age most calbindin-IR V1 cells in both groups are
multipolar with several neurites emerging from their cell bodies. The cell bodies of the
lateral group are spindle-shaped while those of the medial group are more rounded. At
this age there are few calbindin-IR V1-INs close to the progenitor area, these few cells
are now oriented radially in a ventro-lateral direction pointing towards the motor pools.
Medial V1 cells are not as tightly clustered as the lateral group because the basal plate
(or developing ventral horn) medial to motoneurons has added by now many other cell
types in addition to V1-INs.
In addition, at this age we observed V1 calbindin-IR putative axons oriented
longitudinally and therefore cross-sectioned in the incipient marginal layer (future
white matter). These axons are located just external to the lateral group of calbindin-IR
V1 INs (Figs. 49G-L, 50D-I). This suggests that early calbindin-IR V1 axons (many of
which probably arise from developing Renshaw cells) contribute also to pioneer the
ventral funiculus. The majority are positioned just medial to the ventral root exit. In
Tuj1-immunostained sections it is clear that a large contribution to the early white
matter comes from commissural axons that cross just ventral to the floor plate in a
region that will later become the ventral white commissure. As already suggested by
the early neuroanatomists (Cajal, 1995), the formation of the white matter starts
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Figure 50. Calbindin-IR V1-INs, presumably Renshaw cells, position their cell
bodies in front of the motor axon exit by E11.5. Low (A to C) and high (D to I)
magnification images of ventral portion of the spinal cord in a wild-type animal.
Markings as in Figure 47. Sections were immunostained for Tuj1 (red, Cy3) and
calbindin (green, FITC). At E11.5 a group calbindin-IR cells (B, E, and H) are located
in front of the motor axon exit (A, D, and G) where they sent their projections at E10.5.
The remaining calbindin-IR cells are located in between the motor pools or more
medially (C, F, and I). Scale bars; 100 μm in A (B and C have same magnification); 50
μm in D (E, F, G, H, and I have same magnification).

205

206

ventrally and at this age there is yet no evidence of axons accumulating in the dorsal
marginal layer.
These observations suggest that by E11.5 most developing V1 Renshaw cells
have established a close spatial relationship with motor axons. The nature of calbindinIR V1 cells found interspersed in between the motor pools or just medial to them is
more difficult to interpret. They could represent late Renshaw cells traveling in between
motoneurons towards the motor axons or alternatively could represent populations of
V1 INs that settle away from the Renshaw and motor axon region and become a
different class of V1-INs. They could become V1-INs that later downregulate calbindin
immunoreactivity (Siembab et al., 2010) or from part of the novel groups of calbindinIR V1 cells described in Aim 1 and located more dorsally. Whether they are migrating
or not can only be fully proven in future time-lapse studies, however, a multipolar
appearance and extension of dendrites occurs in motoneurons and INs only after they
appear to reach their final destinations and stop migration (Wentworth, 1984a,b). Most
of these cells show well developed dendrites and morphology and therefore the more
plausible interpretation is that they are not migrating Renshaw cells.
At E12.0 it is still noticeable how some V1-INs are still leaving the progenitor
zone (Fig. 51), but these late generated cells are not calbindin-immunoreactive, as also
explained in Aim 2. In addition, non-V1 calbindin-IR neurons start to appear more
dorsally (arrows in Fig. 51). In the ventral horn the two same groups consisting of a
lateral differentiating clustered group of calbindin-IR V1 Renshaw cells and a more
medial calbindin-IR V1 group are still visible. By E12.5 no more V1 cells are leaving
the progenitor cell area (corroborating our conclusions from BrdU analyses in Aim1)
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Figure 51. Location of calbindin-IR V1-INs with respect to Islet1-IR motoneurons
in the embryonic spinal cord at E12.0. Low (A to F) and high (G to L) magnification
confocal images of spinal cord from the En1-Cre/R26-tdTomato line. Markings as in
Figure 47. Sections were immunostained for Islet1 (B and H, green, FITC) and
calbindin (C and I, white, Cy5). V1-INs (A and G) are shown in red. At E12.0 the V1INs are grouped in pools (A and G). Calbindin-IR V1-INs are located with respect to
islet1 motoneurons in similar relative positions as in E11.5. In addition a new group of
calbindin negative V1-INs is added at this age and this group is located medio-dorsal to
islet1-IR motoneurons. Scale bars; 100 μm in A (B to F are at same magnification); 50
μm in G (H to L are at the same magnification).
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and calbindin-IR V1 INs are fixed at the same positions in relation to islet1-labeled
motoneurons and Tuj1-labeled ventral roots (Figs. 52 and 53). At E12.0 and E12.5 V1INs display a greater variety of morphologies, including dendritic arbors with mediolateral and dorso-ventral orientation. At this age the cellular density has also increased
considerably and the commissural axons (best visualized in Tuj1-immunostained
sections) divide the mantle layer into a lateral and medial region. Most V1-INs with
multipolar morphologies are located in the lateral regions in close proximity with the
motor pools. At E12.5 the pool of Renshaw cells is located in a more ventral and less
lateral positions. This change of location seems related to morphogenetic movements of
the spinal cord due to its increase in size and cellular density. Thus, calbindin-IR V1
Renshaw cells and ventral roots move together and there is no change in their spatial
relations. At the same time the marginal zone significantly increases in thickness by the
addition of further axons many of which express tdTomato but lack calbindin,
suggesting that V1 axons from late born V1-INs have now reached the marginal layer.
Renshaw cell axons (tdTomato and calbindin) remain closer to the border between the
mantle layer (future grey matter) and the marginal layer (future white matter). At E12.5
there is considerable growth of the dorsal marginal layer that becomes invaded with
many axons (Fig. 53A). V1 axons travelling in the white matter do not extend
collaterals back to the developing motor columns and therefore there is no yet evidence
of terminal arborizations and synaptic varicosities.
The above descriptions correspond to spinal cord regions located at the level of
the lower limb buds and therefore correspond to mid to high lumbar locations.
Interestingly, cross sections through the more caudal neural tube demonstrates a
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Figure 52. Location of calbindin-IR V1-INs with respect to Islet1-IR motoneurons
in the embryonic spinal cord at E12.5. Low (A to F) and high (G to L) magnification
confocal images of the ventral horns of E12.5 spinal cords. Markings as in Figure 48.
Sections were immunolabeled for Islet1 (B and H, green, FITC) and calbindin (C and I,
white, Cy5). V1-INs (A and G) are shown in red. At E12.5, the relationships between
V1-INs (A and G) and Islet-1 motoneurons is similar than at E12.0. Scale bars; 100 μm
in A (B to F are at same magnification); 50 μm in G (H to L are at the same
magnification).
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Figure 53. Calbindin-IR V1-INs retain their position close to the motor axon exit
at E12.5. Low (A to E) and high (F to L) magnification confocal images of an
embryonic spinal cord from wild type animal. Markings as in Figure 47. Section were
immunostained for Tuj1 (red, Cy3) and calbindin (green, FITC). At E12.5, a group of
calbindin-IR cells (B, D, H, and K) remains located in front of the motor axon exit (C,
E, I, and L) with some other cells located further away in between the motor pools or
medial to the motor pools. Scale bars; 100 μm in A (B, C, D, E, and F are at same
magnification); 50 μm in G (H, I, J, K and L are at same magnification).
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significant delay in the generation of V1-INs. In caudal cross sections early generated
calbindin-IR V1 INs are still exiting the progenitor layer and none have yet reached
their final locations in front of the ventral root exit (Fig. 54). Thus, despite the lack of
differences in V1-IN generation between upper and lower lumbar segments (Aim 1)
significant rostro-caudal temporal gradients in the emergence of V1-INs exist
nevertheless. Neurogenesis and migration of more caudal V1-INs seems considerably
delayed compared to lumbar levels.
In summary, the early born Renshaw cells appear to follow a unique migratory
pathway. First, at the time of birth they immediately reach the lateral surface being
among the first to exit the ventricular zone. Second, these cells extend process that
travel ventrally towards the ventral root exit. Third, the cells appear to follow these
processes and settle at the ventral root exit. By E11.5 Renshaw cells have reach their
final positions between exiting motor axons. In contrast, other V1-INs are continuously
added from E10.5 to E12.0, but these cells do not migrate in between motor pools to
reach the external surface of the embryonic spinal cord. Instead, they take a ventrolateral migratory direction towards the motor pools and settle just medial of the
motoneuron pools or in between them.

DISCUSSION
Our analyses of V1-derived IN migratory routes are based on static confocal
images obtained at different embryonic ages. These images provided enough
information to propose 1) a possible migratory mechanism and 2) different routes of
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Figure 54. V1-INs in caudal segments of the spinal cord at embryonic E12.5
resemble earlier embryonic stages of lumbar regions. Low (A to E) and high (F to
L) magnification confocal images of an embryonic spinal cord from a wild type animal.
Sections were immunostained for Tuj1 (red, Cy3) and calbindin (green, FITC). Caudal
embryonic section from E12.5 embryo resembles an E10.5 (A to C) of more rostral
segments. At this age and level we can observe calbindin-IR cells exiting the progenitor
area, sending their projections to the motor axon exit and with cell bodies still located
dorsal to the motor axon exit region (B, C, F, I, and L). Scale bars; 100 μm in A and D
(B, C same magnification as A; E and F same magnification as D). 50 μm in G (H, I, J,
K and L have same magnification).
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migration for Renshaw cells and other V1-derived INs. This different route of
migration suggests a special relationship between developing Renshaw cells and motor
axons.
However, further analyses using time-lapse microscopy will be needed to
confirm these migratory pathways. The use of multiphoton confocal microscopy for
this time lapse studies would be preferred over single photon confocal microscopy
because it will better preserve fluorochromes and cells for the long exposure times that
we expect will be necessary.

Interpretation of static images into a model of migratory behavior.
We believe that our static images suggest a clear migratory path for Renshaw
cells. In other parts of the nervous system, cell migration in situ has been demonstrated
to proceed through neurite elongation followed by nuclear translocation. Pyramidal
cells of the neocortex migrate along radial glia (Hatten, 1990) by extending a leading
neurite towards the surface of the cortex while retracting a trailing neurite that initially
was attached to the ventricle, while the leading edge moves forward and the trailing
edge is retracted the nucleus is pushed in the forward direction (Noctor et al., 2001).
More dramatic are time lapse images of cortical INs in vitro in which migratory
movements occur through initial extension of a neurite followed by nuclear
translocation to its leading edge when this stops. Then the leading neurite is extended
again in another cycle of neurite extension and nuclear translocation. This stop-and-go
movement continues until the neurons stop migrating (Bortone and Polleux, 2009).
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Our images suggest a similar mechanism for calbindin-IR V1 Renshaw cell
precursors in the spinal cord. Initially the cells leaving the progenitor area have a
medio-lateral bipolar morphology in which the lateral extension seems to be a leading
edge in search for the surface of the neural tube while the medial neurite appears as a
shorter trailing end. We don‟t know if at this point the cells follow radial glial surfaces,
but because these are among the first neurons to be generated, above the motor pools,
their final position is very close to the point they exit from the progenitor area, and
therefore radial glial interactions might not be necessary or essential. According to the
model of neurite extension-nuclear translocation, once the lateral “leading” neurite
reaches the surface, the nucleus should be translocated to this lateral position at which
point the neuron becomes unipolar by retracting the trailing end. Then the leading
neurite turns 90° in the ventral direction. Ventrally directed neurites that can be
followed to their end-bulb within single sections always seem to stop in front or close
to the ventral root exit. These end-bulbs resemble growth cones, however this will need
to be further confirmed with more specific markers like the growth protein GAP-43
(Goslin et al., 1988). The route these neurites followed to get there can be deduced by
the location of the neurite stem between the cell body and the end-bulbs. Sometimes
this follows a lateral course between the spinal cord surface and the motor pools, others
it goes through the motor pools. In any case it seems these neurites are attracted by the
ventral root exit region. Following the model, the nucleus of the cell is translocated to
the ventral root exit region once the tip of the neurite reaches this position. Indeed, by
E11.5 many of the cell bodies of these cells have relocated to the ventral root exit
region. The route they might have followed is then given by the course of the neurites
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as seen in E10.5 spinal cords. It is unlikely that this ventrally directed migration follows
any scaffold from motoneurons or radial glial cells. First, the pathway followed by
these neurites is quite tortuous. Second, their direction is orthogonal to radial glia (see
Cajal, 1995 for a representation of radial glial orientation in the spinal cord at this age).
In summary, our images suggest that Renshaw cell migration towards the
ventral root is a two step process in which the cells first position themselves at the
lateral edge of the spinal cord above motoneurons and then move to the ventral root exit
in a second step. This model clearly suggests the presence of a powerful attractor for
these cells in the ventral root exit zone.

Comparison with the migration of non-Renshaw V1 interneurons
The early migration of ventral INs (Leber and Sanes, 1995) and V1-INs (Matise
and Joyner, 1997) was initially proposed based also on static images from different
developmental stages. These authors postulated that the neurons leave the progenitor
area and migrate medio-laterally to the surface and then most migrate ventrally, settling
mostly medial to motor pools. Our analyses confirm this overall migratory behavior,
however the migration of Renshaw cells is quite different from that of other V1-INs.
The lack of markers for specific subgroups of V1-INs might have resulted in a global
description of migratory routes that includes those taken by several different
subpopulations. Non-Renshaw V1-INs seem to migrate in a ventro-lateral radial path.
This makes sense since this is the main orientation taken by radial glial cells after the
growth imposed by cell additions in the ventral spinal cord (Cajal, 1995). These cells
then stop far away from the ventral root exit zone. There are several possible
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explanations. One is that they have lower chemotropism for this region, another that
they cannot pass the motor pools which then will be acting like a barrier. Finally, it is
possible that a signal to stop migration is triggered before they can reach the ventral
root exit zone. In this case signals that propel migration could be as important as
guidance molecules for the final position of the cells.

Mechanisms that permit migration
Recently,

Bortone

and

Polleux

(2009)

demonstrated

that

prior

to

synaptogenesis, migrating cortical INs respond to ambient GABA, likely released in a
paracrine manner. During migration, GABA strongly depolarizes the neurons and
stimulates motility, but later as the potassium-chloride cotransporter KCC2 is
upregulated, GABA signaling is interpreted as a stop signal. This study pointed out the
importance of distinguishing between molecules that attract INs to their final
destination from permissive mechanism that allow the INs to actually migrate.
In the spinal cord, KCC2 is first detected in the developing ventral horn at
E11.5 (Delpy et al., 2008) and therefore it is possible that in resemblance to the
mechanisms found in the cortex GABA provides a signal to stop migration once a
certain level of internal chloride concentration is reached. However, it is clear that at
this early age the effects of GABA and glycine are still depolarizing in ventral neurons
(Scain et al., 2010). It will be interesting to study the relationships between chloride
homeostasis and IN migration in the spinal cord ventral horn. It is important to note that
V1-INs are a likely source of paracrine GABA release in this early spinal cord. In this
sense, they might autoregulate their own migration.
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Mechanisms and significance of Renshaw cells ventral root chemotropism
It is unclear what signals attract developing Renshaw cells into the ventral root,
but our observations indicate it is a powerful one. One possibility is that the signals are
provided by the motor axon themselves, for example released acethylcholine. But there
are also alternative possibilities since the presence of molecular cues in this region is
necessary for the motor axons themselves to pierce the surface of the neural tube
precisely at this point. Whether the signals are provided by some intrinsic motoneuron
factor or by other cells outside the neural tube surrounding or in the vicinity of this area
is unknown. What is clear is that this attractor positions developing Renshaw cells in
the right place to interact with motor axons and this could be the basis of the specific
synaptic coupling between motor axons and Renshaw cells. Up-to-date and despite
some evidence of possible alternative INs that could be more weakly linked to motor
axons (Machaceck and Hochman, 2006; O‟Donovan et al., 2010), Renshaw cells
remain the main spinal interneuronal target of motoneurons. The results from this aim
suggest that their special birth-date and migratory route might be responsible for
establishing this strong linkage. Moreover this might influence their final differentiation
since they upregulate the transcription factor MafB once they reach this position.
A migration dependent on birthdate that then defines specific patterns of
synaptic connections has already been suggested in other parts of the central nervous
system. One example are gonadotropin-releasing hormone (GnRH) neurons from the
hypothalamus (Jasoni et al., 2009). These authors postulate that first generated neurons
settle more rostrally than later-generated neurons and this defines their activity and
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modulation in the adult. Furthermore, recent studies in cortical INs in the mouse
telencephalon have shown that the transcriptional control of interneuronal development
results from the interplay between migration and time of differentiation (Butt et al.,
2007; Leone et al., 2008).
Overall our experiments suggest there are two main groups of V1-derived INs,
early and late generated from the p1 domain. The early generated V1-derived INs,
which include among others Renshaw cells and big-calbindin-IR cells, are generated in
between E9.5 and E10.5. Both populations upregulate calbindin expression right after
they become postmitotic cells and as they leave the progenitor area. In the case of the
Renshaw cells, they will extend lateral projections to the surface of the spinal cord in a
first step and then once they reach the surface they will project ventrally and locate
their cell bodies in between the motor pools and motor axon exit. At this time they
upregulate MafB expression. The late generated V1-derived INs, which will include
IaINs, are generated mostly between E10.5 and E12.0, with its maximum at E12.0.
These cells upregulated the Foxp2 transcription factor immediately as the cells become
postmitotic and take a more diagonal path towards their final positions settling just
medial to the lateral motoneuron pools.
In conclusion, our study suggests that Renshaw cells and IaINs are
differentiated early during embryonic development, exiting the cell cycle at different
times, expressing different transcription factors and following distinct migratory
pathways to reach their final locations.
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CONCLUSIONS
In this thesis, we hypothesized that Renshaw cells and IaINs differentiate from
each other early during embryonic development. We determined that:

1. Different classes of V1 INs have different birth dates. Renshaw cells are the
earliest group and are born at the same time as motoneurons. V1-derived IaINs are
generated later and through a much broader window time. There were no apparent
differences in generation time between lower and upper lumbar segments.

2. Foxp2 and MafB are transcription factor that divide V1-INs into two nonoverlapping populations. MafB is present in 100% of Renshaw cells, although is not
exclusive of this cell type at P0. FoxP2 is expressed at P5 in several V1 and non-V1
ventral IN populations including 70% of V1-derived IaINs that we can recognize with
histological criteria. Both transcription factors are expressed early during development,
pointing to an early differentiation of both subtypes. MafB expression in Renshaw cells
appears after the cells migrate and reach their final locations. In contrast, FoxP2 is
upregulated in late-generated V1-INs before migration and as they become postmitotic
and exit the progenitor area. Interestingly, calbindin is upregulated in early generated
V1-INs, including Renshaw cells, as they become postmitotic and before migration.
Calbindin expression is therefore an earlier marker of phenotypic differentiation in
Renshaw cells than MafB.
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3. V1-IN migration depends on time of exit from the cell cycle. Renshaw cells
are generated very early and migrate in two steps, first straight from the progenitor area
to the lateral edge of the spinal cord and then send projections to the ventral motor axon
exit where they finally relocate their cell bodies. Later generated neurons follow a
diagonal path towards the motor pools and stop medial to motor pools or in between
them.

Overall our experiments support the idea that there are two main groups of V1derived INs, early and late generated. The early generated V1-derived INs, which
include among others Renshaw cells and big-calbindin-IR cells, are generated in
between E9.5 and E10.5. Both populations upregulate calbindin expression right after
they become postmitotic cells and as they leave the progenitor area. In the case of the
Renshaw cells, they will migrate ventrally towards the ventral root region. When they
reach their final position they upregulate MafB. The late generated V1-derived INs,
which will include IaINs, are generated mostly between E10.5 and E12.0, with its
maximum at E12.0. These cells express the transcription factor FoxP2 immediately
after they become postmitotic and take a ventro-lateral diagonal path towards their final
positions settling just medial and dorsal to the lateral motoneuron pools.
In conclusion, our study shows that Renshaw cells and IaINs are differentiated
early during embryonic development, exit the cell cycle at different times, express
different transcription factors and follow distinct migratory pathways to reach their
final locations. Time of birth, transcription factor expression and migration all seem
interrelated in directing the differentiation of these subclasses of V1-INs.
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Figure 55. Summary of Renshaw cell and V1-derived IaIN differentiation. A) At
E10.5 calbindin-IR V1-INs exit the progenitor area and extend projections, first
laterally, then ventrally to the area in between motor pools and motor axon exit. B) At
E11.5 differentiating Renshaw cells have migrated ventrally through the lateral edge of
the spinal cord and position themselves at the motor axon exit region. A few upregulate
MafB expression at this age but only once they have reached their final location. In
addition, other calbindin-IR V1-INs are located more medially to motoneurons. Finally,
there are new V1-INs exiting the progenitor area and these are calbindin negative and
upregulate FoxP2 expression. C) At E12 more FoxP2 positive V1-INs leave the
progenitor area and MafB is clearly expressed by all Renshaw cells. D) At E12.5 there
are no more V1-INs added from the progenitor area. FoxP2 V1-INs finalize their
migration and start to differentiate. They remain different from Renshaw cells and other
calbindin-IR V1-INs. V1 cells have reached at this age their final position in relation to
the motor pools. E) At P0/ P5, MafB and FoxP2 start to downregulate. MafB is present
in calbindin-IR V1-INs that receive strong input from motor axons. FoxP2 is present in
more dorsal V1-INs that receive inputs from Ia afferents and some can be defined as
V1-derived IaINs. F) At P15 Renshaw cells and V1-derived IaINs have matured and
Mafb and FoxP2 are downregulated.
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